Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
signal peptide processing (GO:0006465),7/25,1.6625190058737664e-4,0.848383448697383,0,0,5.6000000000000005,48.73123609977917,IMMP1L;SPCS3;SPCS2;PROS1;FURIN;F2;GAS6
apoptotic cell clearance (GO:0043277),6/26,0.0014960500995122165,1,0,0,4.615384615384615,30.022739589285415,XKR8;ITGB3;RHOG;HMGB1;RAC1;GAS6
cellular response to light stimulus (GO:0071482),10/66,0.0015400571002888613,1,0,0,3.0303030303030303,19.62404783374038,YY1;KDM1A;PDE6G;ERCC4;NEDD4;GNB1;CNGA1;INO80;AURKB;TAF1
cellular defense response (GO:0006968),9/56,0.0017147470665692054,1,0,0,3.2142857142857144,20.47014543950664,SPN;NCR2;GNLY;KLRC4;CLEC5A;CD300C;LILRB2;KIR3DL2;CCR3
negative regulation of cytokinesis (GO:0032466),3/6,0.0022241766503380937,1,0,0,10,61.08368476639271,E2F7;AURKB;E2F8
positive regulation of protein acetylation (GO:1901985),3/6,0.0022241766503380937,1,0,0,10,61.08368476639271,FAM161A;KAT5;RAPGEF3
signal transduction involved in DNA damage checkpoint (GO:0072422),4/13,0.003089430511931893,1,0,0,6.153846153846154,35.56780618709874,BABAM1;CDC5L;BRCA1;DTL
positive regulation of insulin receptor signaling pathway (GO:0046628),3/7,0.0037478971295969244,1,0,0,8.571428571428571,47.88480310052898,IRS1;PRKCZ;INS
DNA synthesis involved in DNA repair (GO:0000731),9/65,0.004852134353358818,1,0,0,2.769230769230769,14.755393655941617,RAD51B;BARD1;KAT5;UBA7;UBB;RPA3;WRNIP1;BRCA1;DTL
negative regulation of protein metabolic process (GO:0051248),7/43,0.005091984867777607,1,0,0,3.255813953488372,17.19098278622693,PRNP;ITGB3;IRAK3;FMN2;LILRB2;EGFR;INS
negative regulation of cellular component organization (GO:0051129),8/54,0.00511337968954388,1,0,0,2.962962962962963,15.632280610371833,DNAJB2;DFFA;DDX3X;DNAJB6;IRAK3;PRKCZ;NOP53;RAPGEF3
endoderm development (GO:0007492),4/15,0.005444864346461733,1,0,0,5.333333333333333,27.803106327047363,DUSP1;TBX20;SOX7;MIXL1
angiogenesis involved in wound healing (GO:0060055),3/8,0.005774732022768516,1,0,0,7.5,38.65697569976054,ITGB3;NDNF;HPSE
late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),3/8,0.005774732022768516,1,0,0,7.5,38.65697569976054,LEPROT;TMEM50B;VPS25
cardiac ventricle development (GO:0003231),4/16,0.006976160030101439,1,0,0,5,24.82628326271881,HEYL;SALL1;HES1;STRA6
artery development (GO:0060840),4/16,0.006976160030101439,1,0,0,5,24.82628326271881,HOXA1;HES1;TGFBR1;STRA6
regulation of protein acetylation (GO:1901983),3/9,0.008342411451160579,1,0,0,6.666666666666666,31.90935307720135,FAM161A;KAT5;RAPGEF3
engulfment of apoptotic cell (GO:0043652),3/9,0.008342411451160579,1,0,0,6.666666666666666,31.90935307720135,XKR8;RHOG;RAC1
negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),4/17,0.008766901403579476,1,0,0,4.705882352941176,22.2906910717708,PRNP;CD300A;PTPRJ;PTPN2
negative regulation of cytokine production (GO:0001818),12/110,0.008890716934843255,1,0,0,2.1818181818181817,10.30417655480451,RPS6KA4;PRNP;CYLD;KAT5;UBA7;UBB;GPNMB;IRAK3;HMGB1;RAC1;F2;GAS6
positive regulation of stress fiber assembly (GO:0051496),6/37,0.00947038015667372,1,0,0,3.2432432432432434,15.11217155458284,TGFB3;FHOD1;LPAR1;RAC1;TGFBR1;RAPGEF3
modulation by host of viral transcription (GO:0043921),5/27,0.009967540662847309,1,0,0,3.7037037037037033,17.06822740434755,CCNT1;CCL3;RRP1B;CHD1;POU2F3
Rap protein signal transduction (GO:0032486),3/10,0.011479073193892965,1,0,0,5.999999999999999,26.803377741534163,RAPGEF1;RAPGEF2;RAPGEF3
negative regulation of protein maturation (GO:1903318),3/10,0.011479073193892965,1,0,0,5.999999999999999,26.803377741534163,PRNP;SERPINE2;GAS1
actin filament-based transport (GO:0099515),3/10,0.011479073193892965,1,0,0,5.999999999999999,26.803377741534163,SUN2;MYO5A;MYO19
regulation of astrocyte differentiation (GO:0048710),3/10,0.011479073193892965,1,0,0,5.999999999999999,26.803377741534163,SERPINE2;HES1;F2
ventricular septum development (GO:0003281),5/28,0.011645740044549789,1,0,0,3.571428571428571,15.902910097331779,HEYL;SALL1;HES1;TGFBR1;STRA6
DNA biosynthetic process (GO:0071897),6/39,0.012216841663084205,1,0,0,3.076923076923077,13.55366096929348,BARD1;RAD51B;KAT5;WRNIP1;BRCA1;TYMS
endothelial cell development (GO:0001885),4/19,0.01318872540853091,1,0,0,4.2105263157894735,18.224812421427043,RAPGEF1;RAPGEF2;F2RL1;RAPGEF3
cognition (GO:0050890),6/40,0.013780888720110962,1,0,0,2.9999999999999996,12.853417565998171,GTF2A1L;TTC8;HOXA1;LINS1;INS;STRA6
response to ionizing radiation (GO:0010212),9/77,0.014429387177365874,1,0,0,2.3376623376623376,9.908154644608496,BABAM1;RAD51B;PRKAA1;KAT5;ERCC4;FIGNL1;DMC1;BRCA1;INO80
negative regulation of cell division (GO:0051782),3/11,0.015204352818016067,1,0,0,5.454545454545454,22.833673759197463,E2F7;AURKB;E2F8
response to sterol (GO:0036314),3/11,0.015204352818016067,1,0,0,5.454545454545454,22.833673759197463,SMAD2;CCL3;TGFBR1
rhodopsin mediated signaling pathway (GO:0016056),3/11,0.015204352818016067,1,0,0,5.454545454545454,22.833673759197463,PDE6G;GNB1;CNGA1
cellular response to cAMP (GO:0071320),5/30,0.01555659746473132,1,0,0,3.333333333333333,13.877568186921728,KCNE1;RAPGEF1;RAPGEF2;AHR;RAPGEF3
cellular response to organic cyclic compound (GO:0071407),13/135,0.017785006611426558,1,0,0,1.9259259259259258,7.760324966506788,KCNE1;AHR;BRCA1;EGFR;KAT5;GNB1;NRIP1;RAPGEF1;CCL3;RAPGEF2;DRD1;RAPGEF3;TAF1
establishment of endothelial barrier (GO:0061028),4/21,0.018817877540921516,1,0,0,3.8095238095238093,15.135039725595712,RAPGEF1;RAPGEF2;F2RL1;RAPGEF3
pulmonary valve morphogenesis (GO:0003184),3/12,0.01953037772410442,1,0,0,5,19.678920967843133,HEYL;TBX20;STRA6
signal transduction involved in G2 DNA damage checkpoint (GO:0072425),3/12,0.01953037772410442,1,0,0,5,19.678920967843133,BABAM1;BRCA1;DTL
positive regulation of DNA-dependent DNA replication (GO:2000105),3/12,0.01953037772410442,1,0,0,5,19.678920967843133,INO80;E2F7;E2F8
negative regulation of fatty acid metabolic process (GO:0045922),3/12,0.01953037772410442,1,0,0,5,19.678920967843133,ERLIN2;BRCA1;INS
cyclic-nucleotide-mediated signaling (GO:0019935),5/32,0.020257193169988103,1,0,0,3.125,12.185141656980141,GUCY1B2;KSR1;RAPGEF2;AHR;RAPGEF3
regulation of potassium ion transmembrane transport (GO:1901379),5/32,0.020257193169988103,1,0,0,3.125,12.185141656980141,KCNE1;CAB39;KCNIP2;NEDD4;KCNIP4
positive regulation of actin filament bundle assembly (GO:0032233),6/44,0.021431508882189775,1,0,0,2.727272727272727,10.480617442273918,TGFB3;FHOD1;LPAR1;RAC1;TGFBR1;RAPGEF3
negative regulation of sequence-specific DNA binding transcription factor activity (GO:0043433),13/140,0.023287956211958078,1,0,0,1.8571428571428572,6.982520912387565,PRNP;KDM1A;SETD6;IRAK3;COMMD7;PARP10;CYLD;HEYL;NLRP9;IRAK2;GAS6;TNFRSF4;TAF1
regulation of cAMP-dependent protein kinase activity (GO:2000479),3/13,0.02446267254220388,1,0,0,4.615384615384615,17.125877967461363,PRKAR1B;ATP2B4;RAPGEF2
cellular response to catecholamine stimulus (GO:0071870),4/23,0.025734894590821872,1,0,0,3.4782608695652173,12.730112841155169,GNB1;ATP2B4;MAPK1;DRD1
negative regulation of T cell proliferation (GO:0042130),4/24,0.02969412469495944,1,0,0,3.333333333333333,11.722686914871057,SPN;PRNP;GPNMB;LILRB2
oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),3/14,0.030000982735417972,1,0,0,4.285714285714286,15.027964885753896,ALG8;ALG12;ALG11
negative regulation of T cell receptor signaling pathway (GO:0050860),3/14,0.030000982735417972,1,0,0,4.285714285714286,15.027964885753896,PRNP;PTPRJ;PTPN2
protein phosphorylation (GO:0006468),33/470,0.031590578954330976,1,0,0,1.4042553191489362,4.851556558616737,PRKAA1;CCNT1;CAB39;NLK;PRKCZ;EGFR;AURKB;RPS6KA4;NUAK2;IRAK2;RPS6KA2;TLK1;MAPK1;MAP3K8;CAMK2G;MARK1;SRPK2;SMAD2;KSR1;NEK6;DCLK3;GTF2H1;IRAK3;TNNI3K;KSR2;MERTK;TGFBR1;SBK1;PRKAR1B;FAM20C;TOP1;GAS6;TAF1
glycosaminoglycan metabolic process (GO:0030203),7/61,0.03192067196399525,1,0,0,2.2950819672131146,7.905413175681799,EXT1;EXT2;FUCA1;HPSE;HSPG2;DCN;HS3ST2
negative regulation of MAP kinase activity (GO:0043407),7/61,0.03192067196399525,1,0,0,2.2950819672131146,7.905413175681799,RGS4;UCHL1;RGS3;CD300A;DUSP1;PTPRJ;IRAK3
regulation of DNA replication (GO:0006275),7/61,0.03192067196399525,1,0,0,2.2950819672131146,7.905413175681799,CCDC88A;KITLG;TGFB3;ZBTB38;TERF1;EGFR;INS
endoderm formation (GO:0001706),5/36,0.032227243715029656,1,0,0,2.7777777777777777,9.541508627909957,DUSP1;LAMA3;TBX20;SOX7;MIXL1
regulation of glomerular filtration (GO:0003093),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,F2RL1;GAS6
neuron projection maintenance (GO:1990535),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,PRNP;INS
histone-serine phosphorylation (GO:0035404),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,RPS6KA4;AURKB
prepulse inhibition (GO:0060134),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,GRID2;DRD1
"regulation of phagocytosis, engulfment (GO:0060099)",2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,CD300A;F2RL1
"heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,EXT1;EXT2
cellular response to monoamine stimulus (GO:0071868),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,GNB1;DRD1
negative regulation of meiotic cell cycle (GO:0051447),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,DUSP1;FBXO43
ceramide transport (GO:0035627),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,PSAP;PLEKHA8
immune response-inhibiting cell surface receptor signaling pathway (GO:0002767),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,CLEC12B;LILRB2
intermediate filament bundle assembly (GO:0045110),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,PKP2;NEFM
release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0014808),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,RYR1;CCL3
negative regulation of meiotic nuclear division (GO:0045835),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,ERCC4;FBXO43
response to catecholamine (GO:0071869),2/6,0.032750693472061776,1,0,0,6.666666666666666,22.792207616037423,GNB1;DRD1
heterotypic cell-cell adhesion (GO:0034113),4/25,0.03399335307152362,1,0,0,3.1999999999999997,10.821088868398542,ITGB3;ITGAX;PKP2;LILRB2
in utero embryonic development (GO:0001701),4/25,0.03399335307152362,1,0,0,3.1999999999999997,10.821088868398542,FUT8;TGFB3;TGFBR1;MYH6
peptidyl-tyrosine dephosphorylation (GO:0035335),4/25,0.03399335307152362,1,0,0,3.1999999999999997,10.821088868398542,DUSP1;PTPRJ;DUSP28;PTPN2
peptide metabolic process (GO:0006518),10/104,0.0352278515074907,1,0,0,1.9230769230769231,6.434458217753877,BACE1;GSTZ1;IMMP1L;SPCS3;SPCS2;GSTO2;PROS1;FURIN;F2;GAS6
transforming growth factor beta receptor signaling pathway (GO:0007179),8/76,0.03570450311581481,1,0,0,2.1052631578947367,7.01574412727019,SMAD2;COL1A2;UBB;TGFB3;FURIN;NLK;PRKCZ;TGFBR1
regulation of mRNA metabolic process (GO:1903311),3/15,0.03614002285058795,1,0,0,4,13.281417446154263,SRPK2;PTCD2;SAFB2
"phototransduction, visible light (GO:0007603)",3/15,0.03614002285058795,1,0,0,4,13.281417446154263,PDE6G;GNB1;CNGA1
mesenchyme morphogenesis (GO:0072132),3/15,0.03614002285058795,1,0,0,4,13.281417446154263,SMAD2;HEYL;TBX20
response to cholesterol (GO:0070723),3/15,0.03614002285058795,1,0,0,4,13.281417446154263,SMAD2;CCL3;TGFBR1
positive regulation of cellular response to insulin stimulus (GO:1900078),3/15,0.03614002285058795,1,0,0,4,13.281417446154263,IRS1;PRKCZ;INS
negative regulation of protein processing (GO:0010955),3/15,0.03614002285058795,1,0,0,4,13.281417446154263,PRNP;SERPINE2;GAS1
embryonic cranial skeleton morphogenesis (GO:0048701),3/15,0.03614002285058795,1,0,0,4,13.281417446154263,EIF4A3;HOXA1;TGFBR1
positive regulation of protein export from nucleus (GO:0046827),3/15,0.03614002285058795,1,0,0,4,13.281417446154263,TPR;GAS6;RAPGEF3
regulation of protein catabolic process (GO:0042176),9/91,0.03805819725018905,1,0,0,1.9780219780219779,6.465439353425976,BARD1;NEDD4;IRAK3;FURIN;FMN2;DTL;OAZ1;EGFR;INS
strand displacement (GO:0000732),4/26,0.038635239533284925,1,0,0,3.076923076923077,10.01104762372913,BARD1;RAD51B;KAT5;BRCA1
regulation of T cell receptor signaling pathway (GO:0050856),4/26,0.038635239533284925,1,0,0,3.076923076923077,10.01104762372913,PRNP;CD300A;PTPRJ;PTPN2
peptidyl-lysine methylation (GO:0018022),3/16,0.04287015534900723,1,0,0,3.75,11.81092265495912,SETD6;EEF2KMT;EEF1AKMT2
regulation of SMAD protein import into nucleus (GO:0060390),3/16,0.04287015534900723,1,0,0,3.75,11.81092265495912,TGFB3;TGFBR1;PBLD
negative regulation of peptide hormone secretion (GO:0090278),3/16,0.04287015534900723,1,0,0,3.75,11.81092265495912,IRS1;BMP8A;CRH
positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),3/16,0.04287015534900723,1,0,0,3.75,11.81092265495912,RAD51B;DTL;RAB11A
regulation of signal transduction by p53 class mediator (GO:1901796),12/138,0.04396024596576249,1,0,0,1.7391304347826086,5.433860094338856,BARD1;PRKAA1;KAT5;UBB;SETD9;ERCC4;RPA3;BRCA1;NOP53;ZNF385A;AURKB;TAF1
phosphate ion transmembrane transport (GO:0035435),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,SLC20A1;XPR1
regulation of chromatin assembly or disassembly (GO:0001672),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,PARP10;TLK1
cellular response to interferon-alpha (GO:0035457),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,TPR;GAS6
regulation of dendritic spine maintenance (GO:1902950),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,PRNP;INS
regulation of DNA endoreduplication (GO:0032875),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,E2F7;E2F8
release of sequestered calcium ion into cytosol by endoplasmic reticulum (GO:1903514),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,RYR1;CCL3
nuclear body organization (GO:0030575),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,SRPK2;AFF2
strand invasion (GO:0042148),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,RAD51B;DMC1
formation of translation preinitiation complex (GO:0001731),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,EIF4H;DENR
regulation of histone H3-K9 acetylation (GO:2000615),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,ZNF451;BRCA1
regulation of dendritic cell differentiation (GO:2001198),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,HMGB1;LILRB2
adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,GNB1;DRD1
forebrain neuron differentiation (GO:0021879),2/7,0.04435183521490911,1,0,0,5.7142857142857135,17.803435376080927,SALL1;RAPGEF2
spindle assembly (GO:0051225),8/80,0.046246853342135685,1,0,0,2,6.147523706367922,HAUS8;KIFC1;NEK6;HAUS4;HAUS3;HAUS6;INO80;RAB11A
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),5/40,0.04785273553053826,1,0,0,2.5,7.599067484612446,UBB;PTPRJ;VPS25;EGFR;PTPN2
response to cAMP (GO:0051591),5/40,0.04785273553053826,1,0,0,2.5,7.599067484612446,KCNE1;RAPGEF1;RAPGEF2;AHR;RAPGEF3
negative regulation of catabolic process (GO:0009895),5/40,0.04785273553053826,1,0,0,2.5,7.599067484612446,PRKAA1;IRAK3;FMN2;EGFR;INS
regulation of cholesterol biosynthetic process (GO:0045540),5/40,0.04785273553053826,1,0,0,2.5,7.599067484612446,PRKAA1;GPAM;NFYC;ERLIN2;ACACB
negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845),6/53,0.04794761992015593,1,0,0,2.2641509433962264,6.87768931830856,SMAD2;ZNF451;UBB;BAMBI;TGFBR1;PBLD
positive regulation of protein import into nucleus (GO:0042307),6/53,0.04794761992015593,1,0,0,2.2641509433962264,6.87768931830856,TGFB3;BAMBI;TPR;F2;TGFBR1;EGFR
regulation of mRNA processing (GO:0050684),4/28,0.04895013769244342,1,0,0,2.8571428571428568,8.619865991683946,SRPK2;CPSF4;PTCD2;SAFB2
negative regulation of protein serine/threonine kinase activity (GO:0071901),7/67,0.04938993805127162,1,0,0,2.08955223880597,6.285391018194011,UCHL1;MYOCD;PRKAR1B;CD300A;DUSP1;PTPRJ;IRAK3
cellular response to UV (GO:0034644),7/67,0.04938993805127162,1,0,0,2.08955223880597,6.285391018194011,YY1;KDM1A;ERCC4;NEDD4;INO80;AURKB;TAF1
phosphorylation (GO:0016310),27/386,0.049999502526916,1,0,0,1.398963730569948,4.190934716205156,PRKAA1;CCNT1;DGKA;NLK;PRKCZ;AURKB;RPS6KA4;NUAK2;IRAK2;RPS6KA2;TLK1;MAPK1;MAP3K8;MARK1;SRPK2;KSR1;NEK6;IRAK3;TNNI3K;KSR2;MERTK;TGFBR1;PRKAR1B;FAM20C;TOP1;GAS6;TAF1
positive regulation of cell cycle G2/M phase transition (GO:1902751),3/17,0.05017800549335433,1,0,0,3.5294117647058822,10.56062995015536,RAD51B;DTL;RAB11A
positive regulation of focal adhesion assembly (GO:0051894),3/17,0.05017800549335433,1,0,0,3.5294117647058822,10.56062995015536,COL16A1;PTPRJ;RAC1
pigment granule transport (GO:0051904),3/17,0.05017800549335433,1,0,0,3.5294117647058822,10.56062995015536,BBS2;MYO5A;RAB11A
negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),3/17,0.05017800549335433,1,0,0,3.5294117647058822,10.56062995015536,F2RL1;GAS6;PTPN2
positive regulation by host of viral transcription (GO:0043923),3/17,0.05017800549335433,1,0,0,3.5294117647058822,10.56062995015536,CCNT1;RRP1B;CHD1
synaptic vesicle transport (GO:0048489),3/17,0.05017800549335433,1,0,0,3.5294117647058822,10.56062995015536,SNAPIN;TMEM230;PLD2
melanosome transport (GO:0032402),3/17,0.05017800549335433,1,0,0,3.5294117647058822,10.56062995015536,BBS2;MYO5A;RAB11A
"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",8/82,0.05220786888704381,1,0,0,1.951219512195122,5.7610186351061445,CNOT6L;KAT5;UBB;SFN;BRCA1;ZNF385A;E2F7;E2F8
positive regulation of DNA metabolic process (GO:0051054),8/82,0.05220786888704381,1,0,0,1.951219512195122,5.7610186351061445,BABAM1;KITLG;TGFB3;HMGB1;BRCA1;EGFR;GNL3;INS
negative regulation of proteolysis (GO:0045861),5/41,0.05234904272896249,1,0,0,2.4390243902439024,7.194686897103624,PRNP;SERPINE2;GAS1;F2;INS
peptidyl-threonine phosphorylation (GO:0018107),7/68,0.05279047635145934,1,0,0,2.0588235294117645,6.0558739225566685,SBK1;DCLK3;MAPK1;NLK;CAMK2G;TGFBR1;TAF1
protein alkylation (GO:0008213),4/29,0.05462119016329882,1,0,0,2.758620689655172,8.020229995291032,KIN;METTL21C;EEF2KMT;EEF1AKMT2
negative regulation of lymphocyte proliferation (GO:0050672),4/29,0.05462119016329882,1,0,0,2.758620689655172,8.020229995291032,SPN;GPNMB;CD300A;LILRB2
respiratory system development (GO:0060541),4/29,0.05462119016329882,1,0,0,2.758620689655172,8.020229995291032,SMCHD1;BASP1;STRA6;CCDC40
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),6/55,0.05575129370727072,1,0,0,2.1818181818181817,6.298591992871788,SMAD2;ZNF451;UBB;BAMBI;TGFBR1;PBLD
DNA recombination (GO:0006310),6/55,0.05575129370727072,1,0,0,2.1818181818181817,6.298591992871788,RAD51B;BARD1;KAT5;DMC1;HMGB1;BRCA1
response to UV (GO:0009411),9/98,0.056454519179306425,1,0,0,1.836734693877551,5.279363146414378,YY1;KDM1A;ERCC4;NEDD4;INO80;DTL;EGFR;AURKB;TAF1
late endosome to vacuole transport (GO:0045324),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,LEPROT;TMEM50B
DNA recombinase assembly (GO:0000730),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,RAD51B;DMC1
negative regulation of glial cell differentiation (GO:0045686),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,HES1;F2
regulation of amyloid precursor protein catabolic process (GO:1902991),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,PRNP;TMED10
positive regulation of behavior (GO:0048520),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,CRH;STRA6
DNA repair complex assembly (GO:0090735),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,RAD51B;DMC1
protein K6-linked ubiquitination (GO:0085020),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,BARD1;BRCA1
bundle of His cell to Purkinje myocyte communication (GO:0086069),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,PKP2;TNNI3K
T-helper cell lineage commitment (GO:0002295),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,SPN;SLAMF6
nodal signaling pathway (GO:0038092),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,SMAD2;TDGF1P3
positive regulation of catenin import into nucleus (GO:0035413),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,BAMBI;EGFR
double-strand break repair via synthesis-dependent strand annealing (GO:0045003),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,RAD51B;DMC1
regulation of long term synaptic depression (GO:1900452),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,GRID2;LILRB2
nose development (GO:0043584),2/8,0.05721089072209802,1,0,0,5,14.305055007400815,SMCHD1;STRA6
establishment of melanosome localization (GO:0032401),3/18,0.058047017485584544,1,0,0,3.333333333333333,9.488339835095955,BBS2;MYO5A;RAB11A
homologous chromosome segregation (GO:0045143),3/18,0.058047017485584544,1,0,0,3.333333333333333,9.488339835095955,RNF212;TERB2;FMN2
response to nutrient levels (GO:0031667),3/18,0.058047017485584544,1,0,0,3.333333333333333,9.488339835095955,PRKAA1;UCN3;INS
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),3/18,0.058047017485584544,1,0,0,3.333333333333333,9.488339835095955,NEDD4;UBAP1;VPS25
peptidyl-serine phosphorylation (GO:0018105),12/145,0.05982997262042847,1,0,0,1.6551724137931034,4.661376875922358,SBK1;CAB39;NEK6;DCLK3;MAPK1;TOP1;NLK;GAS6;PRKCZ;CAMK2G;TGFBR1;TAF1
chordate embryonic development (GO:0043009),6/56,0.059923284693461636,1,0,0,2.142857142857143,6.031478835629902,KIAA1217;FUT8;TGFB3;BRCA1;TGFBR1;MYH6
regulation of cation transmembrane transport (GO:1904062),4/30,0.06063113352204076,1,0,0,2.6666666666666665,7.474524702251736,KCNE1;KCNIP2;KCNIP4;ATP2B4
regulation of intracellular estrogen receptor signaling pathway (GO:0033146),4/30,0.06063113352204076,1,0,0,2.6666666666666665,7.474524702251736,KMT2D;GPAM;BRCA1;KCTD6
artery morphogenesis (GO:0048844),4/30,0.06063113352204076,1,0,0,2.6666666666666665,7.474524702251736,HOXA1;HES1;TGFBR1;STRA6
regulation of blood coagulation (GO:0030193),4/30,0.06063113352204076,1,0,0,2.6666666666666665,7.474524702251736,SERPINE2;F2RL1;HPSE;F2
substantia nigra development (GO:0021762),5/43,0.06205452849740553,1,0,0,2.325581395348837,6.4645157873716,BASP1;ERCC4;NDUFS3;PLP1;CKB
positive regulation of protein phosphorylation (GO:0001934),28/412,0.062341467415660476,1,0,0,1.3592233009708736,3.7720192741880827,CCNT1;CAB39;ITGB3;LPAR1;HMGB1;LRP8;EGFR;INS;RPS6KA4;GPNMB;THPO;MAPK1;RAC1;TNFRSF4;PRNP;KSR1;TGFB3;BMP8A;OSM;ATP2B4;KSR2;F2;MERTK;TGFBR1;RAPGEF2;ROR2;GAS6;RAPGEF3
recombinational repair (GO:0000725),7/71,0.06385495665821075,1,0,0,1.9718309859154928,5.424785208031492,YY1;RAD51B;MORF4L1;ERCC4;RPA3;BRCA1;INO80
regulation of mitochondrial fission (GO:0090140),3/19,0.06645795649124922,1,0,0,3.157894736842105,8.561639256247336,BNIP3;MYO19;DCN
DNA double-strand break processing (GO:0000729),3/19,0.06645795649124922,1,0,0,3.157894736842105,8.561639256247336,BARD1;KAT5;BRCA1
positive regulation of adherens junction organization (GO:1903393),3/19,0.06645795649124922,1,0,0,3.157894736842105,8.561639256247336,COL16A1;PTPRJ;RAC1
activin receptor signaling pathway (GO:0032924),3/19,0.06645795649124922,1,0,0,3.157894736842105,8.561639256247336,SMAD2;TDGF1P3;TGFBR1
positive regulation of neuron apoptotic process (GO:0043525),3/19,0.06645795649124922,1,0,0,3.157894736842105,8.561639256247336,SRPK2;PRNP;CCL3
regulation of protein export from nucleus (GO:0046825),4/31,0.06697579978121662,1,0,0,2.5806451612903225,6.976577863571356,BARD1;TPR;GAS6;RAPGEF3
extracellular matrix organization (GO:0030198),17/229,0.06786867440369677,1,0,0,1.4847161572052403,3.9941547508837534,COL16A1;ITGB3;LAMA3;HTRA1;ICAM4;NDNF;FURIN;HSPG2;TGFBR1;DCN;ADAMTS5;COL1A2;COL4A4;ADAM12;ITGAX;PECAM1;GAS6
protein localization to cell periphery (GO:1990778),10/117,0.068277612477489,1,0,0,1.7094017094017093,4.58833050993522,BBS2;TMEM88;KCNIP4;PKP2;MAP7;MYO5A;RAPGEF2;PIGW;GAS6;RAB11A
negative regulation of phagocytosis (GO:0050765),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,CD300A;HMGB1
regulation of macrophage cytokine production (GO:0010935),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,TGFB3;IRAK3
sarcoplasmic reticulum calcium ion transport (GO:0070296),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,RYR1;CCL3
regulation of interleukin-1 secretion (GO:0050704),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,HMGB1;GAS6
positive regulation of coagulation (GO:0050820),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,HPSE;F2
potassium ion export (GO:0071435),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,KCNE1;KCNIP2
cellular response to dopamine (GO:1903351),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,MAPK1;DRD1
negative regulation of mRNA 3'-end processing (GO:0031441),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,BARD1;CCNT1
response to dopamine (GO:1903350),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,MAPK1;DRD1
epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,CFAP53;CCDC40
positive regulation of astrocyte differentiation (GO:0048711),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,SERPINE2;HES1
oogenesis (GO:0048477),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,KMT2D;FMN2
atrioventricular valve development (GO:0003171),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,HEYL;TBX20
positive regulation of hemostasis (GO:1900048),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,HPSE;F2
negative regulation of lipid localization (GO:1905953),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,ITGB3;PTPN2
positive regulation of vascular endothelial cell proliferation (GO:1905564),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,HMGB1;APLN
neuron projection organization (GO:0106027),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,PRNP;INS
fatty acid homeostasis (GO:0055089),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,PRKAA1;INS
DNA topological change (GO:0006265),2/9,0.07117333236542388,1,0,0,4.444444444444444,11.745053671792467,HMGB1;TOP1
protein N-linked glycosylation (GO:0006487),7/73,0.07195616104041558,1,0,0,1.917808219178082,5.0470924764132885,ALG8;KCNE1;FUT8;MAN1C1;SYVN1;ALG12;ASGR2
G2 DNA damage checkpoint (GO:0031572),4/32,0.07364989211173907,1,0,0,2.5,6.521081502381298,BABAM1;BRCA1;DTL;NOP53
negative regulation of innate immune response (GO:0045824),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,IRAK3;PTPN2;INS
mesoderm formation (GO:0001707),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,SMAD2;ITGB3;TBX20
inactivation of MAPK activity (GO:0000188),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,RGS4;RGS3;DUSP1
melanosome localization (GO:0032400),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,BBS2;MYO5A;RAB11A
heparan sulfate proteoglycan metabolic process (GO:0030201),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,EXT1;EXT2;HPSE
negative regulation of interferon-gamma production (GO:0032689),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,PRNP;HMGB1;GAS6
cellular response to estradiol stimulus (GO:0071392),3/20,0.07538936106098607,1,0,0,2.9999999999999996,7.755267341732064,KAT5;NRIP1;EGFR
protein methylation (GO:0006479),5/46,0.07838227433911542,1,0,0,2.1739130434782608,5.535124934351927,KIN;METTL21C;EEF2KMT;RAB6A;EEF1AKMT2
RNA secondary structure unwinding (GO:0010501),5/46,0.07838227433911542,1,0,0,2.1739130434782608,5.535124934351927,DDX3X;EIF4A3;DDX23;DDX42;DDX54
regulation of stress fiber assembly (GO:0051492),6/60,0.07841676268446238,1,0,0,2,5.091435129458053,TGFB3;FHOD1;LPAR1;RAC1;TGFBR1;RAPGEF3
cAMP-mediated signaling (GO:0019933),7/75,0.08063866676431897,1,0,0,1.8666666666666667,4.699850414889133,UCN3;KSR1;PTGER1;RAPGEF2;AHR;DRD1;RAPGEF3
entry into host cell (GO:0030260),4/33,0.08064706826013496,1,0,0,2.4242424242424243,6.103449276278521,UBB;ITGB3;GAS6;CBLL1
regulation of cell-substrate adhesion (GO:0010810),4/33,0.08064706826013496,1,0,0,2.4242424242424243,6.103449276278521,FZD4;NDNF;RSU1;RAC1
positive regulation of nucleocytoplasmic transport (GO:0046824),4/33,0.08064706826013496,1,0,0,2.4242424242424243,6.103449276278521,NEDD4;TPR;GAS6;RAPGEF3
regulation of cytokine-mediated signaling pathway (GO:0001959),8/90,0.0808316388583679,1,0,0,1.7777777777777777,4.4717987912343435,CYLD;IFNA7;UBB;IRAK2;IRAK3;GAS6;USP18;PTPN2
regulation of cytosolic calcium ion concentration (GO:0051480),11/137,0.0821398931296985,1,0,0,1.605839416058394,4.013524990777432,RYR1;PTGER1;LPAR1;ATP2B4;F2RL1;FPR3;CCL1;SELENOT;HMGB1;F2;CCR3
positive regulation of leukocyte chemotaxis (GO:0002690),6/61,0.08348906656118887,1,0,0,1.9672131147540983,4.884668055906092,EDN3;CCL3;F2RL1;CCL1;HMGB1;GAS6
negative regulation of cellular biosynthetic process (GO:0031327),5/47,0.08428928588938157,1,0,0,2.127659574468085,5.26276705761003,ATP2B4;RAPGEF2;BRCA1;ERLIN2;INS
postreplication repair (GO:0006301),5/47,0.08428928588938157,1,0,0,2.127659574468085,5.26276705761003,UBA7;UBB;RPA3;BRCA1;DTL
embryonic skeletal system morphogenesis (GO:0048704),3/21,0.08481794993785322,1,0,0,2.8571428571428568,7.049280242253078,OSR2;EIF4A3;TGFBR1
regulation of nuclear division (GO:0051783),3/21,0.08481794993785322,1,0,0,2.8571428571428568,7.049280242253078,CDC16;FBXO43;OBSL1
ventricular septum morphogenesis (GO:0060412),3/21,0.08481794993785322,1,0,0,2.8571428571428568,7.049280242253078,HEYL;HES1;TGFBR1
"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",3/21,0.08481794993785322,1,0,0,2.8571428571428568,7.049280242253078,ERCC4;RPA3;GTF2H1
double-strand break repair via homologous recombination (GO:0000724),7/76,0.08519720761440963,1,0,0,1.8421052631578945,4.536712195036593,YY1;RAD51B;MORF4L1;ERCC4;RPA3;BRCA1;INO80
adrenal gland development (GO:0030325),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,SALL1;STRA6
regulation of coagulation (GO:0050818),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,F2RL1;F2
glycine metabolic process (GO:0006544),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,TDH;GCAT
nerve growth factor signaling pathway (GO:0038180),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,RAPGEF1;RAPGEF2
regulation of respiratory burst (GO:0060263),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,RAC1;INS
positive regulation of glucose import in response to insulin stimulus (GO:2001275),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,IRS1;INS
mesenchymal to epithelial transition (GO:0060231),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,SALL1;BASP1
negative regulation of inclusion body assembly (GO:0090084),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,DNAJB2;DNAJB6
positive regulation of glial cell differentiation (GO:0045687),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,SERPINE2;HES1
cellular copper ion homeostasis (GO:0006878),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,PRNP;ATOX1
positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,KMT2D;TAF1
regulation of dendritic cell apoptotic process (GO:2000668),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,RAPGEF2;GAS6
pulmonary valve development (GO:0003177),2/10,0.08609691405925976,1,0,0,4,9.809126838186547,HEYL;STRA6
positive regulation of cell cycle process (GO:0090068),9/107,0.08740344947079064,1,0,0,1.6822429906542054,4.099997152379927,EDN3;SOX15;TPR;INO80;BRCA1;AURKB;E2F7;INS;E2F8
regulation of insulin receptor signaling pathway (GO:0046626),4/34,0.08796002427126849,1,0,0,2.352941176470588,5.719700793788988,IRS1;PRKCZ;PTPN2;INS
anterior/posterior pattern specification (GO:0009952),4/34,0.08796002427126849,1,0,0,2.352941176470588,5.719700793788988,SMAD2;BASP1;TDGF1P3;TGFBR1
"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",6/62,0.08873881335310585,1,0,0,1.9354838709677418,4.687854010251747,CNOT6L;UBB;SFN;ZNF385A;E2F7;E2F8
cytoplasmic microtubule organization (GO:0031122),5/48,0.0904238200779985,1,0,0,2.0833333333333335,5.006765728864707,CCDC88A;KATNAL1;FIGNL1;STMN3;RAB11A
interstrand cross-link repair (GO:0036297),5/48,0.0904238200779985,1,0,0,2.0833333333333335,5.006765728864707,UBB;ERCC4;RPA3;FANCB;FANCF
carbohydrate homeostasis (GO:0033500),6/63,0.09416438282354153,1,0,0,1.9047619047619047,4.500406229636559,PRKAA1;IRS1;PDK4;SELENOT;PTPN2;INS
positive regulation of cell projection organization (GO:0031346),6/63,0.09416438282354153,1,0,0,1.9047619047619047,4.500406229636559,SCARB2;RAPGEF1;RAPGEF2;NDNF;SERPINI1;INS
signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431),6/63,0.09416438282354153,1,0,0,1.9047619047619047,4.500406229636559,CNOT6L;UBB;SFN;ZNF385A;E2F7;E2F8
NAD biosynthetic process (GO:0009435),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,PARP10;NMNAT1;RNLS
"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,ERCC4;RPA3;GTF2H1
negative regulation of protein import into nucleus (GO:0042308),3/22,0.09471898702745883,1,0,0,2.727272727272727,6.427747642616689,PARP10;GAS6;PBLD
circulatory system development (GO:0072359),9/109,0.0954227547053641,1,0,0,1.651376146788991,3.879806218422705,FOXC2;SALL1;ADAP2;PKP2;TDGF1P3;HSPG2;TGFBR1;MIXL1;STRA6
positive regulation of DNA replication (GO:0045740),4/35,0.09558057758683013,1,0,0,2.2857142857142856,5.366367183732389,KITLG;TGFB3;EGFR;INS
negative regulation of protein complex assembly (GO:0031333),4/35,0.09558057758683013,1,0,0,2.2857142857142856,5.366367183732389,DDX3X;PRKCZ;NOP53;INS
non-recombinational repair (GO:0000726),5/49,0.0967823010309069,1,0,0,2.0408163265306123,4.765900289809773,BABAM1;BARD1;KAT5;ERCC4;BRCA1
positive regulation of transcription from RNA polymerase II promoter (GO:0045944),51/848,0.09839207924728047,1,0,0,1.2028301886792452,2.78911659562582,DDX3X;CCNT1;KDM1A;FHOD1;BRCA1;HMGB1;AHR;ELK4;RPS6KA4;SALL1;KAT5;SOX15;EPC1;HOXA1;PITX2;OSR2;FOXD2;MYOCD;ZBTB38;EBF1;DCN;GNL3;RFX4;HOXB2;HOXB7;KMT2D;FOXC2;EGFR;UBB;GALR2;NRIP1;HES1;E2F7;E2F8;SMAD2;GSX1;TGFB3;OSM;CDC5L;GTF2H1;ERLIN2;INO80;RRP1B;POU2F3;APLN;NR4A2;HEYL;F2RL1;SP7;MIXL1;TAF1
macroautophagy (GO:0016236),9/110,0.09958757105985591,1,0,0,1.6363636363636362,3.7746293084737976,VMP1;PRKAA1;UBB;MTMR14;LIX1L;AMBRA1;VPS25;ATG12;TECPR1
L-phenylalanine metabolic process (GO:0006558),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,GSTZ1;IL4I1
L-phenylalanine catabolic process (GO:0006559),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,GSTZ1;IL4I1
negative regulation of blood vessel diameter (GO:0097756),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,EDN3;INS
regulation of inclusion body assembly (GO:0090083),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,DNAJB2;DNAJB6
negative regulation of fatty acid biosynthetic process (GO:0045717),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,ERLIN2;BRCA1
cell-substrate junction assembly (GO:0007044),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,LAMA3;KRT5
negative regulation of histone acetylation (GO:0035067),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,ZNF451;BRCA1
negative regulation of nucleocytoplasmic transport (GO:0046823),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,BARD1;TPR
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,KDM1A;ZNF385A
photoreceptor cell development (GO:0042461),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,RP1L1;MYO7A
establishment of synaptic vesicle localization (GO:0097480),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,SNAPIN;TMEM230
positive regulation of glucose metabolic process (GO:0010907),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,IRS1;PTPN2
embryonic hemopoiesis (GO:0035162),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,KITLG;THPO
hemidesmosome assembly (GO:0031581),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,LAMA3;KRT5
erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,GSTZ1;IL4I1
protein carboxylation (GO:0018214),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,PROS1;F2
peptidyl-glutamic acid carboxylation (GO:0017187),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,PROS1;F2
cardiac muscle cell membrane repolarization (GO:0099622),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,KCNE1;KCNIP2
membrane repolarization during action potential (GO:0086011),2/11,0.10185083146627981,1,0,0,3.6363636363636362,8.306348991662196,KCNE1;KCNIP2
double-strand break repair via nonhomologous end joining (GO:0006303),5/50,0.10336068197068972,1,0,0,2,4.5390612819119465,BABAM1;BARD1;KAT5;ERCC4;BRCA1
regulation of potassium ion transport (GO:0043266),4/36,0.10349974906541197,1,0,0,2.222222222222222,5.040413535040945,KCNE1;KCNIP2;KCNIP4;DRD1
regulation of nitric-oxide synthase activity (GO:0050999),4/36,0.10349974906541197,1,0,0,2.222222222222222,5.040413535040945,ATP2B4;EGFR;CYGB;INS
"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",4/36,0.10349974906541197,1,0,0,2.222222222222222,5.040413535040945,FZD4;PDE6G;GNB1;NLK
cardiac muscle tissue morphogenesis (GO:0055008),4/36,0.10349974906541197,1,0,0,2.222222222222222,5.040413535040945,TBX20;S1PR1;PKP2;MYH6
positive regulation of protein kinase B signaling (GO:0051897),10/127,0.10391551943251265,1,0,0,1.574803149606299,3.565633107235882,KITLG;THPO;IRS1;CCL3;PTPRJ;HPSE;GAS6;TGFBR1;EGFR;INS
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),7/80,0.10486246218988873,1,0,0,1.7499999999999998,3.9464349249119546,NEDD4;MAPK1;F2RL1;NOP53;DCN;EGFR;INS
negative regulation of viral transcription (GO:0032897),3/23,0.10506660809461679,1,0,0,2.6086956521739126,5.877810696891578,CCL3;POU2F3;MID2
lamellipodium assembly (GO:0030032),3/23,0.10506660809461679,1,0,0,2.6086956521739126,5.877810696891578,CCDC88A;S1PR1;RAC1
regulation of monooxygenase activity (GO:0032768),3/23,0.10506660809461679,1,0,0,2.6086956521739126,5.877810696891578,POR;EGFR;CYGB
positive regulation of cell junction assembly (GO:1901890),3/23,0.10506660809461679,1,0,0,2.6086956521739126,5.877810696891578,COL16A1;PTPRJ;RAC1
cellular macromolecule biosynthetic process (GO:0034645),24/367,0.10938273015598082,1,0,0,1.307901907356948,2.8942590880740413,BARD1;TSFM;GTF3C2;ALAS2;PABPC4;BRCA1;TYMS;PWP1;RPS15;EXT1;MRPL52;NR4A2;EXT2;FAM111A;KIN;MRPL51;KAT5;ERCC4;RPA3;EPC1;POLR2F;RPL15;TOP1;RPL29
intracellular steroid hormone receptor signaling pathway (GO:0030518),6/66,0.1114753492102168,1,0,0,1.8181818181818181,3.9890032651653162,KAT5;MED30;NEDD4;NRIP1;DDX54;BRCA1
positive regulation of cellular protein localization (GO:1903829),6/66,0.1114753492102168,1,0,0,1.8181818181818181,3.9890032651653162,CCDC88A;TPR;F2;OAZ1;GNL3;INS
"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",4/37,0.11170784333278796,1,0,0,2.1621621621621623,4.739174827095357,UBB;ERCC4;RPA3;GTF2H1
regulation of macromolecule metabolic process (GO:0060255),10/129,0.1121294602199553,1,0,0,1.5503875968992247,3.3924049308497413,SRPK2;NLRP9;DDX3X;EDN3;EIF4A3;MAPK1;AHR;NLK;AFF2;INS
protein localization to organelle (GO:0033365),8/97,0.11221289529851242,1,0,0,1.6494845360824741,3.608012142083881,BBS2;OBSCN;DDX3X;RAB6A;OBSL1;RAB11A;CNTLN;GET4
regulation of intracellular signal transduction (GO:1902531),27/422,0.1137968510625483,1,0,0,1.2796208530805686,2.7810517331214184,PRKAA1;SETD9;ARHGAP19;BRCA1;EGFR;AURKB;NLRP9;KAT5;UBB;MAPK1;SRGAP3;RAC1;ZNF385A;BARD1;SPHKAP;TGFB3;BMP8A;RHOG;CYLD;ARHGAP10;OBSCN;ERCC4;RPA3;ARHGEF3;F2RL1;NOP53;TAF1
negative regulation of NF-kappaB transcription factor activity (GO:0032088),7/82,0.11553692430953495,1,0,0,1.7073170731707317,3.6846721375201086,PARP10;CYLD;NLRP9;IRAK2;SETD6;IRAK3;COMMD7
positive regulation of cell cycle arrest (GO:0071158),7/82,0.11553692430953495,1,0,0,1.7073170731707317,3.6846721375201086,CNOT6L;UBB;SFN;BRCA1;ZNF385A;E2F7;E2F8
ear morphogenesis (GO:0042471),3/24,0.11583411237416653,1,0,0,2.5,5.388990442839107,OSR2;SALL1;HOXA1
camera-type eye development (GO:0043010),3/24,0.11583411237416653,1,0,0,2.5,5.388990442839107,CRYBA4;PITX2;STRA6
"protein alpha-1,2-demannosylation (GO:0036508)",3/24,0.11583411237416653,1,0,0,2.5,5.388990442839107,UBB;SYVN1;MAN1C1
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),3/24,0.11583411237416653,1,0,0,2.5,5.388990442839107,KDM1A;DDIAS;ZNF385A
cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),3/24,0.11583411237416653,1,0,0,2.5,5.388990442839107,CYLD;UBB;IRAK2
regulation of cell cycle G1/S phase transition (GO:1902806),3/24,0.11583411237416653,1,0,0,2.5,5.388990442839107,ATP2B4;INO80;TAF1
protein localization to plasma membrane (GO:0072659),10/130,0.11637022564102487,1,0,0,1.5384615384615385,3.309197799796174,BBS2;TMEM88;KCNIP4;PKP2;MAP7;MYO5A;RAPGEF2;PIGW;GAS6;RAB11A
positive regulation of autophagy (GO:0010508),6/67,0.11758211344423333,1,0,0,1.7910447761194028,3.8339433163846697,PRKAA1;BNIP3;WAC;GNAI3;MID2;DCN
histone H3-K9 demethylation (GO:0033169),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,KDM4A;KDM1A
negative regulation of oxidoreductase activity (GO:0051354),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,DAOA;INS
carbohydrate derivative transport (GO:1901264),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,SLC17A5;SLC29A2
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,KDM1A;ZNF385A
UDP-N-acetylglucosamine metabolic process (GO:0006047),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,SLC35A3;RENBP
protein insertion into membrane (GO:0051205),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,EGFR;GET4
entry of bacterium into host cell (GO:0035635),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,UBB;CBLL1
cellular response to arsenic-containing substance (GO:0071243),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,DDX3X;GSTO2
regulation of actomyosin structure organization (GO:0110020),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,FHOD1;RAC1
skeletal muscle fiber development (GO:0048741),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,RYR1;ACTA1
regulation of bone remodeling (GO:0046850),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,ITGB3;S1PR1
negative regulation by host of viral transcription (GO:0043922),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,CCL3;POU2F3
cytoplasmic translational initiation (GO:0002183),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,EIF4H;DENR
negative regulation of vascular smooth muscle cell proliferation (GO:1904706),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,TGFB3;APLN
"regulation of protein import into nucleus, translocation (GO:0033158)",2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,PARP10;GAS6
ribosomal subunit export from nucleus (GO:0000054),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,RPS15;NOP53
regulation of vascular endothelial cell proliferation (GO:1905562),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,HMGB1;APLN
regulation of hormone secretion (GO:0046883),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,EDN3;OSM
endosome transport via multivesicular body sorting pathway (GO:0032509),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,LEPROT;TMEM50B
negative regulation of leukocyte apoptotic process (GO:2000107),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,MERTK;GAS6
positive regulation of SMAD protein import into nucleus (GO:0060391),2/12,0.1183149351744569,1,0,0,3.333333333333333,7.114684225538833,TGFB3;TGFBR1
negative regulation of signal transduction (GO:0009968),19/283,0.11853210394660882,1,0,0,1.342756183745583,2.8635234825899634,EGFL7;LEPROT;IRS1;PTPRJ;IRAK3;NLK;MERTK;PRKCZ;EGFR;KCTD6;DCN;APLN;DKK4;NR4A2;UBB;FRZB;NEDD4;ROR2;PTPN2
muscle filament sliding (GO:0030049),4/38,0.12019452718952628,1,0,0,2.1052631578947367,4.4603027132352775,ACTA1;TNNC2;TNNI1;MYH6
actin-myosin filament sliding (GO:0033275),4/38,0.12019452718952628,1,0,0,2.1052631578947367,4.4603027132352775,ACTA1;TNNC2;TNNI1;MYH6
positive regulation of DNA repair (GO:0045739),4/38,0.12019452718952628,1,0,0,2.1052631578947367,4.4603027132352775,BABAM1;HMGB1;BRCA1;EGFR
lamellipodium organization (GO:0097581),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,CCDC88A;S1PR1;RAC1
"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,CYLD;UBB;IRAK2
response to alcohol (GO:0097305),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,SMAD2;CCL3;TGFBR1
regulation of glucose metabolic process (GO:0010906),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,IRS1;PDK4;PDK1
female gamete generation (GO:0007292),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,KMT2D;DMC1;FMN2
regulation of apoptotic signaling pathway (GO:2001233),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,NR4A2;CYLD;TGFBR1
regulation of potassium ion transmembrane transporter activity (GO:1901016),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,KCNE1;CAB39;NEDD4
negative regulation of insulin receptor signaling pathway (GO:0046627),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,IRS1;PRKCZ;PTPN2
positive regulation of Rho protein signal transduction (GO:0035025),3/25,0.1269942219814603,1,0,0,2.4,4.9526728554420085,LPAR1;F2RL1;RAC1
heart development (GO:0007507),11/149,0.12713006204451544,1,0,0,1.476510067114094,3.045367874601788,FOXC2;MYOCD;SALL1;ADAP2;PKP2;TDGF1P3;TGFBR1;MYH6;MIXL1;STRA6;APLN
cellular response to transforming growth factor beta stimulus (GO:0071560),8/100,0.12742605989598135,1,0,0,1.5999999999999999,3.2963504079810266,SMAD2;COL1A2;UBB;TGFB3;FURIN;NLK;PRKCZ;TGFBR1
negative regulation of protein catabolic process (GO:0042177),4/39,0.1289489055490016,1,0,0,2.051282051282051,4.201721095583098,IRAK3;FMN2;EGFR;INS
regulation of type I interferon-mediated signaling pathway (GO:0060338),4/39,0.1289489055490016,1,0,0,2.051282051282051,4.201721095583098,ZBP1;IFNA7;USP18;PTPN2
positive regulation of phagocytosis (GO:0050766),4/39,0.1289489055490016,1,0,0,2.051282051282051,4.201721095583098,SPACA3;F2RL1;MERTK;GAS6
positive regulation of fat cell differentiation (GO:0045600),4/39,0.1289489055490016,1,0,0,2.051282051282051,4.201721095583098,FRZB;ZNF385A;INS;MEDAG
regulation of peptidyl-tyrosine phosphorylation (GO:0050730),7/85,0.13256322548057173,1,0,0,1.6470588235294117,3.3282044747059696,PRNP;ITGB3;OSM;LRP8;PRKCZ;EGFR;INS
regulation of acyl-CoA biosynthetic process (GO:0050812),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,PDK4;PDK1
regulation of plasma membrane bounded cell projection organization (GO:0120035),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,CCDC88A;FRMD7
nucleotide-sugar metabolic process (GO:0009225),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,FUT8;SLC35A3
glucosamine-containing compound metabolic process (GO:1901071),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,RENBP;CHST5
muscle cell development (GO:0055001),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,KDM1A;HES1
regulation of glucose import in response to insulin stimulus (GO:2001273),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,IRS1;INS
regulation of biomineral tissue development (GO:0070167),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,S1PR1;GAS6
positive regulation of glycogen biosynthetic process (GO:0045725),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,IRS1;INS
regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,PDK4;PDK1
placenta development (GO:0001890),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,E2F7;E2F8
"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,KAT5;BRCA1
copper ion homeostasis (GO:0055070),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,PRNP;ATOX1
phosphate ion transport (GO:0006817),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,SLC20A1;XPR1
synaptic vesicle localization (GO:0097479),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,SNAPIN;TMEM230
toll-like receptor 9 signaling pathway (GO:0034162),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,UNC93B1;IRAK2
membrane repolarization (GO:0086009),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,KCNE1;KCNIP2
negative regulation of reactive oxygen species biosynthetic process (GO:1903427),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,ATP2B4;INS
motile cilium assembly (GO:0044458),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,SPATA6;CCDC40
negative regulation of hormone secretion (GO:0046888),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,OSM;CRH
negative regulation of blood pressure (GO:0045776),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,RNLS;APLN
regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,ZNF451;TAF1
regulation of cellular carbohydrate metabolic process (GO:0010675),2/13,0.13537899404817505,1,0,0,3.076923076923077,6.1528525246417765,PDK4;PDK1
positive regulation of MAPK cascade (GO:0043410),19/289,0.1365446390437467,1,0,0,1.3148788927335637,2.618060217666568,EDN3;KSR1;LPAR1;OSM;HMGB1;KSR2;MERTK;PRKCZ;EGFR;INS;GPNMB;THPO;CCL3;RAPGEF2;F2RL1;CCL1;ROR2;GAS6;TNFRSF4
plasma membrane bounded cell projection organization (GO:0120036),9/118,0.13654988198303988,1,0,0,1.5254237288135593,3.0372182471277855,SNAPIN;FAM161A;NEDD4;PLP1;STMN3;RAPGEF2;HMGB1;RAC1;RAB11A
"nucleotide-excision repair, DNA incision (GO:0033683)",4/40,0.1379595947094308,1,0,0,2,3.961588857315027,UBB;ERCC4;RPA3;GTF2H1
positive regulation of epithelial to mesenchymal transition (GO:0010718),4/40,0.1379595947094308,1,0,0,2,3.961588857315027,SMAD2;TGFB3;BAMBI;TGFBR1
positive regulation of mitotic cell cycle phase transition (GO:1901992),4/40,0.1379595947094308,1,0,0,2,3.961588857315027,RAD51B;DDX3X;DTL;RAB11A
androgen receptor signaling pathway (GO:0030521),4/40,0.1379595947094308,1,0,0,2,3.961588857315027,MED30;KAT5;NRIP1;BRCA1
negative regulation of cytokine-mediated signaling pathway (GO:0001960),4/40,0.1379595947094308,1,0,0,2,3.961588857315027,F2RL1;IRAK3;GAS6;PTPN2
neuron migration (GO:0001764),4/40,0.1379595947094308,1,0,0,2,3.961588857315027,NR4A2;RAPGEF2;NDNF;MARK1
positive regulation of wound healing (GO:0090303),3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,FOXC2;HPSE;F2
negative regulation of cellular response to insulin stimulus (GO:1900077),3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,IRS1;PRKCZ;PTPN2
regulation of histone acetylation (GO:0035065),3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,RPS6KA4;MYOCD;BRCA1
endocrine system development (GO:0035270),3/26,0.1385193121264188,1,0,0,2.3076923076923075,4.561720443090936,SALL1;TGFBR1;STRA6
regulation of RNA splicing (GO:0043484),5/55,0.13937991022954382,1,0,0,1.8181818181818181,3.582821649166955,SRPK2;CLK1;RRP1B;AFF2;PTBP3
regulation of MAPK cascade (GO:0043408),14/203,0.13998325257717914,1,0,0,1.379310344827586,2.712044811002935,KSR1;DUSP1;TGFB3;LPAR1;BMP8A;OSM;HMGB1;KSR2;MERTK;EGFR;INS;MAPK1;ROR2;TNFRSF4
regulation of neuron projection development (GO:0010975),9/119,0.141612082259451,1,0,0,1.5126050420168065,2.956634281015857,SCARB2;CCDC88A;FRMD7;LPAR1;RAPGEF1;RAPGEF2;NDNF;SERPINI1;RTN4IP1
regulation of MAP kinase activity (GO:0043405),7/87,0.14456531199301625,1,0,0,1.6091954022988504,3.1122223475945634,UCHL1;EDN3;CD300A;DUSP1;PTPRJ;IRAK3;EGFR
spermatogenesis (GO:0007283),11/153,0.14464591030939392,1,0,0,1.437908496732026,2.7801479386463286,NPAP1;ADGRG2;DMC1;SPATA46;TDRD12;SPATA6;OR7C1;FKBP6;DEDD;TCFL5;FAM50A
peptidyl-serine modification (GO:0018209),12/170,0.14489126203534128,1,0,0,1.4117647058823528,2.727207155135461,SBK1;CAB39;NEK6;DCLK3;MAPK1;NDNF;TOP1;GAS6;PRKCZ;CAMK2G;TGFBR1;TAF1
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),5/56,0.14716977791840904,1,0,0,1.7857142857142856,3.4217292978951037,CYLD;UBB;F2RL1;GAS6;PTPN2
glycosaminoglycan catabolic process (GO:0006027),5/56,0.14716977791840904,1,0,0,1.7857142857142856,3.4217292978951037,FUCA1;SPACA3;HPSE;HSPG2;DCN
odontogenesis (GO:0042476),4/41,0.14721479282726987,1,0,0,1.951219512195122,3.7382684546071134,OSR2;COL1A2;TGFB3;PITX2
spliceosomal complex assembly (GO:0000245),4/41,0.14721479282726987,1,0,0,1.951219512195122,3.7382684546071134,SRPK2;DDX23;SNRPG;SMN1
positive regulation of viral transcription (GO:0050434),4/41,0.14721479282726987,1,0,0,1.951219512195122,3.7382684546071134,CCNT1;POLR2F;RRP1B;CHD1
regulation of GTPase activity (GO:0043087),13/188,0.14867924364464086,1,0,0,1.3829787234042552,2.63590768820473,RGS16;ARHGEF38;STMN3;RRP1B;DNMBP;PRR5-ARHGAP8;RAPGEF1;CCL3;RAPGEF2;F2RL1;CCL1;RSU1;RAPGEF3
male gamete generation (GO:0048232),11/154,0.1492134810124754,1,0,0,1.4285714285714284,2.717681771403963,NPAP1;ADGRG2;DMC1;SPATA46;TDRD12;SPATA6;OR7C1;FKBP6;DEDD;TCFL5;FAM50A
regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,GPAM;SAFB2;KCTD6
regulation of cilium assembly (GO:1902017),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,TCHP;CYLD;CCDC88A
negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,CD300A;PRKCZ;PTPN2
positive regulation of lipid kinase activity (GO:0090218),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,IRS1;AMBRA1;F2
peptidyl-glutamic acid modification (GO:0018200),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,TTLL7;PROS1;F2
protein targeting to vacuole (GO:0006623),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,SCARB2;TMEM50B;NEDD4
muscle fiber development (GO:0048747),3/27,0.15038161447469178,1,0,0,2.222222222222222,4.210175820273459,RYR1;ACTA1;MYH6
intermediate filament organization (GO:0045109),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,DNAJB6;PKP2
ubiquinone metabolic process (GO:0006743),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,COQ2;COQ9
myotube cell development (GO:0014904),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,RYR1;ACTA1
regulation of calcineurin-NFAT signaling cascade (GO:0070884),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,PRNP;ATP2B4
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,KDM1A;ZNF385A
thymus development (GO:0048538),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,HES1;TGFBR1
pancreas development (GO:0031016),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,SELENOT;CCDC40
N-acetylglucosamine metabolic process (GO:0006044),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,RENBP;CHST5
positive regulation of mitochondrial fission (GO:0090141),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,BNIP3;DCN
negative regulation of biomineral tissue development (GO:0070168),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,CCL3;GAS6
positive regulation of glycogen metabolic process (GO:0070875),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,IRS1;INS
cellular response to osmotic stress (GO:0071470),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,DDX3X;CAB39
quinone biosynthetic process (GO:1901663),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,COQ2;COQ9
regulation of fatty acid metabolic process (GO:0019217),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,PDK4;INS
"DNA damage response, signal transduction resulting in transcription (GO:0042772)",2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,KAT5;BRCA1
necroptotic process (GO:0070266),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,CYLD;TRPM7
regulation of synapse organization (GO:0050807),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,NEDD4;KLK8
regulation of protein modification by small protein conjugation or removal (GO:1903320),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,DNAJB2;TGFBR1
regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,DUSP1;TPR
positive regulation of blood vessel diameter (GO:0097755),2/14,0.15294200533335325,1,0,0,2.8571428571428568,5.364847084446157,F2RL1;INS
protein homotetramerization (GO:0051289),5/57,0.15514033768438892,1,0,0,1.7543859649122806,3.2691669601382802,RYR1;MCOLN1;ACACB;THG1L;GNMT
determination of left/right symmetry (GO:0007368),4/42,0.1567023472093967,1,0,0,1.9047619047619047,3.5302993347271023,TDGF1P3;PITX2;CFAP53;CCDC40
regulation of telomerase activity (GO:0051972),4/42,0.1567023472093967,1,0,0,1.9047619047619047,3.5302993347271023,PARM1;MAPK1;TERF1;AURKB
translesion synthesis (GO:0019985),4/42,0.1567023472093967,1,0,0,1.9047619047619047,3.5302993347271023,UBA7;UBB;RPA3;DTL
negative regulation of cellular protein metabolic process (GO:0032269),7/89,0.15706487379765424,1,0,0,1.5730337078651684,2.9118369551802306,DDX3X;SERPINE2;EIF4A3;ENC1;F2;TYMS;INS
peptidyl-threonine modification (GO:0018210),7/89,0.15706487379765424,1,0,0,1.5730337078651684,2.9118369551802306,SBK1;DCLK3;MAPK1;NLK;CAMK2G;TGFBR1;TAF1
regulation of protein complex assembly (GO:0043254),6/73,0.1575316394218323,1,0,0,1.643835616438356,3.03802020110663,DDX3X;FBLIM1;HJURP;PRKCZ;NOP53;MPP7
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway (GO:0051482),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,LPAR1;F2RL1;DRD1
positive regulation of protein tyrosine kinase activity (GO:0061098),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,PRNP;GAS6;LRP8
dopamine receptor signaling pathway (GO:0007212),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,GNB1;GNAI3;DRD1
regulation of fatty acid biosynthetic process (GO:0042304),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,PDK4;BRCA1;ERLIN2
nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),3/28,0.16255339603696525,1,0,0,2.142857142857143,3.893033014692501,CYLD;UBB;IRAK2
regulation of cell cycle process (GO:0010564),7/90,0.16349418407909133,1,0,0,1.5555555555555556,2.8170766721365488,CDC16;PRPF40A;FBXO43;OBSL1;MYO19;AURKB;RAB11A
glucose homeostasis (GO:0042593),6/74,0.1647057705275506,1,0,0,1.6216216216216217,2.924748009429989,PRKAA1;IRS1;PDK4;SELENOT;PTPN2;INS
cardiac ventricle morphogenesis (GO:0003208),4/43,0.16640981850387015,1,0,0,1.8604651162790697,3.336375343076965,HEYL;TBX20;PKP2;MYH6
negative regulation of ERBB signaling pathway (GO:1901185),4/43,0.16640981850387015,1,0,0,1.8604651162790697,3.336375343076965,UBB;PTPRJ;EGFR;PTPN2
negative regulation of DNA metabolic process (GO:0051053),4/43,0.16640981850387015,1,0,0,1.8604651162790697,3.336375343076965,DFFA;TGFB3;ERCC4;TERF1
digestive tract development (GO:0048565),4/43,0.16640981850387015,1,0,0,1.8604651162790697,3.336375343076965,SALL1;MIXL1;STRA6;CCDC40
regulation of interferon-gamma production (GO:0032649),4/43,0.16640981850387015,1,0,0,1.8604651162790697,3.336375343076965,PRNP;SLAMF6;HMGB1;GAS6
regulation of response to external stimulus (GO:0032101),8/107,0.16677126238578838,1,0,0,1.495327102803738,2.6783283615039006,SCARB2;NLRP9;PDE6G;SETD6;CNGA1;F2RL1;F2;USP18
double-strand break repair (GO:0006302),10/141,0.16866989291733908,1,0,0,1.4184397163120568,2.524555702946532,YY1;BARD1;BABAM1;RAD51B;MORF4L1;KAT5;ERCC4;RPA3;INO80;BRCA1
modification-dependent protein catabolic process (GO:0019941),10/141,0.16866989291733908,1,0,0,1.4184397163120568,2.524555702946532,UBL4A;RNF144B;UBA7;NEDD4;SYVN1;KLHL3;FBXO8;DTL;KCTD6;TAF1
positive regulation of peptidyl-lysine acetylation (GO:2000758),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,RPS6KA4;BRCA1
NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,PARP10;RNLS
membrane repolarization during cardiac muscle cell action potential (GO:0086013),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,KCNE1;KCNIP2
ubiquinone biosynthetic process (GO:0006744),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,COQ2;COQ9
apoptotic DNA fragmentation (GO:0006309),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,DFFA;HMGB1
heparan sulfate proteoglycan biosynthetic process (GO:0015012),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,EXT1;EXT2
epithelial cilium movement (GO:0003351),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,CFAP53;CCDC40
endocardial cushion morphogenesis (GO:0003203),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,HEYL;TBX20
positive regulation of glycolytic process (GO:0045821),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,PRKAA1;INS
negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,PTPRJ;PTPN2
positive regulation of CREB transcription factor activity (GO:0032793),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,RPS6KA4;LRP8
positive regulation of coenzyme metabolic process (GO:0051197),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,PRKAA1;INS
negative regulation of insulin secretion (GO:0046676),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,IRS1;BMP8A
ventricular cardiac muscle cell action potential (GO:0086005),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,KCNE1;PKP2
intracellular lipid transport (GO:0032365),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,ACACB;PLEKHA8
negative regulation of interleukin-2 production (GO:0032703),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,PRNP;KAT5
negative regulation of lipid catabolic process (GO:0050995),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,PRKAA1;INS
regulation of mitotic sister chromatid separation (GO:0010965),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,NEK6;TPR
negative regulation of platelet activation (GO:0010544),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,SERPINE2;F2
negative regulation of cytokine production involved in immune response (GO:0002719),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,TGFB3;IRAK3
positive regulation of collagen metabolic process (GO:0010714),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,TGFB3;F2
positive regulation of collagen biosynthetic process (GO:0032967),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,TGFB3;F2
regulation of protein complex disassembly (GO:0043244),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,BNIP3;IRAK3
positive regulation of potassium ion transport (GO:0043268),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,KCNE1;DRD1
regulation of peptide secretion (GO:0002791),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,LLGL1;INS
regulation of cell junction assembly (GO:1901888),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,RAPGEF1;RAPGEF2
establishment of protein localization to endoplasmic reticulum (GO:0072599),2/15,0.17091154886530205,1,0,0,2.6666666666666665,4.710957638403321,SPCS3;SPCS2
regulation of cytokine production (GO:0001817),8/108,0.17280406327587397,1,0,0,1.4814814814814814,2.6008843089787628,RPS6KA4;ZBP1;NLRP9;TMIGD2;UBB;GPNMB;LURAP1;CARD11
"nucleotide-excision repair, preincision complex assembly (GO:0006294)",3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,UBB;RPA3;GTF2H1
determination of bilateral symmetry (GO:0009855),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,TDGF1P3;PITX2;CFAP53
cardiac muscle cell action potential (GO:0086001),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,KCNE1;KCNIP2;PKP2
positive regulation of histone modification (GO:0031058),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,RPS6KA4;KDM1A;BRCA1
negative regulation of Notch signaling pathway (GO:0045746),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,EGFL7;UBB;EGFR
positive regulation of interleukin-1 secretion (GO:0050716),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,PANX1;CCL3;HMGB1
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,PAN2;CNOT6L;EIF4A3
regulation of activated T cell proliferation (GO:0046006),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,PRNP;TMIGD2;HMGB1
MyD88-dependent toll-like receptor signaling pathway (GO:0002755),3/29,0.17500711584969555,1,0,0,2.068965517241379,3.6060592632145636,UBB;IRAK2;IRAK3
positive regulation of macroautophagy (GO:0016239),4/44,0.17632454152329277,1,0,0,1.8181818181818181,3.155325447401995,BNIP3;GNAI3;WAC;DCN
negative regulation of type I interferon production (GO:0032480),4/44,0.17632454152329277,1,0,0,1.8181818181818181,3.155325447401995,YY1;CYLD;UBA7;UBB
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),10/144,0.18461991668402528,1,0,0,1.3888888888888888,2.346466766255298,SMAD2;COL1A2;UBB;TGFB3;BMP8A;FURIN;TDGF1P3;NLK;PRKCZ;TGFBR1
non-canonical Wnt signaling pathway (GO:0035567),9/127,0.18537679054393458,1,0,0,1.4173228346456692,2.388706043433952,UBB;FZD4;FRZB;PDE6G;GNB1;ROR2;RAC1;NLK;PSMA7
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),6/77,0.18702582489369443,1,0,0,1.5584415584415583,2.612740629548293,SMAD2;ZNF451;UBB;BAMBI;TGFBR1;PBLD
ERAD pathway (GO:0036503),6/77,0.18702582489369443,1,0,0,1.5584415584415583,2.612740629548293,SDF2L1;SYVN1;ERLIN2;UBXN4;GET4;RNF121
regulation of cytokinesis (GO:0032465),6/77,0.18702582489369443,1,0,0,1.5584415584415583,2.612740629548293,PRPF40A;MYO19;AURKB;E2F7;RAB11A;E2F8
hippo signaling (GO:0035329),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,MOB1B;AMOTL2;FAT4
regulation of leukocyte chemotaxis (GO:0002688),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,EDN3;F2RL1;MST1L
negative regulation of secretion by cell (GO:1903531),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,GRM7;OSM;INS
activation of protein kinase B activity (GO:0032148),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,CCDC88A;GAS6;INS
response to estradiol (GO:0032355),3/30,0.1877155615267818,1,0,0,2,3.345654864900365,KAT5;NRIP1;EGFR
negative regulation of immune effector process (GO:0002698),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,CD300A;INS
establishment of skin barrier (GO:0061436),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,SFN;RPTN
positive regulation of dendrite morphogenesis (GO:0050775),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,LRP8;OBSL1
embryonic digit morphogenesis (GO:0042733),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,OSR2;SALL1
histone H2A acetylation (GO:0043968),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,MORF4L1;EPC1
regulation of cell cycle phase transition (GO:1901987),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,ATP2B4;TAF1
regulation of water loss via skin (GO:0033561),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,SFN;RPTN
neuromuscular process (GO:0050905),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,HOXA1;STRA6
regulation of energy homeostasis (GO:2000505),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,PRKAA1;BMP8A
heme biosynthetic process (GO:0006783),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,ALAS2;CPOX
negative regulation of translational initiation (GO:0045947),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,TPR;C8ORF88
negative regulation of DNA replication (GO:0008156),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,TGFB3;TERF1
T cell migration (GO:0072678),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,S1PR1;CCL3
cardiac epithelial to mesenchymal transition (GO:0060317),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,HEYL;TGFBR1
embryonic heart tube development (GO:0035050),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,TBX20;HES1
negative regulation of lipid storage (GO:0010888),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,ITGB3;PTPN2
programmed necrotic cell death (GO:0097300),2/16,0.18920318276808346,1,0,0,2.5,4.1623345006609895,CYLD;TRPM7
positive regulation of sequence-specific DNA binding transcription factor activity (GO:0051091),14/215,0.18984526730970086,1,0,0,1.3023255813953487,2.1638737578312,MYOCD;KDM1A;FZD4;IRAK3;PRKCZ;LRP8;MID2;INS;RPS6KA4;UBB;IRAK2;NEUROG2;CARD11;TAF1
regulation of protein kinase B signaling (GO:0051896),11/163,0.19351846366375716,1,0,0,1.3496932515337423,2.2167123764108663,KITLG;THPO;IRS1;CCL3;PTPRJ;HPSE;GAS6;NOP53;TGFBR1;EGFR;INS
positive regulation of protein modification process (GO:0031401),11/163,0.19351846366375716,1,0,0,1.3496932515337423,2.2167123764108663,KAT5;FAM161A;THPO;GPNMB;ITGB3;RAC1;LILRB2;F2;GAS6;RAPGEF3;EGFR
extracellular matrix disassembly (GO:0022617),6/78,0.19471584243590756,1,0,0,1.5384615384615385,2.5172523099552775,ADAMTS5;LAMA3;HTRA1;FURIN;HSPG2;DCN
cellular response to ionizing radiation (GO:0071479),4/46,0.19672429496904084,1,0,0,1.7391304347826086,2.82774269288294,KDM1A;ERCC4;FIGNL1;INO80
regulation of G1/S transition of mitotic cell cycle (GO:2000045),4/46,0.19672429496904084,1,0,0,1.7391304347826086,2.82774269288294,DDX3X;GPNMB;INO80;E2F7
aminoglycan biosynthetic process (GO:0006023),4/46,0.19672429496904084,1,0,0,1.7391304347826086,2.82774269288294,EXT1;EXT2;HSPG2;HS3ST2
transcription elongation from RNA polymerase II promoter (GO:0006368),7/95,0.19731095294472298,1,0,0,1.4736842105263155,2.3917516785909614,CCNT1;POLR2F;ELOB;GTF2H1;MLLT3;GTF2E1;TAF1
diterpenoid metabolic process (GO:0016101),5/62,0.19745752815386772,1,0,0,1.6129032258064515,2.616502846917968,NAPEPLD;HSPG2;LRP8;PNLIP;STRA6
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),5/62,0.19745752815386772,1,0,0,1.6129032258064515,2.616502846917968,DDX3X;DDIAS;NDUFS3;SYVN1;INS
second-messenger-mediated signaling (GO:0019932),5/62,0.19745752815386772,1,0,0,1.6129032258064515,2.616502846917968,INPP5A;EDN3;CCL3;NDNF;KSR2
negative regulation of toll-like receptor signaling pathway (GO:0034122),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,CD300A;F2RL1;IRAK3
regulation of protein tyrosine kinase activity (GO:0061097),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,PRNP;GAS6;LRP8
positive regulation of viral genome replication (GO:0045070),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,SRPK2;DDX3X;FKBP6
regulation of protein autophosphorylation (GO:0031952),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,MOB1B;GPNMB;INS
sarcomere organization (GO:0045214),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,OBSCN;OBSL1;MYH6
liver development (GO:0001889),3/31,0.20065196718317338,1,0,0,1.9354838709677418,3.1087420224475646,E2F7;E2F8;CCDC40
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),6/79,0.20252260341125683,1,0,0,1.5189873417721518,2.425676623110086,SMAD2;ZNF451;UBB;BAMBI;TGFBR1;PBLD
positive regulation of developmental process (GO:0051094),8/113,0.20436439196106676,1,0,0,1.415929203539823,2.248284096927963,EDN3;BNIP3;LILRB2;MST1L;DCN;RAPGEF3;MIXL1;INS
kidney development (GO:0001822),5/63,0.20636211070548938,1,0,0,1.5873015873015872,2.504956879983314,OSR2;SALL1;C1GALT1;TGFBR1;STRA6
regulation of viral genome replication (GO:0045069),5/63,0.20636211070548938,1,0,0,1.5873015873015872,2.504956879983314,SRPK2;PARP10;FAM111A;DDX3X;FKBP6
regulation of telomere maintenance via telomere lengthening (GO:1904356),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,ERCC4;TERF1
response to interferon-alpha (GO:0035455),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,TPR;GAS6
positive regulation of lymphocyte migration (GO:2000403),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,SPN;CCL3
cardiac muscle cell contraction (GO:0086003),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,KCNE1;PKP2
positive regulation of interleukin-6 secretion (GO:2000778),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,F2RL1;HMGB1
regulation of lipid catabolic process (GO:0050994),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,PRKAA1;INS
negative regulation of telomere maintenance (GO:0032205),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,ERCC4;TERF1
positive regulation of monocyte chemotaxis (GO:0090026),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,CCL1;HMGB1
negative regulation of lipid biosynthetic process (GO:0051055),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,ERLIN2;BRCA1
gastrulation (GO:0007369),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,SMAD2;MIXL1
cardiac atrium morphogenesis (GO:0003209),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,TBX20;MYH6
positive regulation of hormone secretion (GO:0046887),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,EDN3;INS
N-glycan processing (GO:0006491),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,FUT8;MAN1C1
negative regulation of reactive oxygen species metabolic process (GO:2000378),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,BRCA1;INS
negative regulation of intracellular transport (GO:0032387),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,MRLN;CD300A
regulation of collagen biosynthetic process (GO:0032965),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,TGFB3;F2
pharyngeal system development (GO:0060037),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,HES1;TGFBR1
embryo development ending in birth or egg hatching (GO:0009792),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,OSR2;BRCA1
regulation of transcription from RNA polymerase I promoter (GO:0006356),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,RASL11A;TAF1
neurotrophin signaling pathway (GO:0038179),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,RAPGEF1;RAPGEF2
positive chemotaxis (GO:0050918),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,GPNMB;PTPRJ
positive regulation of telomere capping (GO:1904355),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,MAPK1;AURKB
viral entry into host cell (GO:0046718),2/17,0.20773987788556972,1,0,0,2.352941176470588,3.6975731035436015,ITGB3;GAS6
negative regulation of MAPK cascade (GO:0043409),6/80,0.21044099394584637,1,0,0,1.4999999999999998,2.337824968427116,UCHL1;CD300A;DUSP1;PTPRJ;IRAK3;PTPN2
protein targeting to ER (GO:0045047),7/97,0.21155364258994297,1,0,0,1.4432989690721647,2.241842635816865,RPS15;SRP19;SPCS3;SPCS2;RPL15;SEC62;RPL29
cellular response to organonitrogen compound (GO:0071417),7/97,0.21155364258994297,1,0,0,1.4432989690721647,2.241842635816865,KCNE1;RAPGEF1;RAPGEF2;AHR;BRCA1;RAPGEF3;TAF1
positive regulation of multicellular organismal process (GO:0051240),13/202,0.21226754057719424,1,0,0,1.2871287128712872,1.9949308523901688,SMAD2;TGFB3;LILRB2;MST1L;RAB11A;TGFBR1;TMIGD2;BAMBI;CRH;F2RL1;GAS6;LURAP1;CARD11
negative regulation of receptor activity (GO:2000272),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,HEYL;CLEC12B;VPS25
purine ribonucleoside triphosphate metabolic process (GO:0009205),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,FIGNL1;GNAI3;MYH6
positive regulation of telomere maintenance (GO:0032206),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,MAPK1;AURKB;GNL3
aminoglycan catabolic process (GO:0006026),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,FUCA1;HPSE;HSPG2
global genome nucleotide-excision repair (GO:0070911),3/32,0.21379011498548872,1,0,0,1.875,2.8926759681127634,UBB;ERCC4;GTF2H1
neuron projection development (GO:0031175),11/167,0.2149152187279412,1,0,0,1.3173652694610778,2.025464462435552,SNAPIN;UBB;NEDD4;RHOG;PLP1;STMN3;RAPGEF2;HMGB1;RAC1;KLK8;RAB11A
inorganic anion transmembrane transport (GO:0098661),5/64,0.21539586226514373,1,0,0,1.5625,2.3988714437251204,CLCN7;SLC20A1;SLC1A1;SLC26A11;XPR1
positive regulation of cell adhesion (GO:0045785),5/64,0.21539586226514373,1,0,0,1.5625,2.3988714437251204,FOXC2;PTPRJ;NDNF;RAC1;RSU1
protein deubiquitination (GO:0016579),16/257,0.2172028648864235,1,0,0,1.245136186770428,1.9012277054313118,BARD1;INO80C;SMAD2;USP48;USP5;USP21;INO80;BRCA1;USP18;PSMA7;TGFBR1;BABAM1;YY1;CYLD;UCHL1;UBB
pattern recognition receptor signaling pathway (GO:0002221),4/48,0.21779787247025076,1,0,0,1.6666666666666665,2.540313061339135,UNC93B1;IRAK2;IRAK3;HMGB1
negative regulation of cell cycle process (GO:0010948),6/81,0.21846581133310103,1,0,0,1.4814814814814814,2.253519624534179,EPC1;BRCA1;FBXO43;AURKB;E2F7;E2F8
histone modification (GO:0016570),7/98,0.21881398496006546,1,0,0,1.4285714285714284,2.1707618483434215,RPS6KA4;MORF4L1;KDM4A;KAT5;USP21;BRMS1L;AURKB
positive regulation of intracellular signal transduction (GO:1902533),28/479,0.2216170748952432,1,0,0,1.1691022964509394,1.761608337387452,IRS1;SLC20A1;LPAR1;PTPRJ;HMGB1;EGFR;INS;UBB;THPO;TSPAN6;CCL3;TNFRSF4;LURAP1;KSR1;NEK6;OSM;KSR2;MERTK;MID2;TGFBR1;DCN;KITLG;NEDD4;RAPGEF2;F2RL1;ROR2;HPSE;GAS6
positive regulation of cytosolic calcium ion concentration (GO:0007204),9/133,0.22164004840978987,1,0,0,1.3533834586466165,2.0391436915940395,PTGER1;LPAR1;F2RL1;FPR3;CCL1;SELENOT;DRD1;HMGB1;CCR3
regulation of cell division (GO:0051302),5/65,0.2245509341987312,1,0,0,1.5384615384615385,2.2979272602185437,PRPF40A;SFN;MYO19;AURKB;RAB11A
small GTPase mediated signal transduction (GO:0007264),7/99,0.2261619520902503,1,0,0,1.414141414141414,2.1021267756043183,DNMBP;KSR1;ARHGEF38;GNB1;RAPGEF2;KSR2;PLD2
porphyrin-containing compound biosynthetic process (GO:0006779),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,ALAS2;CPOX
mitotic recombination (GO:0006312),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,RAD51B;DMC1
regulation of amyloid-beta formation (GO:1902003),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,PRNP;TMED10
glucan biosynthetic process (GO:0009250),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,UBB;PGM2
negative regulation of fibroblast proliferation (GO:0048147),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,PARP10;CD300A
positive regulation of metabolic process (GO:0009893),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,ACACB;INS
anion homeostasis (GO:0055081),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,PRKAA1;INS
regulation of cardiac muscle cell proliferation (GO:0060043),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,TBX20;TGFBR1
insulin secretion (GO:0030073),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,SELENOT;CAMK2G
skeletal muscle contraction (GO:0003009),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,TNNC2;TNNI1
heart trabecula morphogenesis (GO:0061384),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,S1PR1;TGFBR1
dolichol-linked oligosaccharide biosynthetic process (GO:0006488),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,ALG8;ALG12
glycogen biosynthetic process (GO:0005978),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,UBB;PGM2
DNA conformation change (GO:0071103),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,HMGB1;TOP1
positive regulation of carbohydrate metabolic process (GO:0045913),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,PRKAA1;INS
piRNA metabolic process (GO:0034587),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,TDRD12;FKBP6
negative regulation of calcium-mediated signaling (GO:0050849),2/18,0.22645148897005046,1,0,0,2.222222222222222,3.3004989638462865,PRNP;ATP2B4
positive regulation of cell-matrix adhesion (GO:0001954),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,COL16A1;PTPRJ;RAC1
cellular response to glucose starvation (GO:0042149),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,PRKAA1;NUAK2;BHLHA15
embryonic organ morphogenesis (GO:0048562),3/33,0.22710442121127872,1,0,0,1.8181818181818181,2.695173385335862,OSR2;TBX20;HES1
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),4/49,0.22855481299593203,1,0,0,1.6326530612244896,2.4097619846443257,GNLY;DEFB126;RNASE7;F2
gonad development (GO:0008406),4/49,0.22855481299593203,1,0,0,1.6326530612244896,2.4097619846443257,KITLG;SALL1;BASP1;SOX15
cellular response to metal ion (GO:0071248),7/100,0.2335936861063974,1,0,0,1.4000000000000001,2.035840879866453,RYR1;PRNP;BNIP3;ZNF658;MAPK1;MCOLN1;EGFR
positive regulation of peptidyl-serine phosphorylation (GO:0033138),6/83,0.23481354624178025,1,0,0,1.4457831325301203,2.0948869879664898,IFNA7;OSM;ATP2B4;GAS6;RAPGEF3;EGFR
protein modification by small protein removal (GO:0070646),16/261,0.23511657448253095,1,0,0,1.2260536398467432,1.7749257639332798,BARD1;INO80C;SMAD2;USP48;USP5;USP21;INO80;BRCA1;USP18;PSMA7;TGFBR1;BABAM1;YY1;CYLD;UCHL1;UBB
calcium ion transport (GO:0006816),8/118,0.23800829236656018,1,0,0,1.3559322033898304,1.9463725614119634,RYR1;PANX1;CACNA1B;CCL3;ATP2B4;TRPM7;GAS6;MCOLN1
regulation of bone mineralization (GO:0030500),4/50,0.2394412597417243,1,0,0,1.5999999999999999,2.287115446802478,OSR2;TGFB3;S1PR1;CCL3
wound healing (GO:0042060),4/50,0.2394412597417243,1,0,0,1.5999999999999999,2.287115446802478,ITGB3;HPSE;TGFBR1;INS
heart morphogenesis (GO:0003007),4/50,0.2394412597417243,1,0,0,1.5999999999999999,2.287115446802478,HEYL;TBX20;HES1;TGFBR1
negative regulation of cellular metabolic process (GO:0031324),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,ITGB3;BRCA1;INS
regulation of wound healing (GO:0061041),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,TNFRSF12A;F2RL1;F2
ventricular cardiac muscle tissue morphogenesis (GO:0055010),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,PKP2;TGFBR1;MYH6
regulation of alcohol biosynthetic process (GO:1902930),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,GPAM;NFYC;ACACB
negative regulation of T cell activation (GO:0050868),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,SPN;GPNMB;LILRB2
macromolecule catabolic process (GO:0009057),3/34,0.24057000906593404,1,0,0,1.7647058823529411,2.5142543537821203,BACE1;NAPSA;NEDD4
protein processing (GO:0016485),7/101,0.24110527590989309,1,0,0,1.3861386138613863,1.9718121345751627,IMMP1L;SPCS3;SPCS2;PROS1;FURIN;F2;GAS6
intrinsic apoptotic signaling pathway (GO:0097193),7/101,0.24110527590989309,1,0,0,1.3861386138613863,1.9718121345751627,DDX3X;BNIP3;SFN;BRCA1;ZNF346;ZNF385A;PDK1
positive regulation of hydrolase activity (GO:0051345),11/172,0.24295245186518546,1,0,0,1.2790697674418605,1.80974241713587,DNAJB2;DNMBP;RGS16;ARHGEF38;RAPGEF1;CCL3;RAPGEF2;F2RL1;CCL1;RSU1;RAPGEF3
regulation of mitotic nuclear division (GO:0007088),6/84,0.2431257250643128,1,0,0,1.4285714285714284,2.020252260491723,EDN3;TPR;CDC16;FBXO43;OBSL1;INS
positive regulation of endothelial cell proliferation (GO:0001938),5/67,0.2431934021901658,1,0,0,1.4925373134328357,2.1102959080752326,EGFL7;ITGB3;HMGB1;TGFBR1;APLN
insulin receptor signaling pathway (GO:0008286),5/67,0.2431934021901658,1,0,0,1.4925373134328357,2.1102959080752326,FOXC2;IRS1;PDK4;PTPN2;INS
negative regulation of smoothened signaling pathway (GO:0045879),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,RFX4;KCTD6
positive regulation of chromosome organization (GO:2001252),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,TERF1;GNL3
primary alcohol metabolic process (GO:0034308),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,GDE1;NAPEPLD
regulation of gluconeogenesis (GO:0006111),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,PTPN2;INS
error-free translesion synthesis (GO:0070987),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,UBB;RPA3
positive regulation of heart contraction (GO:0045823),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,EDN3;APLN
endoplasmic reticulum mannose trimming (GO:1904380),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,UBB;SYVN1
protein targeting to lysosome (GO:0006622),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,SCARB2;NEDD4
regulation of long-term synaptic potentiation (GO:1900271),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,LILRB2;INS
positive regulation of activated T cell proliferation (GO:0042104),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,TMIGD2;HMGB1
acylglycerol biosynthetic process (GO:0046463),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,GPAM;MOGAT2
positive regulation of mononuclear cell migration (GO:0071677),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,CCL1;HMGB1
Rac protein signal transduction (GO:0016601),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,RHOG;RAC1
endocardial cushion development (GO:0003197),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,HEYL;TBX20
positive regulation of toll-like receptor signaling pathway (GO:0034123),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,F2RL1;HMGB1
negative regulation of lipid metabolic process (GO:0045833),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,PRKAA1;INS
cellular polysaccharide biosynthetic process (GO:0033692),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,EXT1;EXT2
positive regulation of blood coagulation (GO:0030194),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,HPSE;F2
positive regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902895),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,GNL3;APLN
triglyceride biosynthetic process (GO:0019432),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,GPAM;MOGAT2
regulation of catenin import into nucleus (GO:0035412),2/19,0.24527425978553977,1,0,0,2.1052631578947367,2.958691088070133,BAMBI;EGFR
detection of chemical stimulus involved in sensory perception (GO:0050907),7/102,0.24869276443562,1,0,0,1.3725490196078431,1.9099527754862085,OR4C45;OR4A47;OR4K17;OR4C15;OR7C1;OR4C3;OR4A16
protein polyubiquitination (GO:0000209),17/283,0.2517235860592716,1,0,0,1.2014134275618373,1.6572581244827387,BARD1;UBE3D;SYVN1;KLHL3;FBXL15;BRCA1;PSMA7;FBXL12;RNF144B;HECTD1;UBB;RUSC1;NEDD4;CDC16;DTL;RNF187;TAF1
DNA replication (GO:0006260),8/120,0.2519691354453672,1,0,0,1.3333333333333333,1.8379315698176057,BARD1;FAM111A;KIN;KAT5;ERCC4;RPA3;BRCA1;TOP1
regulation of epithelial to mesenchymal transition (GO:0010717),5/68,0.25266492029805,1,0,0,1.4705882352941175,2.023075137913094,SMAD2;TGFB3;BAMBI;TGFBR1;PBLD
protein sumoylation (GO:0016925),5/68,0.25266492029805,1,0,0,1.4705882352941175,2.023075137913094,RNF212;ZNF451;TPR;TOP1;AURKB
positive regulation of GTPase activity (GO:0043547),12/192,0.2540277465811737,1,0,0,1.25,1.7128897242764174,DNMBP;RGS16;ARHGEF38;RHOG;RAPGEF1;CCL3;RAPGEF2;F2RL1;CCL1;RSU1;TBC1D22B;RAPGEF3
regulation of heart rate by cardiac conduction (GO:0086091),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,KCNE1;KCNH6;PKP2
anatomical structure homeostasis (GO:0060249),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,ERCC4;RPA3;TERF1
regulation of sodium ion transport (GO:0002028),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,NEDD4;ATP2B4;PKP2
positive regulation of telomerase activity (GO:0051973),3/35,0.25416276879858296,1,0,0,1.7142857142857142,2.3481949631326344,PARM1;MAPK1;AURKB
ribonucleoprotein complex assembly (GO:0022618),10/156,0.2545021417753139,1,0,0,1.282051282051282,1.75441798385497,RPS15;SRPK2;DDX3X;DDX23;SNRPG;EIF4H;DENR;SMN1;NOP53;EDC3
plasma membrane bounded cell projection morphogenesis (GO:0120039),4/52,0.26155152638965784,1,0,0,1.5384615384615385,2.0632676511450203,UBB;RHOG;RAC1;KLK8
positive regulation of mitotic cell cycle (GO:0045931),4/52,0.26155152638965784,1,0,0,1.5384615384615385,2.0632676511450203,EDN3;TPR;HES1;INS
regulation of DNA binding (GO:0051101),4/52,0.26155152638965784,1,0,0,1.5384615384615385,2.0632676511450203,KDM1A;HJURP;HES1;HMGB1
negative regulation of cell cycle G2/M phase transition (GO:1902750),5/69,0.26222604197239524,1,0,0,1.4492753623188406,1.9399252051607478,BABAM1;UBB;BRCA1;DTL;PSMA7
cell projection assembly (GO:0030031),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,RHOG;RAC1
negative regulation of intracellular protein transport (GO:0090317),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,BARD1;KCNE1
synapsis (GO:0007129),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,RNF212;TERB2
negative regulation of ion transport (GO:0043271),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,NEDD4;LILRB2
embryonic digestive tract development (GO:0048566),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,SALL1;STRA6
error-prone translesion synthesis (GO:0042276),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,UBB;RPA3
regulation of glycogen biosynthetic process (GO:0005979),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,IRS1;INS
aromatic amino acid family catabolic process (GO:0009074),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,GSTZ1;IL4I1
covalent chromatin modification (GO:0016569),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,CHD1;AURKB
dorsal/ventral pattern formation (GO:0009953),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,TBX20;FBXL15
inositol phosphate-mediated signaling (GO:0048016),2/20,0.2641503607881601,1,0,0,2,2.66247357905395,INPP5A;EDN3
sphingosine-1-phosphate signaling pathway (GO:0003376),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,S1PR1
negative regulation of membrane potential (GO:0045837),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BNIP3
protein sulfation (GO:0006477),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CHST5
hindlimb morphogenesis (GO:0035137),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,OSR2
smooth muscle tissue development (GO:0048745),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,STRA6
granzyme-mediated apoptotic signaling pathway (GO:0008626),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BNIP3
vocal learning (GO:0042297),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,STRA6
epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,HEYL
negative regulation of chromosome organization (GO:2001251),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ERCC4
positive regulation of growth hormone secretion (GO:0060124),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SELENOT
negative regulation of transforming growth factor beta production (GO:0071635),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,FURIN
tRNA transcription from RNA polymerase III promoter (GO:0042797),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GTF3C2
B cell chemotaxis (GO:0035754),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GAS6
regulation of hydrogen peroxide metabolic process (GO:0010310),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RAC1
COPI coating of Golgi vesicle (GO:0048205),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TMED10
regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,UBB
embryonic skeletal joint development (GO:0072498),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,OSR2
determination of liver left/right asymmetry (GO:0071910),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CCDC40
"SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SRP19
T-helper 17 cell lineage commitment (GO:0072540),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SLAMF6
vascular smooth muscle cell differentiation (GO:0035886),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,HES1
catecholamine transport (GO:0051937),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SLC6A3
spinal cord motor neuron differentiation (GO:0021522),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TBX20
"establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,UBB
negative regulation of catecholamine secretion (GO:0033604),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CRH
regulation of nuclear cell cycle DNA replication (GO:0033262),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,INO80
negative regulation of acute inflammatory response (GO:0002674),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,INS
regulation of T cell tolerance induction (GO:0002664),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,LILRB2
negative regulation of oligodendrocyte differentiation (GO:0048715),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,HES1
positive regulation of activin receptor signaling pathway (GO:0032927),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SMAD2
negative regulation of type I interferon-mediated signaling pathway (GO:0060339),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PTPN2
negative regulation of receptor biosynthetic process (GO:0010871),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ITGB3
astral microtubule organization (GO:0030953),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RAB11A
N-acetylneuraminate catabolic process (GO:0019262),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RENBP
establishment of endothelial intestinal barrier (GO:0090557),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RAPGEF2
5S class rRNA transcription from RNA polymerase III type 1 promoter (GO:0042791),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GTF3C2
regulation of NAD(P)H oxidase activity (GO:0033860),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,INS
bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PKP2
negative regulation of protein targeting to membrane (GO:0090315),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,KCNE1
muscle tissue development (GO:0060537),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,STRA6
vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TAP1
Golgi transport vesicle coating (GO:0048200),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TMED10
positive regulation of cardiac muscle tissue development (GO:0055025),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,MYOCD
vascular smooth muscle cell development (GO:0097084),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,HES1
amino sugar catabolic process (GO:0046348),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RENBP
rRNA transport (GO:0051029),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TST
negative regulation of neurological system process (GO:0031645),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,KLK8
ear development (GO:0043583),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,STRA6
glomerular epithelial cell differentiation (GO:0072311),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BASP1
renal filtration cell differentiation (GO:0061318),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BASP1
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TGFBR1
monoamine transport (GO:0015844),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SLC6A3
phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GTF2H1
hematopoietic stem cell differentiation (GO:0060218),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SP7
queuosine metabolic process (GO:0046116),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TXNDC9
oxygen homeostasis (GO:0032364),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ALAS2
aortic valve development (GO:0003176),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TBX20
positive regulation of osteoblast proliferation (GO:0033690),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,HPSE
COPI-coated vesicle budding (GO:0035964),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TMED10
nucleus localization (GO:0051647),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SUN2
negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PTPN2
negative regulation of response to interferon-gamma (GO:0060331),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PTPN2
regulation of interleukin-5 secretion (GO:2000662),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PRKCZ
spinal cord dorsal/ventral patterning (GO:0021513),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RFX4
positive regulation of T-helper 2 cell differentiation (GO:0045630),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PRKCZ
antigen processing and presentation of endogenous peptide antigen (GO:0002483),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TAP1
regulation of NK T cell activation (GO:0051133),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CD300A
regulation of protein K63-linked ubiquitination (GO:1900044),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PARP10
photoreceptor cell differentiation (GO:0046530),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RP1L1
embryonic skeletal joint morphogenesis (GO:0060272),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,OSR2
deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,EDC3
negative regulation of leukocyte degranulation (GO:0043301),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,CD300A
chemical homeostasis within a tissue (GO:0048875),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NAPSA
alpha-beta T cell activation (GO:0046631),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,INS
pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TYMS
response to UV-A (GO:0070141),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,EGFR
aortic valve morphogenesis (GO:0003180),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TBX20
negative regulation of amino acid transport (GO:0051956),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GRM7
adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway (GO:0007196),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GRM7
regulation of response to wounding (GO:1903034),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TNFRSF12A
corticosteroid receptor signaling pathway (GO:0031958),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NEDD4
ribosomal small subunit export from nucleus (GO:0000056),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RPS15
regulation of mitotic spindle checkpoint (GO:1903504),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,DUSP1
bile acid secretion (GO:0032782),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ABCB11
positive regulation of histone phosphorylation (GO:0033129),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,RPS6KA4
gland morphogenesis (GO:0022612),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TGFB3
positive regulation of toll-like receptor 3 signaling pathway (GO:0034141),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,F2RL1
ribonucleoside biosynthetic process (GO:0042455),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TXNDC9
dosage compensation by inactivation of X chromosome (GO:0009048),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,BRCA1
negative regulation of T cell differentiation in thymus (GO:0033085),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PTPN2
ventricular compact myocardium morphogenesis (GO:0003223),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TGFBR1
glycosyl compound catabolic process (GO:1901658),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,FUCA1
regulation of male gonad development (GO:2000018),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SRY
regulation of interleukin-10 secretion (GO:2001179),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PRKCZ
SREBP signaling pathway (GO:0032933),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ERLIN2
coronary vasculature development (GO:0060976),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,APLN
negative regulation of phospholipase activity (GO:0010519),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ANXA8
lipoprotein catabolic process (GO:0042159),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,LYPLA2
mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SALL1
cellular nitrogen compound catabolic process (GO:0044270),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TST
regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,ATP2B4
regulation of anion channel activity (GO:0010359),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PRNP
imitative learning (GO:0098596),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,STRA6
regulation of dendritic cell chemotaxis (GO:2000508),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GAS6
negative regulation of delayed rectifier potassium channel activity (GO:1902260),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,KCNE1
queuosine biosynthetic process (GO:0008616),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TXNDC9
positive regulation of megakaryocyte differentiation (GO:0045654),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,THPO
glomerulus vasculature development (GO:0072012),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PECAM1
venous blood vessel morphogenesis (GO:0048845),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,TBX20
surfactant homeostasis (GO:0043129),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NAPSA
positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,KMT2D
insulin secretion involved in cellular response to glucose stimulus (GO:0035773),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SELENOT
equilibrioception (GO:0050957),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,MYO7A
negative regulation of glial cell proliferation (GO:0060253),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,HES1
negative regulation of interleukin-6 secretion (GO:1900165),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,GAS6
regulation of interleukin-13 secretion (GO:2000665),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PRKCZ
L-amino acid import (GO:0043092),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,SLC1A1
neutrophil extravasation (GO:0072672),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PECAM1
glucocorticoid receptor signaling pathway (GO:0042921),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,NEDD4
dendritic spine maintenance (GO:0097062),1/6,0.26493667555327055,1,0,0,3.333333333333333,4.427548139092615,PRNP
histone deacetylation (GO:0016575),3/36,0.2678594070249647,1,0,0,1.6666666666666665,2.1954883946257717,ELK4;MORF4L1;BRMS1L
organic substance transport (GO:0071702),6/87,0.2685502192059934,1,0,0,1.379310344827586,1.813403236377029,SLC48A1;ABCA6;PSAP;TAP1;SLC6A3;PLEKHA8
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),29/512,0.26941847070315844,1,0,0,1.1328125,1.4856716482236545,DDX3X;KDM1A;ZC3H4;EIF4A3;AHR;BRCA1;TYMS;FERD3L;DMBX1;SALL1;KAT5;BASP1;ENC1;TBX20;EPC1;HES1;ZBED6;TNFRSF4;SOX7;SMAD2;KDM4A;TGFB3;ZBTB38;ZNF12;TERF1;COMMD7;HEYL;ZNF658;GAS6
calcium-mediated signaling (GO:0019722),5/70,0.2718688550208947,1,0,0,1.4285714285714284,1.860622113738027,PRNP;PRKAA1;CCL3;KSR2;EGFR
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),4/53,0.272750159994601,1,0,0,1.5094339622641508,1.9610551964847422,NEDD4;F2RL1;DCN;INS
embryonic organ development (GO:0048568),4/53,0.272750159994601,1,0,0,1.5094339622641508,1.9610551964847422,KITLG;SALL1;THPO;STRA6
positive regulation of apoptotic process (GO:0043065),18/307,0.2764616901572173,1,0,0,1.1726384364820845,1.5076413268485669,SRPK2;BARD1;PRNP;DDX3X;TNFRSF12A;TGFB3;BNIP3;RRP1B;HMGB1;TGFBR1;OBSCN;UBB;FRZB;RPS6KA2;ARHGEF3;CCL3;RAC1;SOX7
negative regulation of translation (GO:0017148),6/88,0.2771694338705115,1,0,0,1.3636363636363635,1.7497176615936614,DDX3X;EIF4A3;ENC1;TPR;TYMS;C8ORF88
protein localization to membrane (GO:0072657),10/160,0.27958919759892664,1,0,0,1.25,1.5930423807072653,BBS2;TMEM88;KCNIP4;PKP2;MAP7;MYO5A;RAPGEF2;PIGW;GAS6;RAB11A
"DNA-templated transcription, termination (GO:0006353)",7/106,0.27972134756360467,1,0,0,1.320754716981132,1.6825904736403015,CPSF4;EIF4A3;CPSF2;SNRPG;POLR2F;GTF2H1;SMN1
positive regulation of cellular catabolic process (GO:0031331),7/106,0.27972134756360467,1,0,0,1.320754716981132,1.6825904736403015,PRKAA1;IRS1;BNIP3;FURIN;MID2;DCN;INS
positive regulation of cellular component organization (GO:0051130),7/106,0.27972134756360467,1,0,0,1.320754716981132,1.6825904736403015,GRID2;TGFB3;BNIP3;CBLL1;TGFBR1;RAPGEF3;MPP7
negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436),5/71,0.2815854896327663,1,0,0,1.408450704225352,1.7849565976318464,ANAPC16;UBB;CDC16;FBXO43;PSMA7
defense response to Gram-negative bacterium (GO:0050829),5/71,0.2815854896327663,1,0,0,1.408450704225352,1.7849565976318464,DEFB126;RNASE7;SPACA3;F2;LYPD8
positive regulation of growth (GO:0045927),5/71,0.2815854896327663,1,0,0,1.408450704225352,1.7849565976318464,DDX3X;INO80;TGFBR1;EGFR;INS
nuclear import (GO:0051170),5/71,0.2815854896327663,1,0,0,1.408450704225352,1.7849565976318464,NPAP1;IPO11;TPR;SNRPG;SMN1
epithelial to mesenchymal transition (GO:0001837),3/37,0.2816374857336128,1,0,0,1.6216216216216217,2.054812778279635,HEYL;HNRNPAB;TGFBR1
protein monoubiquitination (GO:0006513),3/37,0.2816374857336128,1,0,0,1.6216216216216217,2.054812778279635,UBE3D;WAC;DTL
protein peptidyl-prolyl isomerization (GO:0000413),3/37,0.2816374857336128,1,0,0,1.6216216216216217,2.054812778279635,FKBP11;FKBP6;PPIAL4F
regulation of regulated secretory pathway (GO:1903305),3/37,0.2816374857336128,1,0,0,1.6216216216216217,2.054812778279635,SYT12;SYTL1;SYTL5
regulation of DNA repair (GO:0006282),3/37,0.2816374857336128,1,0,0,1.6216216216216217,2.054812778279635,BABAM1;BRCA1;EGFR
regulation of dendrite development (GO:0050773),3/37,0.2816374857336128,1,0,0,1.6216216216216217,2.054812778279635,NEDD4;RTN4IP1;LRP8
positive regulation of transcription from RNA polymerase I promoter (GO:0045943),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,RASL11A;TAF1
dendritic cell differentiation (GO:0097028),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,F2RL1;GAS6
establishment of protein localization to vacuole (GO:0072666),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,TMEM50B;VPS25
regulation of interleukin-17 production (GO:0032660),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,PRNP;SLAMF6
histone lysine demethylation (GO:0070076),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,KDM4A;KDM1A
ventricular cardiac muscle tissue development (GO:0003229),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,PKP2;MYH6
negative regulation of ion transmembrane transporter activity (GO:0032413),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,CAB39;NEDD4
mitochondrial fission (GO:0000266),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,DNM3;MTFR1
positive regulation of histone acetylation (GO:0035066),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,RPS6KA4;BRCA1
positive regulation of BMP signaling pathway (GO:0030513),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,SMAD2;FBXL15
regulation of interleukin-2 production (GO:0032663),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,PRNP;KAT5
positive regulation of lipid metabolic process (GO:0045834),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,F2;INS
embryonic skeletal system development (GO:0048706),2/21,0.28302745680273733,1,0,0,1.9047619047619047,2.404212124839451,KIAA1217;OSR2
action potential (GO:0001508),4/54,0.2840279876642483,1,0,0,1.4814814814814814,1.8647148112043361,SCARB2;KCNE1;CACNA1B;SCN3A
regulation of neuron apoptotic process (GO:0043523),6/89,0.2858516905884061,1,0,0,1.348314606741573,1.6884703375813395,SRPK2;PRNP;GRID2;TGFB3;CCL3;NDNF
negative regulation of multicellular organismal process (GO:0051241),8/125,0.2879156477186434,1,0,0,1.28,1.5937122964641617,RPS6KA4;BBS2;MYOCD;GPNMB;GAS6;EGFR;PBLD;INS
lysosomal transport (GO:0007041),5/72,0.2913681345785638,1,0,0,1.3888888888888888,1.712732977852415,SCARB2;CCDC91;SNAPIN;NEDD4;M6PR
regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439),5/72,0.2913681345785638,1,0,0,1.3888888888888888,1.712732977852415,ANAPC16;UBB;CDC16;FBXO43;PSMA7
positive regulation of neuron death (GO:1901216),3/38,0.29547545275268733,1,0,0,1.5789473684210524,1.9250044986274375,SRPK2;PRNP;CCL3
mitochondrion disassembly (GO:0061726),3/38,0.29547545275268733,1,0,0,1.5789473684210524,1.9250044986274375,BNIP3;AMBRA1;ATG12
DNA damage checkpoint (GO:0000077),3/38,0.29547545275268733,1,0,0,1.5789473684210524,1.9250044986274375,ERCC4;WAC;CDC5L
"DNA-templated transcription, elongation (GO:0006354)",7/108,0.29558593657898286,1,0,0,1.296296296296296,1.5799203089302307,CCNT1;POLR2F;ELOB;GTF2H1;MLLT3;GTF2E1;TAF1
transcription-coupled nucleotide-excision repair (GO:0006283),5/73,0.30120905235381457,1,0,0,1.36986301369863,1.6437681222088858,UBB;ERCC4;RPA3;POLR2F;GTF2H1
nucleic acid phosphodiester bond hydrolysis (GO:0090305),5/73,0.30120905235381457,1,0,0,1.36986301369863,1.6437681222088858,UBB;ERCC4;RPA3;GTF2H1;EDC3
cellular response to caffeine (GO:0071313),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,RYR1
histone H3-K4 demethylation (GO:0034720),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,KDM1A
cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PKP2
cellular divalent inorganic anion homeostasis (GO:0072501),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,XPR1
positive regulation of dendritic spine morphogenesis (GO:0061003),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,LRP8
smooth muscle cell migration (GO:0014909),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ITGB3
progesterone receptor signaling pathway (GO:0050847),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NEDD4
negative regulation of leukocyte migration (GO:0002686),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CD300A
cellular trivalent inorganic anion homeostasis (GO:0072502),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,XPR1
negative regulation of glial cell apoptotic process (GO:0034351),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GAS6
positive regulation of dendritic cell chemotaxis (GO:2000510),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GAS6
regulation of mitochondrial fusion (GO:0010635),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,BNIP3
oxygen transport (GO:0015671),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CYGB
radial glial cell differentiation (GO:0060019),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,HES1
regulation of ER to Golgi vesicle-mediated transport (GO:0060628),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GAS1
bone cell development (GO:0098751),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ZNF385A
regulation of lymphocyte migration (GO:2000401),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SPN
glycoside catabolic process (GO:0016139),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,FUCA1
protein localization to ciliary membrane (GO:1903441),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,BBS2
vesicle transport along actin filament (GO:0030050),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,MYO5A
ribosomal protein import into nucleus (GO:0006610),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,TNPO1
positive regulation of histone H4 acetylation (GO:0090240),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,BRCA1
posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SEC62
regulation of natural killer cell chemotaxis (GO:2000501),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CCL3
left/right pattern formation (GO:0060972),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PITX2
negative regulation of striated muscle tissue development (GO:0045843),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SOX15
negative regulation of telomere capping (GO:1904354),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ERCC4
translational readthrough (GO:0006451),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SELENOT
cellular response to sterol depletion (GO:0071501),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ERLIN2
regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,MYOCD
negative regulation of synapse organization (GO:1905809),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,LILRB2
regulation of toll-like receptor 9 signaling pathway (GO:0034163),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,HMGB1
negative regulation of dendrite morphogenesis (GO:0050774),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,RAPGEF2
gas homeostasis (GO:0033483),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ALAS2
positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031659),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,EGFR
negative regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000587),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PTPN2
negative regulation of calcium ion import (GO:0090281),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,MRLN
regulation of interleukin-18 production (GO:0032661),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NLRP9
regulation of response to biotic stimulus (GO:0002831),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SCARB2
positive regulation of protein deubiquitination (GO:1903003),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,NOP53
phosphorylated carbohydrate dephosphorylation (GO:0046838),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,INPP5A
regulation of smooth muscle cell differentiation (GO:0051150),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,MYOCD
determination of digestive tract left/right asymmetry (GO:0071907),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CCDC40
pituitary gland development (GO:0021983),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SALL1
negative regulation of nitrogen compound metabolic process (GO:0051172),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,LILRB2
regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ITGB3
membrane fusion involved in viral entry into host cell (GO:0039663),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GAS6
regulation of interleukin-23 production (GO:0032667),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,RAC1
inositol phosphate dephosphorylation (GO:0046855),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,INPP5A
protein localization to cytoplasmic stress granule (GO:1903608),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,DDX3X
cellular lipid biosynthetic process (GO:0097384),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,DHRS7B
negative regulation of nitric oxide metabolic process (GO:1904406),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ATP2B4
granulocyte migration (GO:0097530),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CCL3
negative regulation of cardiocyte differentiation (GO:1905208),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,EGFR
positive regulation of hemopoiesis (GO:1903708),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,THPO
tRNA transcription (GO:0009304),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GTF3C2
regulation of meiotic nuclear division (GO:0040020),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,FBXO43
negative regulation of alpha-beta T cell activation (GO:0046636),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CD300A
positive regulation of fatty acid beta-oxidation (GO:0032000),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,IRS1
pericardium morphogenesis (GO:0003344),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,TBX20
ion homeostasis (GO:0050801),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,KLHL3
negative regulation of B cell apoptotic process (GO:0002903),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,AURKB
female genitalia development (GO:0030540),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,STRA6
regulation of toll-like receptor 3 signaling pathway (GO:0034139),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,F2RL1
negative regulation of axon regeneration (GO:0048681),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,KLK8
V(D)J recombination (GO:0033151),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,HMGB1
pharyngeal arch artery morphogenesis (GO:0061626),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,HES1
regulation of growth hormone secretion (GO:0060123),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SELENOT
negative regulation of dendritic cell apoptotic process (GO:2000669),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GAS6
fusion of virus membrane with host plasma membrane (GO:0019064),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GAS6
vascular smooth muscle contraction (GO:0014829),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,EDN3
positive regulation of interleukin-5 production (GO:0032754),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PRKCZ
negative regulation of glycogen metabolic process (GO:0070874),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,INS
epithelial cell differentiation involved in kidney development (GO:0035850),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SALL1
positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,TPR
tetrahydrofolate interconversion (GO:0035999),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,TYMS
proline metabolic process (GO:0006560),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,PYCR1
negative regulation of nitric oxide biosynthetic process (GO:0045019),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ATP2B4
alditol metabolic process (GO:0019400),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,COQ2
regulation of activation of Janus kinase activity (GO:0010533),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,CD300A
positive regulation of membrane depolarization (GO:1904181),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,DCN
response to caffeine (GO:0031000),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,RYR1
tooth mineralization (GO:0034505),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,FAM20C
regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,TAF1
positive regulation of type I interferon-mediated signaling pathway (GO:0060340),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ZBP1
cleavage furrow formation (GO:0036089),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,AURKB
outer mitochondrial membrane organization (GO:0007008),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,TOMM20L
kidney epithelium development (GO:0072073),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SALL1
sensory organ morphogenesis (GO:0090596),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,STRA6
"regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,MLLT3
amino acid import across plasma membrane (GO:0089718),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SLC1A1
glyoxylate metabolic process (GO:0046487),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,GRHPR
myoblast fusion (GO:0007520),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,ADAM12
T-helper 1 type immune response (GO:0042088),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,HMGB1
negative regulation of dendrite development (GO:2000171),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,RAPGEF2
malate metabolic process (GO:0006108),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,FH
negative regulation of heart rate (GO:0010459),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,RNLS
selenocysteine incorporation (GO:0001514),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,SELENOT
cellular phosphate ion homeostasis (GO:0030643),1/7,0.30170081801752857,1,0,0,2.8571428571428568,3.423769775600227,XPR1
regulation of natural killer cell mediated cytotoxicity (GO:0042269),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,CLEC12B;SLAMF6
regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,ITGB3;NEDD4
regulation of calcium ion import (GO:0090279),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,PRNP;CCL3
positive regulation of protein autophosphorylation (GO:0031954),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,GPNMB;INS
glutathione derivative biosynthetic process (GO:1901687),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,GSTZ1;GSTO2
cellular response to nerve growth factor stimulus (GO:1990090),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,RAPGEF1;RAPGEF2
lymphocyte activation involved in immune response (GO:0002285),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,IFNA7;F2RL1
activation of phospholipase C activity (GO:0007202),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,LPAR1;EGFR
hematopoietic progenitor cell differentiation (GO:0002244),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,SP7;MIXL1
negative regulation of cell cycle G1/S phase transition (GO:1902807),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,GPNMB;E2F7
regulation of transcription from RNA polymerase III promoter (GO:0006359),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,NAB2;BRCA1
"DNA catabolic process, endonucleolytic (GO:0000737)",2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,DFFA;HMGB1
positive regulation of interleukin-10 production (GO:0032733),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,HMGB1;PRKCZ
histone lysine methylation (GO:0034968),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,KMT2D;SETD6
"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,UBB;GTF2H1
negative regulation of nervous system development (GO:0051961),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,RFX4;KLK8
regulation of bone resorption (GO:0045124),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,ITGB3;S1PR1
regulation of monocyte chemotaxis (GO:0090025),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,CCL1;HMGB1
glutathione derivative metabolic process (GO:1901685),2/22,0.30185830293267685,1,0,0,1.8181818181818181,2.1778137587293127,GSTZ1;GSTO2
positive regulation of ERK1 and ERK2 cascade (GO:0070374),12/201,0.3054856995308486,1,0,0,1.1940298507462686,1.4159430585223085,GPNMB;THPO;CCL3;RAPGEF2;F2RL1;CCL1;ROR2;HMGB1;GAS6;MERTK;PRKCZ;EGFR
"positive regulation of transcription, DNA-templated (GO:0045893)",60/1120,0.30571783968468397,1,0,0,1.0714285714285714,1.269742173163187,DDX3X;CCNT1;KDM1A;FHOD1;RASL11A;BRCA1;HMGB1;AHR;ELK4;RPS6KA4;SALL1;KAT5;SOX15;EPC1;HOXA1;PITX2;OSR2;FOXD2;MYOCD;ZBTB38;EBF1;RHOG;TGFBR1;DCN;RFX4;WAC;HOXB2;HOXB7;KMT2D;FOXC2;MLLT3;EGFR;MED30;UBB;GALR2;NRIP1;HES1;SRY;E2F7;E2F8;SMAD2;GSX1;FZD4;TGFB3;USP21;OSM;CDC5L;GTF2H1;INO80;RRP1B;HNRNPAB;POU2F3;NR4A2;HEYL;BAMBI;F2RL1;SP7;MIXL1;TAF1;RNF187
positive regulation of cytokine production (GO:0001819),13/220,0.30778361127791426,1,0,0,1.1818181818181817,1.3926052680162264,ZBP1;BRCA1;LILRB2;HMGB1;PRKCZ;INS;NLRP9;TMIGD2;POLR2F;SLAMF6;HPSE;LURAP1;CARD11
signal transduction by p53 class mediator (GO:0072331),3/39,0.3093526636827237,1,0,0,1.5384615384615385,1.8050359176351607,ZNF346;E2F7;ZNF385A
positive regulation of peptide hormone secretion (GO:0090277),3/39,0.3093526636827237,1,0,0,1.5384615384615385,1.8050359176351607,CRH;SELENOT;INS
regulation of G0 to G1 transition (GO:0070316),3/39,0.3093526636827237,1,0,0,1.5384615384615385,1.8050359176351607,SOX15;EPC1;BRCA1
regulation of RNA metabolic process (GO:0051252),3/39,0.3093526636827237,1,0,0,1.5384615384615385,1.8050359176351607,CLK1;RRP1B;AFF2
DNA replication-independent nucleosome assembly (GO:0006336),3/39,0.3093526636827237,1,0,0,1.5384615384615385,1.8050359176351607,HJURP;CENPM;CABIN1
positive regulation of NF-kappaB transcription factor activity (GO:0051092),8/128,0.3100735275977645,1,0,0,1.25,1.4636822797847617,RPS6KA4;UBB;IRAK2;IRAK3;PRKCZ;MID2;CARD11;INS
regulation of protein processing (GO:0070613),8/128,0.3100735275977645,1,0,0,1.25,1.4636822797847617,PRNP;C8G;SERPINE2;C7;PROS1;SUSD4;GAS1;F2
mitotic spindle organization (GO:0007052),5/74,0.31110059336369467,1,0,0,1.3513513513513513,1.577890496988918,SUN2;KIFC1;WDR62;AURKB;RAB11A
regulation of G-protein coupled receptor protein signaling pathway (GO:0008277),5/74,0.31110059336369467,1,0,0,1.3513513513513513,1.577890496988918,RGS4;RGS3;PDE6G;RGS16;CNGA1
cellular respiration (GO:0045333),4/57,0.31821716196314576,1,0,0,1.4035087719298245,1.6070473403738648,LYRM7;NDUFS3;MTFR1;SDHA
regulation of protein binding (GO:0043393),7/111,0.31972881428169575,1,0,0,1.261261261261261,1.4381936369296577,DNAJB2;SNAPIN;KDM1A;BAMBI;RAPGEF2;AURKB;TAF1
"nucleotide-excision repair, DNA gap filling (GO:0006297)",2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,UBB;RPA3
melanosome organization (GO:0032438),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,TRAPPC6A;SNAPIN
regulation of telomere capping (GO:1904353),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,MAPK1;AURKB
TOR signaling (GO:0031929),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,CCDC88A;CARD11
metanephros development (GO:0001656),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,OSR2;BASP1
positive regulation of ATP metabolic process (GO:1903580),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,PRKAA1;INS
cellular response to ammonium ion (GO:0071242),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,MAPK1;DRD1
positive regulation of blood circulation (GO:1903524),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,F2RL1;APLN
apoptotic nuclear changes (GO:0030262),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,DFFA;HMGB1
protein localization to Golgi apparatus (GO:0034067),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,RAB6A;OBSL1
response to alkaloid (GO:0043279),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,RYR1;MAPK1
autophagosome maturation (GO:0097352),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,LIX1L;TECPR1
positive regulation of monooxygenase activity (GO:0032770),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,POR;INS
regulation of androgen receptor signaling pathway (GO:0060765),2/23,0.32060036735466374,1,0,0,1.7391304347826086,1.9783650312564471,HEYL;SAFB2
retinoid metabolic process (GO:0001523),5/75,0.32103520904984706,1,0,0,1.3333333333333333,1.5149393018047932,NAPEPLD;HSPG2;LRP8;PNLIP;STRA6
negative regulation of cellular amide metabolic process (GO:0034249),5/75,0.32103520904984706,1,0,0,1.3333333333333333,1.5149393018047932,PRNP;DDX3X;EIF4A3;ENC1;TYMS
gland development (GO:0048732),5/75,0.32103520904984706,1,0,0,1.3333333333333333,1.5149393018047932,SALL1;TGFB3;HES1;TGFBR1;STRA6
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),6/93,0.32110195783620454,1,0,0,1.2903225806451613,1.465802039518082,DDX3X;DNAJB6;SFN;HMGB1;GAS6;SOX7
embryonic heart tube morphogenesis (GO:0003143),3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,TBX20;HES1;CCDC40
autophagy of mitochondrion (GO:0000422),3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,BNIP3;AMBRA1;ATG12
positive regulation of Ras protein signal transduction (GO:0046579),3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,LPAR1;F2RL1;RAC1
peptidyl-proline modification (GO:0018208),3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,FKBP11;FKBP6;PPIAL4F
phosphatidic acid biosynthetic process (GO:0006654),3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,GPAM;DGKA;PLD2
regulation of viral transcription (GO:0046782),3/40,0.3232493972692518,1,0,0,1.4999999999999998,1.693996688892286,CCNT1;POLR2F;MID2
Ras protein signal transduction (GO:0007265),13/223,0.32477677919338055,1,0,0,1.1659192825112108,1.31121283914441,KSR1;RHOG;KSR2;RAB11A;RAB30;COL1A2;GNB1;RAPGEF1;ARHGEF3;RAPGEF2;RAC1;RAB6A;RAPGEF3
regulation of G2/M transition of mitotic cell cycle (GO:0010389),9/149,0.3288746551668815,1,0,0,1.2080536912751678,1.3434506433973514,RAD51B;UBB;HAUS8;HAUS4;HAUS3;HAUS6;DTL;PSMA7;RAB11A
ubiquitin-dependent ERAD pathway (GO:0030433),4/58,0.3296936338803053,1,0,0,1.379310344827586,1.5304709488498607,SYVN1;ERLIN2;UBXN4;RNF121
regulation of epidermal growth factor receptor signaling pathway (GO:0042058),4/58,0.3296936338803053,1,0,0,1.379310344827586,1.5304709488498607,UBB;PTPRJ;EGFR;PTPN2
neutrophil migration (GO:1990266),4/58,0.3296936338803053,1,0,0,1.379310344827586,1.5304709488498607,EDN3;PECAM1;CCL3;CCL1
nucleic acid-templated transcription (GO:0097659),5/76,0.3310054642700082,1,0,0,1.3157894736842104,1.4547636781220141,NR4A2;GTF3C2;EPC1;POLR2F;PWP1
peptidyl-cysteine modification (GO:0018198),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,RAB6A
Golgi to lysosome transport (GO:0090160),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CCDC91
biomineral tissue development (GO:0031214),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,FAM20C
regulation of stress-activated protein kinase signaling cascade (GO:0070302),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,MAPK1
cell migration involved in heart development (GO:0060973),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PITX2
"regulation of synaptic transmission, dopaminergic (GO:0032225)",1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,DRD1
regulation of brown fat cell differentiation (GO:0090335),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,INS
negative regulation of appetite (GO:0032099),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,BBS2
regulation of fibroblast apoptotic process (GO:2000269),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GAS6
ribosomal large subunit export from nucleus (GO:0000055),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,NOP53
cellular response to prostaglandin E stimulus (GO:0071380),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GNB1
response to epinephrine (GO:0071871),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ATP2B4
integrin activation (GO:0033622),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,COL16A1
regulation of dopamine uptake involved in synaptic transmission (GO:0051584),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,DRD1
cellular response to forskolin (GO:1904322),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,AHR
negative regulation of interleukin-1 production (GO:0032692),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GAS6
ventricular cardiac muscle cell membrane repolarization (GO:0099625),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,KCNE1
negative regulation of leukocyte mediated cytotoxicity (GO:0001911),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CLEC12B
galactose catabolic process (GO:0019388),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PGM2
T-helper 17 cell differentiation (GO:0072539),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SLAMF6
negative regulation of platelet aggregation (GO:0090331),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SERPINE2
microvillus organization (GO:0032528),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,RAPGEF2
positive regulation of steroid biosynthetic process (GO:0010893),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PRKAA1
cytoskeletal anchoring at nuclear membrane (GO:0090286),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SUN2
negative regulation of potassium ion transmembrane transporter activity (GO:1901017),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CAB39
negative regulation of activated T cell proliferation (GO:0046007),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PRNP
SMAD protein complex assembly (GO:0007183),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SMAD2
"nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,EDC3
negative regulation of monooxygenase activity (GO:0032769),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ATP2B4
coronary vasculature morphogenesis (GO:0060977),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TGFBR1
desmosome organization (GO:0002934),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PKP2
negative regulation of execution phase of apoptosis (GO:1900118),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,DFFA
regulation of T cell mediated immunity (GO:0002709),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,HMGB1
microvillus assembly (GO:0030033),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,RAPGEF2
negative regulation of protein complex disassembly (GO:0043242),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,IRAK3
protein localization to microtubule (GO:0035372),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,MID2
regulation of endodeoxyribonuclease activity (GO:0032071),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,HMGB1
spleen development (GO:0048536),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PITX2
response to forskolin (GO:1904321),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,AHR
excitatory synapse assembly (GO:1904861),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GRID2
glycerolipid biosynthetic process (GO:0045017),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,HDHD5
multi-ciliated epithelial cell differentiation (GO:1903251),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,DEUP1
regulation of cytoplasmic transport (GO:1903649),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,MAPK1
plasma membrane to endosome transport (GO:0048227),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,RAB11A
positive regulation of cAMP-mediated signaling (GO:0043950),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,RAPGEF2
positive regulation of spindle checkpoint (GO:0090232),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TPR
regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CHD6
negative regulation of voltage-gated potassium channel activity (GO:1903817),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,KCNE1
central nervous system myelination (GO:0022010),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PLP1
regulation of positive chemotaxis (GO:0050926),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,F2RL1
regulation of toll-like receptor 2 signaling pathway (GO:0034135),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,F2RL1
TORC1 signaling (GO:0038202),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CARD11
positive regulation of metanephros development (GO:0072216),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,BASP1
genetic imprinting (GO:0071514),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ZFP57
regulation of metaphase/anaphase transition of cell cycle (GO:1902099),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,NEK6
lung epithelium development (GO:0060428),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,STRA6
cell junction maintenance (GO:0034331),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,F2RL1
regulation of chemokine secretion (GO:0090196),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,F2RL1
protein localization to microtubule cytoskeleton (GO:0072698),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,MID2
positive regulation of tumor necrosis factor biosynthetic process (GO:0042535),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SPN
cellular response to epinephrine stimulus (GO:0071872),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ATP2B4
negative regulation of centriole replication (GO:0046600),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,BRCA1
negative regulation of biosynthetic process (GO:0009890),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,INS
diol biosynthetic process (GO:0034312),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ACER3
negative regulation of establishment of protein localization (GO:1904950),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TERF1
negative regulation of mRNA polyadenylation (GO:1900364),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CCNT1
early endosome to Golgi transport (GO:0034498),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,RAB6A
sphingosine biosynthetic process (GO:0046512),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ACER3
positive regulation of regulatory T cell differentiation (GO:0045591),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,LILRB2
inositol phosphate catabolic process (GO:0071545),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,INPP5A
positive regulation of vasculogenesis (GO:2001214),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,RAPGEF2
cGMP-mediated signaling (GO:0019934),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GUCY1B2
polyol transport (GO:0015791),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SLC2A13
regulation of lipid transport (GO:0032368),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ITGB3
regulation of cytoplasmic mRNA processing body assembly (GO:0010603),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CNOT6L
cellular response to purine-containing compound (GO:0071415),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,RYR1
ventricular trabecula myocardium morphogenesis (GO:0003222),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TGFBR1
leptin-mediated signaling pathway (GO:0033210),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,BBS2
membrane lipid catabolic process (GO:0046466),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,FUCA1
regulation of sensory perception (GO:0051931),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CCL3
positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,F2RL1
negative regulation of neuron projection regeneration (GO:0070571),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,KLK8
positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,BNIP3
monocyte activation (GO:0042117),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SPACA3
positive regulation of respiratory burst (GO:0060267),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,INS
negative regulation of cAMP-dependent protein kinase activity (GO:2000480),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PRKAR1B
negative regulation of vascular permeability (GO:0043116),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PTPRJ
calcium ion import into cytosol (GO:1902656),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ATP2B4
negative regulation of cilium assembly (GO:1902018),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TCHP
positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,EGFR
regulation of T-helper 2 cell differentiation (GO:0045628),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PRKCZ
regulation of cilium movement (GO:0003352),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CCDC40
osteoblast development (GO:0002076),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,CLEC5A
calcium ion import across plasma membrane (GO:0098703),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ATP2B4
peptidyl-lysine monomethylation (GO:0018026),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SETD6
ribosome disassembly (GO:0032790),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,DENR
glycerol-3-phosphate metabolic process (GO:0006072),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,GPAM
histone H3-K36 demethylation (GO:0070544),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,KDM4A
negative regulation of telomerase activity (GO:0051974),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TERF1
interleukin-1 beta secretion (GO:0050702),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,F2RL1
telomeric D-loop disassembly (GO:0061820),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,TERF1
regulation of T-helper 2 cell cytokine production (GO:2000551),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,PRKCZ
positive regulation of non-canonical Wnt signaling pathway (GO:2000052),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,MLLT3
succinate metabolic process (GO:0006105),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,SDHA
kidney mesenchyme development (GO:0072074),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,BASP1
cellular monovalent inorganic anion homeostasis (GO:0030320),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,XPR1
polyol biosynthetic process (GO:0046173),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,ACER3
regulation of apoptotic cell clearance (GO:2000425),1/8,0.33662794865636386,1,0,0,2.5,2.721942421048515,HMGB1
regulation of phagocytosis (GO:0050764),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,SPACA3;MERTK;GAS6
mesenchymal cell differentiation (GO:0048762),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,HEYL;HNRNPAB;TGFBR1
regulation of cholesterol metabolic process (GO:0090181),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,GPAM;NFYC;ACACB
phosphatidic acid metabolic process (GO:0046473),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,GPAM;DGKA;PLD2
regulation of stress-activated MAPK cascade (GO:0032872),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,MAPK1;F2RL1;EGFR
telomere organization (GO:0032200),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,ERCC4;RPA3;TERF1
regulation of protein localization (GO:0032880),3/41,0.3371468638537048,1,0,0,1.4634146341463412,1.5910780182096236,KDM1A;DNAJB6;INS
regulation of heart contraction (GO:0008016),6/95,0.33896434675202747,1,0,0,1.263157894736842,1.3665604407859686,RYR1;KCNIP2;ATP2B4;TNNI3K;MYH6;APLN
interleukin-1-mediated signaling pathway (GO:0070498),6/95,0.33896434675202747,1,0,0,1.263157894736842,1.3665604407859686,RPS6KA4;UBB;IRAK2;MAP3K8;IRAK3;PSMA7
histone mRNA metabolic process (GO:0008334),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,CPSF2;SNRPG
response to dsRNA (GO:0043331),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,IFNA7;IRAK3
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,GPNMB;E2F7
proteasomal ubiquitin-independent protein catabolic process (GO:0010499),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,ENC1;PSMA7
regulation of actin filament bundle assembly (GO:0032231),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,FHOD1;RAC1
eosinophil chemotaxis (GO:0048245),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,CCL3;CCL1
axoneme assembly (GO:0035082),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,RP1L1;CCDC40
regulation of transmembrane transport (GO:0034762),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,NEDD4;INS
regulation of chemotaxis (GO:0050920),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,F2RL1;PTPN2
negative regulation of oxidative stress-induced cell death (GO:1903202),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,PYCR1;INS
negative regulation of endothelial cell apoptotic process (GO:2000352),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,NDNF;GAS6
eosinophil migration (GO:0072677),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,CCL3;CCL1
positive regulation of vascular endothelial growth factor production (GO:0010575),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,BRCA1;HPSE
negative regulation of interleukin-6 production (GO:0032715),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,IRAK3;GAS6
mammary gland development (GO:0030879),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,TGFB3;APLN
proteoglycan biosynthetic process (GO:0030166),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,EXT1;EXT2
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),2/24,0.33921547884608483,1,0,0,1.6666666666666665,1.8018662378583004,WAC;NOP53
negative regulation of ubiquitin protein ligase activity (GO:1904667),5/77,0.34100404859306127,1,0,0,1.2987012987012985,1.397221985795033,ANAPC16;UBB;CDC16;FBXO43;PSMA7
renal system development (GO:0072001),4/59,0.3411916398273588,1,0,0,1.3559322033898304,1.458048767361736,SALL1;C1GALT1;TGFBR1;STRA6
regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),4/59,0.3411916398273588,1,0,0,1.3559322033898304,1.458048767361736,TGFB3;BMP8A;TGFBR1;PBLD
ubiquitin-dependent protein catabolic process (GO:0006511),19/341,0.3465148107363617,1,0,0,1.1143695014662756,1.1810419138602903,ANAPC16;UBA7;SYVN1;KLHL3;PSMA7;KCTD6;RNF144B;UCHL1;KAT5;UBB;UBXN11;NEDD4;CDC16;ENC1;UBAP1;FBXO8;DTL;RNF187;TAF1
ciliary basal body-plasma membrane docking (GO:0097711),6/96,0.3479363200566363,1,0,0,1.25,1.3196697553688395,HAUS8;HAUS4;MKS1;HAUS3;HAUS6;RAB11A
positive regulation of intracellular protein transport (GO:0090316),9/152,0.35009569492044973,1,0,0,1.1842105263157894,1.2428866750394152,PRNP;LEPROT;TPR;TDRD12;ITGAX;HES1;GAS6;OAZ1;RAPGEF3
adenylate cyclase-activating G-protein coupled receptor signaling pathway (GO:0007189),5/78,0.3510237868632946,1,0,0,1.282051282051282,1.3421811397066412,UCN3;PTGER1;GNB1;RAPGEF2;DRD1
regulation of cellular response to heat (GO:1900034),5/78,0.3510237868632946,1,0,0,1.282051282051282,1.3421811397066412,DNAJB6;RPA3;TPR;MAPK1;CAMK2G
regulation of interleukin-6 production (GO:0032675),3/42,0.3510272087326468,1,0,0,1.4285714285714284,1.4955593439482697,IRAK3;LILRB2;GAS6
regulation of protein modification process (GO:0031399),3/42,0.3510272087326468,1,0,0,1.4285714285714284,1.4955593439482697,PPP1R14A;CCDC88A;NOP53
cellular response to radiation (GO:0071478),3/42,0.3510272087326468,1,0,0,1.4285714285714284,1.4955593439482697,ERCC4;FIGNL1;INO80
positive regulation of protein localization to nucleus (GO:1900182),3/42,0.3510272087326468,1,0,0,1.4285714285714284,1.4955593439482697,TPR;F2;INS
negative regulation of protein secretion (GO:0050709),3/42,0.3510272087326468,1,0,0,1.4285714285714284,1.4955593439482697,IRS1;BMP8A;INS
regulation of ion transmembrane transporter activity (GO:0032412),3/42,0.3510272087326468,1,0,0,1.4285714285714284,1.4955593439482697,FXYD6-FXYD2;KCNIP2;NEDD4
adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188),8/134,0.3553149637378668,1,0,0,1.1940298507462686,1.23552317738332,UCN3;GALR2;PTGER1;PSAP;LPAR1;GNAI3;DRD1;CCR3
positive regulation of neuron projection development (GO:0010976),6/97,0.3569285827398046,1,0,0,1.2371134020618557,1.2744984316239885,SCARB2;RAPGEF1;RAPGEF2;NDNF;SERPINI1;LRP8
regulation of telomere maintenance (GO:0032204),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,ERCC4;GNL3
positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,IRS1;AMBRA1
"protein import into nucleus, translocation (GO:0000060)",2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,OR1D2;TNPO1
positive regulation of nuclear division (GO:0051785),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,EDN3;INS
positive regulation of glucose transport (GO:0010828),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,IRS1;INS
positive regulation of interleukin-1 beta secretion (GO:0050718),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,PANX1;CCL3
respiratory tube development (GO:0030323),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,STRA6;CCDC40
peptide hormone secretion (GO:0030072),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,EDN3;CAMK2G
negative regulation of locomotion (GO:0040013),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,MID2;PTPN2
regulation of vascular smooth muscle cell proliferation (GO:1904705),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,TGFB3;APLN
positive regulation of calcium ion transmembrane transport (GO:1904427),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,DRD1;F2
positive regulation of peptidyl-threonine phosphorylation (GO:0010800),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,CAB39;MAPK1
signal transduction in response to DNA damage (GO:0042770),2/25,0.3576694978288805,1,0,0,1.5999999999999999,1.645033455050064,CDC5L;E2F7
regulation of macroautophagy (GO:0016241),7/116,0.3606196265526343,1,0,0,1.206896551724138,1.2309518612816097,UCHL1;PRKAA1;BNIP3;NEDD4;WAC;GNAI3;DCN
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),7/116,0.3606196265526343,1,0,0,1.206896551724138,1.2309518612816097,PRNP;ITGB3;OSM;HES1;GAS6;LRP8;INS
anaphase-promoting complex-dependent catabolic process (GO:0031145),5/79,0.36105764852361333,1,0,0,1.2658227848101267,1.2895160027815111,ANAPC16;UBB;CDC16;AURKB;PSMA7
regulation of cellular ketone metabolic process (GO:0010565),4/61,0.36421006738242967,1,0,0,1.3114754098360655,1.3246222552325246,PDK4;OAZ1;PSMA7;INS
negative regulation of viral life cycle (GO:1903901),4/61,0.36421006738242967,1,0,0,1.3114754098360655,1.3246222552325246,SRPK2;PARP10;FAM111A;MID2
striated muscle contraction (GO:0006941),4/61,0.36421006738242967,1,0,0,1.3114754098360655,1.3246222552325246,TNNC2;TNNI1;OBSL1;MYH6
regulation of B cell proliferation (GO:0030888),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,CD300A;AHR;TNFRSF4
eye development (GO:0001654),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,CRYBA4;PITX2;STRA6
positive regulation of interleukin-6 production (GO:0032755),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,F2RL1;HMGB1;LILRB2
regulation of multicellular organismal development (GO:2000026),3/43,0.36487351009848823,1,0,0,1.3953488372093021,1.4067970229812217,HMGB1;HPSE;TGFBR1
positive regulation of neuron differentiation (GO:0045666),6/98,0.3659360545830404,1,0,0,1.2244897959183672,1.2309755205294757,SCARB2;HEYL;RAPGEF1;RAPGEF2;NDNF;SERPINI1
negative regulation of interleukin-17 production (GO:0032700),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PRNP
negative regulation of serine-type endopeptidase activity (GO:1900004),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ANXA8
regulation of immunoglobulin secretion (GO:0051023),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TNFRSF4
negative regulation of NIK/NF-kappaB signaling (GO:1901223),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TSPAN6
adult heart development (GO:0007512),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,MYH6
negative regulation of cytokine production involved in inflammatory response (GO:1900016),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,F2
dynamin family protein polymerization involved in membrane fission (GO:0003373),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,DNM3
L-fucose metabolic process (GO:0042354),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,FUT8
acidic amino acid transport (GO:0015800),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SLC1A1
megakaryocyte differentiation (GO:0030219),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ZNF385A
response to UV-C (GO:0010225),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,YY1
positive regulation of protein sumoylation (GO:0033235),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,GNL3
negative regulation of response to reactive oxygen species (GO:1901032),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PYCR1
lactation (GO:0007595),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,APLN
neuronal ion channel clustering (GO:0045161),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,KCNIP2
pericardium development (GO:0060039),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TBX20
regulation of muscle system process (GO:0090257),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TNNC2
regulation of mast cell activation involved in immune response (GO:0033006),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CD300A
embryonic forelimb morphogenesis (GO:0035115),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,OSR2
mitochondrial respiratory chain complex III assembly (GO:0034551),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,LYRM7
L-fucose catabolic process (GO:0042355),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,FUT8
positive regulation of long-term synaptic potentiation (GO:1900273),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,INS
nuclear migration (GO:0007097),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SUN2
negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CLEC12B
negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PTPN2
positive regulation of immunoglobulin secretion (GO:0051024),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TNFRSF4
interleukin-1 beta production (GO:0032611),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,F2RL1
regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PTPN2
regulation of integrin activation (GO:0033623),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,FBLIM1
positive regulation of leukocyte apoptotic process (GO:2000108),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,RAPGEF2
ATP synthesis coupled electron transport (GO:0042773),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NDUFV3
central nervous system neuron development (GO:0021954),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,RAPGEF2
negative regulation of gluconeogenesis (GO:0045721),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,INS
sphingoid biosynthetic process (GO:0046520),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ACER3
regulation of sensory perception of pain (GO:0051930),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CCL3
L-ascorbic acid metabolic process (GO:0019852),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,GSTO2
nicotinamide nucleotide biosynthetic process (GO:0019359),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NMNAT1
protein polyglutamylation (GO:0018095),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TTLL7
virion attachment to host cell (GO:0019062),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,GAS6
negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NOP53
regulation of skeletal muscle cell differentiation (GO:2001014),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,MYOCD
respiratory chain complex III assembly (GO:0017062),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,LYRM7
negative regulation of fibrinolysis (GO:0051918),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,F2
interleukin-1 secretion (GO:0050701),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,F2RL1
positive regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901409),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CCNT1
negative regulation of histone methylation (GO:0031061),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,BRCA1
regulation of cytokine secretion involved in immune response (GO:0002739),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,F2RL1
Golgi vesicle budding (GO:0048194),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,TMED10
positive regulation of epidermis development (GO:0045684),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SFN
regulation of striated muscle tissue development (GO:0016202),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SOX15
regulation of Rac protein signal transduction (GO:0035020),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,STMN3
mitochondrial protein processing (GO:0034982),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,IMMP1L
membrane disruption in other organism (GO:0051673),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,RNASE7
negative regulation of alcohol biosynthetic process (GO:1902931),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ERLIN2
positive regulation of cell activation (GO:0050867),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SOX15
negative regulation of lymphocyte apoptotic process (GO:0070229),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,AURKB
negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,NEDD4
toll-like receptor 3 signaling pathway (GO:0034138),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,UNC93B1
positive regulation of myeloid leukocyte mediated immunity (GO:0002888),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,F2RL1
negative regulation of interferon-beta production (GO:0032688),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,YY1
fucose catabolic process (GO:0019317),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,FUT8
glucose import (GO:0046323),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,SLC2A13
protein hexamerization (GO:0034214),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PANX1
granulocyte activation (GO:0036230),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,F2RL1
ether lipid metabolic process (GO:0046485),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,DHRS7B
regulation of hair cycle (GO:0042634),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,HPSE
hexose catabolic process (GO:0019320),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PGM2
dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,DNM3
negative regulation of amyloid-beta formation (GO:1902430),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PRNP
negative regulation of potassium ion transmembrane transport (GO:1901380),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,CAB39
mesodermal cell differentiation (GO:0048333),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ITGB3
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,HLA-F
negative regulation of serine-type peptidase activity (GO:1902572),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ANXA8
mitochondrial fragmentation involved in apoptotic process (GO:0043653),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,BNIP3
sphingosine metabolic process (GO:0006670),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,ACER3
histone phosphorylation (GO:0016572),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,RPS6KA4
positive regulation of triglyceride lipase activity (GO:0061365),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,PNLIP
negative regulation of peptidyl-lysine acetylation (GO:2000757),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,BRCA1
vitamin transmembrane transport (GO:0035461),1/9,0.3698097706633484,1,0,0,2.222222222222222,2.2105923086622967,STRA6
"negative regulation of transcription, DNA-templated (GO:0045892)",43/813,0.372817161329158,1,0,0,1.057810578105781,1.0437069627489353,FOXC2;KDM1A;ZC3H4;NAB2;BRCA1;HMGB1;AHR;LRP8;AURKB;FERD3L;YY1;DMBX1;ELK4;SALL1;KAT5;UBB;BASP1;SOX15;TBX20;TPR;NRIP1;EPC1;HES1;ZBED6;TNFRSF4;SOX7;E2F7;E2F8;TCFL5;TGIF1;SMAD2;OSR2;KDM4A;ZBTB38;ZNF12;COMMD7;KLF8;NR4A2;HEYL;BRMS1L;ZNF658;GAS6;NOP53
negative regulation of gene expression (GO:0010629),33/618,0.37301177472927555,1,0,0,1.0679611650485437,1.0531648751626568,DDX3X;KDM1A;ZC3H4;EIF4A3;AHR;BRCA1;TYMS;FERD3L;YY1;DMBX1;SALL1;KAT5;BASP1;ENC1;TBX20;CCL3;EPC1;HES1;ZBED6;TNFRSF4;SOX7;SMAD2;KDM4A;ZBTB38;ZNF12;COMMD7;PTBP3;APLN;PARP10;HEYL;ZNF658;GAS6;TAF1
glycosaminoglycan biosynthetic process (GO:0006024),6/99,0.37495373657039877,1,0,0,1.2121212121212122,1.1890334906277922,EXT1;EXT2;HSPG2;CHST5;DCN;HS3ST2
positive regulation of catabolic process (GO:0009896),4/62,0.37571023981047774,1,0,0,1.2903225806451613,1.263144608372761,BARD1;NEDD4;DTL;OAZ1
stress-activated MAPK cascade (GO:0051403),4/62,0.37571023981047774,1,0,0,1.2903225806451613,1.263144608372761,UBB;IRAK2;MAPK1;MAP3K8
regulation of translational initiation (GO:0006446),4/62,0.37571023981047774,1,0,0,1.2903225806451613,1.263144608372761,DDX3X;TPR;EIF4H;C8ORF88
bile acid biosynthetic process (GO:0006699),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,CYP39A1;ABCB11
positive regulation of glucose import (GO:0046326),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,IRS1;INS
response to gamma radiation (GO:0010332),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,PRKAA1;KDM1A
regulation of pri-miRNA transcription from RNA polymerase II promoter (GO:1902893),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,GNL3;APLN
positive regulation of cAMP metabolic process (GO:0030816),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,RAPGEF3;GPHB5
regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,TYMS;E2F7
internal peptidyl-lysine acetylation (GO:0018393),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,MORF4L1;KAT5
regulation of muscle contraction (GO:0006937),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,TNNC2;TNNI1
T cell activation involved in immune response (GO:0002286),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,IFNA7;F2RL1
regulation of rhodopsin mediated signaling pathway (GO:0022400),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,PDE6G;CNGA1
RNA biosynthetic process (GO:0032774),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,SMN1;TAF1
negative regulation of telomere maintenance via telomere lengthening (GO:1904357),2/26,0.3759320092394212,1,0,0,1.5384615384615385,1.5051491975911149,ERCC4;TERF1
positive regulation of protein serine/threonine kinase activity (GO:0071902),7/118,0.37711178989119853,1,0,0,1.1864406779661016,1.1570330972966532,DDX3X;CCNT1;EDN3;CAB39;ATP2B4;RAPGEF2;EGFR
muscle contraction (GO:0006936),8/137,0.3782278714972952,1,0,0,1.167883211678832,1.1354842982136466,RYR1;ACTA1;GALR2;KCNIP2;TNNC2;TNNI1;OBSL1;MYH6
positive regulation of cell differentiation (GO:0045597),11/194,0.37826488217333426,1,0,0,1.134020618556701,1.1024501448540955,SMAD2;EDN3;FRZB;TGFB3;BAMBI;RAPGEF2;SP7;ZNF385A;TGFBR1;MEDAG;INS
regulation of focal adhesion assembly (GO:0051893),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,COL16A1;PTPRJ;RAC1
lymphocyte chemotaxis (GO:0048247),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,CCL3;CCL1;GAS6
positive regulation of viral life cycle (GO:1903902),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,SRPK2;DDX3X;FKBP6
negative regulation of immune system process (GO:0002683),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,NLRP9;IRAK3;LILRB2
regulation of dendrite morphogenesis (GO:0048814),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,NEDD4;RAPGEF2;OBSL1
positive regulation of intracellular transport (GO:0032388),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,NEDD4;TPR;OAZ1
protein N-linked glycosylation via asparagine (GO:0018279),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,FUT8;SYVN1;ASGR2
microtubule cytoskeleton organization involved in mitosis (GO:1902850),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,SUN2;WDR62;AURKB
regulation of steroid biosynthetic process (GO:0050810),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,GPAM;NFYC;ACACB
negative regulation of immune response (GO:0050777),3/44,0.3786697727707907,1,0,0,1.3636363636363635,1.3242146804495836,NLRP9;CD300A;IRAK3
positive regulation of binding (GO:0051099),5/81,0.3811403952771392,1,0,0,1.2345679012345678,1.1908487409762,BAMBI;RAPGEF2;HES1;HMGB1;TAF1
positive regulation of protein catabolic process (GO:0045732),5/81,0.3811403952771392,1,0,0,1.2345679012345678,1.1908487409762,BARD1;NEDD4;FURIN;DTL;OAZ1
regulation of signal transduction (GO:0009966),13/233,0.38273790054688067,1,0,0,1.1158798283261802,1.0716964067740429,SCARB2;IGFBP1;RGS16;MERTK;EGFR;RGS4;RGS3;IRAK2;GAS1;ROR2;LLGL1;PTPN2;GPHB5
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),16/291,0.3843203181156588,1,0,0,1.099656357388316,1.0515781854069512,ANAPC16;SYVN1;FBXL15;ERLIN2;PSMA7;AURKB;UCHL1;KAT5;UBB;UBXN11;NEDD4;CDC16;UBXN4;RNF121;RNF187;TAF1
synapse assembly (GO:0007416),4/63,0.38719146599357773,1,0,0,1.2698412698412698,1.204871065559935,DNM3;GRID2;DRD1;PCDHB11
adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193),4/63,0.38719146599357773,1,0,0,1.2698412698412698,1.204871065559935,GRM7;PSAP;GNAI3;LPAR1
"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",4/63,0.38719146599357773,1,0,0,1.2698412698412698,1.204871065559935,PAN2;CNOT6L;EIF4A3;EDC3
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),5/82,0.39117601725719064,1,0,0,1.2195121951219512,1.1446312783908745,SMAD2;TGFB3;BMP8A;FBXL15;TGFBR1
peptidyl-asparagine modification (GO:0018196),3/45,0.3924009183942127,1,0,0,1.3333333333333333,1.2472949477860094,FUT8;SYVN1;ASGR2
protein complex subunit organization (GO:0071822),3/45,0.3924009183942127,1,0,0,1.3333333333333333,1.2472949477860094,COL1A2;TPR;TGFBR1
response to hexose (GO:0009746),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,SELENOT;INS
negative regulation of smooth muscle cell proliferation (GO:0048662),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,TGFB3;APLN
cristae formation (GO:0042407),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,APOO;IMMT
cardiac muscle cell development (GO:0055013),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,OBSL1;MYH6
regulation of double-strand break repair via homologous recombination (GO:0010569),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,KDM1A;FIGNL1
regulation of protein localization to nucleus (GO:1900180),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,F2;INS
negative regulation of myeloid leukocyte differentiation (GO:0002762),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,CCL3;PTPN2
extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,DDX3X;DEDD
regulation of protein transport (GO:0051223),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,LLGL1;INS
regulation of protein targeting to membrane (GO:0090313),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,PRNP;KCNE1
regulation of vascular endothelial growth factor production (GO:0010574),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,BRCA1;HPSE
regulation of blood vessel diameter (GO:0097746),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,F2RL1;INS
negative regulation of organelle assembly (GO:1902116),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,TCHP;BRCA1
cellular response to glucose stimulus (GO:0071333),2/27,0.39397603610044213,1,0,0,1.4814814814814814,1.3799484349837585,SELENOT;GAS6
cellular response to oxygen-containing compound (GO:1901701),15/274,0.3966882830957562,1,0,0,1.094890510948905,1.0123406801059442,KCNE1;FZD4;LILRB2;AHR;EGFR;KAT5;GNB1;NRIP1;PDK4;RAPGEF1;RAPGEF2;MAPK1;DRD1;RAPGEF3;TAF1
glycerophospholipid metabolic process (GO:0006650),4/64,0.39864450306553323,1,0,0,1.25,1.1496065362528942,GDE1;HDHD5;PIGW;PLA1A
positive regulation of endocytosis (GO:0045807),4/64,0.39864450306553323,1,0,0,1.25,1.1496065362528942,SPACA3;GAS6;MERTK;CBLL1
cellular response to decreased oxygen levels (GO:0036294),4/64,0.39864450306553323,1,0,0,1.25,1.1496065362528942,BNIP3;NDNF;FMN2;NOP53
negative regulation of response to cytokine stimulus (GO:0060761),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,IRAK3
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,TSPAN6
regulation of B cell apoptotic process (GO:0002902),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,AURKB
regulation of chromatin organization (GO:1902275),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,TLK1
negative regulation of cellular protein catabolic process (GO:1903363),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,FURIN
endothelium development (GO:0003158),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PECAM1
negative regulation of sodium ion transmembrane transport (GO:1902306),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,NEDD4
dorsal/ventral axis specification (GO:0009950),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SMAD2
positive regulation of calcium ion import (GO:0090280),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CCL3
amino sugar metabolic process (GO:0006040),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SLC35A3
regulation of sequestering of zinc ion (GO:0061088),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SLC30A4
regulation of cellular respiration (GO:0043457),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,NOP53
mitotic spindle midzone assembly (GO:0051256),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,AURKB
macrophage chemotaxis (GO:0048246),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CCL3
regulation of mammary gland epithelial cell proliferation (GO:0033599),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,MST1L
gas transport (GO:0015669),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CYGB
establishment of spindle localization (GO:0051293),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,LLGL1
positive regulation of alcohol biosynthetic process (GO:1902932),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PRKAA1
N-acetylneuraminate metabolic process (GO:0006054),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,RENBP
cellular biogenic amine metabolic process (GO:0006576),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,OAZ1
regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PTPRJ
skeletal muscle thin filament assembly (GO:0030240),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ACTA1
mesoderm morphogenesis (GO:0048332),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SMAD2
pyroptosis (GO:0070269),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,NLRP9
galactose metabolic process (GO:0006012),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PGM2
L-glutamate transport (GO:0015813),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SLC1A1
muscle cell migration (GO:0014812),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ITGB3
hair cell differentiation (GO:0035315),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PITX2
regulation of amyloid-beta clearance (GO:1900221),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,MYOCD
cell-cell junction maintenance (GO:0045217),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,F2RL1
"regulation of DNA-templated transcription, initiation (GO:2000142)",1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,TAF1
positive regulation of cardiac muscle cell differentiation (GO:2000727),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,MYOCD
positive regulation of lipase activity (GO:0060193),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PNLIP
creatine metabolic process (GO:0006600),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CKB
cell differentiation involved in metanephros development (GO:0072202),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SALL1
T cell chemotaxis (GO:0010818),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CCL3
regulation of pH (GO:0006885),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PDK4
positive regulation of natural killer cell activation (GO:0032816),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,GAS6
glycerolipid metabolic process (GO:0046486),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,DGKA
primary miRNA processing (GO:0031053),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SMAD2
negative regulation of B cell proliferation (GO:0030889),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CD300A
negative regulation of reproductive process (GO:2000242),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,DUSP1
negative regulation of cell activation (GO:0050866),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,F2
macrophage migration (GO:1905517),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CCL3
regulation of histone phosphorylation (GO:0033127),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,RPS6KA4
G1 DNA damage checkpoint (GO:0044783),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,WAC
regulation of establishment of protein localization to telomere (GO:0070203),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,TERF1
cellular response to ATP (GO:0071318),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,TAF1
nucleoside metabolic process (GO:0009116),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,MACROD1
regulation of cytoplasmic translation (GO:2000765),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ZNF385A
mitochondrial respiratory chain complex III biogenesis (GO:0097033),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,LYRM7
regulation of fatty acid beta-oxidation (GO:0031998),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,IRS1
insulin-like growth factor receptor signaling pathway (GO:0048009),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,IRS1
positive regulation of circadian rhythm (GO:0042753),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,CRH
cardiovascular system development (GO:0072358),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,HSPG2
IRES-dependent viral translational initiation (GO:0075522),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,DENR
complement receptor mediated signaling pathway (GO:0002430),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,FPR3
negative regulation of centrosome duplication (GO:0010826),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,BRCA1
regulation of gene expression by genetic imprinting (GO:0006349),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ZFP57
negative regulation of stem cell differentiation (GO:2000737),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,HES1
telomere maintenance via recombination (GO:0000722),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,ERCC4
negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,BRCA1
negative regulation of sodium ion transmembrane transporter activity (GO:2000650),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,NEDD4
regulation of mitochondrial depolarization (GO:0051900),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,DCN
negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PBLD
positive regulation of interleukin-13 production (GO:0032736),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PRKCZ
regulation of mRNA 3'-end processing (GO:0031440),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,BARD1
neurotransmitter receptor internalization (GO:0099590),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,DNM3
negative regulation of homotypic cell-cell adhesion (GO:0034111),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SERPINE2
telomeric loop disassembly (GO:0090657),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,TERF1
regulation of plasminogen activation (GO:0010755),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,SERPINE2
histone H2B ubiquitination (GO:0033523),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,WAC
forelimb morphogenesis (GO:0035136),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,OSR2
smooth muscle cell differentiation (GO:0051145),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,MYOCD
regulation of axon regeneration (GO:0048679),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,KLK8
thyroid hormone generation (GO:0006590),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,THPO
positive regulation of type 2 immune response (GO:0002830),1/10,0.40133341390034794,1,0,0,2,1.8259254820662505,PRKCZ
regulation of acute inflammatory response (GO:0002673),7/121,0.40189970418865884,1,0,0,1.1570247933884297,1.054689090068788,C8G;C7;PROS1;SUSD4;OSM;F2;INS
positive regulation of cell motility (GO:2000147),10/179,0.4057408879304794,1,0,0,1.1173184357541899,1.007866514177665,SUN2;GPNMB;CCL3;F2RL1;ROR2;DRD1;CBLL1;TGFBR1;EGFR;INS
positive regulation of ion transport (GO:0043270),3/46,0.40605277189227273,1,0,0,1.3043478260869563,1.175572366691541,CCL3;PKP2;DRD1
regulation of fibroblast proliferation (GO:0048145),3/46,0.40605277189227273,1,0,0,1.3043478260869563,1.175572366691541,PARP10;CD300A;GAS6
mitotic spindle assembly (GO:0090307),3/46,0.40605277189227273,1,0,0,1.3043478260869563,1.175572366691541,KIFC1;AURKB;RAB11A
"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",3/46,0.40605277189227273,1,0,0,1.3043478260869563,1.175572366691541,NDUFB11;NDUFS3;NDUFV3
glycolipid metabolic process (GO:0006664),4/65,0.41006047139933866,1,0,0,1.2307692307692308,1.0971700171589474,FUCA1;PSAP;ARSG;PIGW
regulation of JAK-STAT cascade (GO:0046425),4/65,0.41006047139933866,1,0,0,1.2307692307692308,1.0971700171589474,LEPROT;HES1;NLK;DCN
negative regulation of apoptotic signaling pathway (GO:2001234),4/65,0.41006047139933866,1,0,0,1.2307692307692308,1.0971700171589474,NR4A2;DDX3X;NDUFS3;TGFBR1
positive regulation of angiogenesis (GO:0045766),6/103,0.41102972546232486,1,0,0,1.1650485436893203,1.035832709563524,FOXC2;TMIGD2;ADAM12;BRCA1;CCR3;RAPGEF3
protein import into nucleus (GO:0006606),6/103,0.41102972546232486,1,0,0,1.1650485436893203,1.035832709563524,NPAP1;IPO11;OR1D2;TPR;HES1;TNPO1
negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,HEYL;BRCA1
cellular response to ketone (GO:1901655),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,GNB1;AHR
cellular response to alcohol (GO:0097306),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,GNB1;BRCA1
negative regulation of proteasomal protein catabolic process (GO:1901799),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,WAC;NOP53
negative regulation of response to DNA damage stimulus (GO:2001021),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,KDM1A;DDIAS
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,CYLD;TNFRSF12A
organelle fission (GO:0048285),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,DNM3;MTFR1
positive regulation of phospholipid metabolic process (GO:1903727),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,IRS1;AMBRA1
regulation of NIK/NF-kappaB signaling (GO:1901222),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,TSPAN6;EGFR
cardiac muscle cell action potential involved in contraction (GO:0086002),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,KCNE1;PKP2
regulation of lipid biosynthetic process (GO:0046890),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,PDK4;INS
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,TAP1;HLA-F
protein K63-linked deubiquitination (GO:0070536),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,BABAM1;CYLD
transcription elongation from RNA polymerase I promoter (GO:0006362),2/28,0.4117777723443979,1,0,0,1.4285714285714284,1.2675306609542623,POLR2F;GTF2H1
positive regulation of macromolecule biosynthetic process (GO:0010557),8/142,0.41656279001234714,1,0,0,1.1267605633802817,0.9867245886261043,KITLG;DDX3X;IRS1;TGFB3;EIF4A3;F2;EGFR;INS
response to glucose (GO:0009749),3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,SELENOT;GAS6;INS
myofibril assembly (GO:0030239),3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,OBSCN;OBSL1;MYH6
regulation of intrinsic apoptotic signaling pathway (GO:2001242),3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,CYLD;DDX3X;NDUFS3
negative regulation of JAK-STAT cascade (GO:0046426),3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,LEPROT;DCN;PTPN2
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,GRID2;SMAGP;FAT4
positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),3/47,0.4196120451603213,1,0,0,1.276595744680851,1.1086272722292005,TGFB3;BMP8A;TGFBR1
regulation of cellular response to stress (GO:0080135),6/104,0.4200266801120024,1,0,0,1.1538461538461537,1.0008888988224178,DNAJB6;NEK6;RPA3;TPR;MAPK1;CAMK2G
positive regulation of vasculature development (GO:1904018),6/104,0.4200266801120024,1,0,0,1.1538461538461537,1.0008888988224178,TMIGD2;ADAM12;RAPGEF2;BRCA1;CCR3;RAPGEF3
organelle assembly (GO:0070925),20/376,0.4204542726130784,1,0,0,1.0638297872340425,0.921722926334509,BBS2;DDX3X;NEK6;RFX2;HAUS4;HAUS3;HAUS6;INO80;AMBRA1;ATG12;RAB11A;EDC3;TTC8;TRAPPC6A;FAM161A;HAUS8;RFX4;MKS1;VPS25;MYH6
viral process (GO:0016032),12/220,0.42067033009209204,1,0,0,1.0909090909090908,0.9446245265113338,RPS15;UBB;NEDD4;TPR;UBAP1;DENR;FURIN;CCL1;RAC1;RPL15;RPL29;GAS6
regulation of type I interferon production (GO:0032479),5/85,0.42118396120911705,1,0,0,1.176470588235294,1.0172771508801166,ZBP1;CYLD;UBA7;UBB;POLR2F
platelet degranulation (GO:0002576),7/124,0.42665940706055616,1,0,0,1.129032258064516,0.9616749321100159,ISLR;TGFB3;PROS1;ITGB3;PSAP;PECAM1;GAS6
negative regulation of macromolecule metabolic process (GO:0010605),7/124,0.42665940706055616,1,0,0,1.129032258064516,0.9616749321100159,YY1;PARP10;KDM4A;CCL3;LILRB2;APLN;TAF1
positive regulation of cell migration (GO:0030335),12/221,0.4268281136170111,1,0,0,1.085972850678733,0.9245689314229618,SUN2;GPNMB;CCL3;RAPGEF2;F2RL1;ROR2;DRD1;CBLL1;EGFR;RAB11A;TGFBR1;INS
regulation of striated muscle contraction (GO:0006942),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,TNNI1;TNNI3K
cellular response to cadmium ion (GO:0071276),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,MAPK1;EGFR
collagen fibril organization (GO:0030199),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,COL1A2;TGFBR1
lung development (GO:0030324),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,STRA6;CCDC40
vacuolar transport (GO:0007034),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,TMEM50B;NEDD4
negative regulation of epithelial cell apoptotic process (GO:1904036),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,NDNF;GAS6
skeletal muscle organ development (GO:0060538),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,BASP1;STRA6
carbohydrate derivative biosynthetic process (GO:1901137),2/29,0.42931633359945176,1,0,0,1.379310344827586,1.1662913895494167,ALG8;ALG11
toll-like receptor signaling pathway (GO:0002224),5/86,0.4311336138274714,1,0,0,1.1627906976744184,0.9782991023729873,UBB;UNC93B1;IRAK2;IRAK3;HMGB1
regulation of peptidyl-serine phosphorylation (GO:0033135),5/86,0.4311336138274714,1,0,0,1.1627906976744184,0.9782991023729873,OSM;ATP2B4;GAS6;RAPGEF3;EGFR
formation of extrachromosomal circular DNA (GO:0001325),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TERF1
sulfate transmembrane transport (GO:1902358),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SLC26A11
atrial septum morphogenesis (GO:0060413),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TBX20
regulation of histone H3-K9 methylation (GO:0051570),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,BRCA1
negative regulation of defense response to virus (GO:0050687),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TSPAN6
negative regulation of leukocyte activation (GO:0002695),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CD300A
regulation of tumor necrosis factor biosynthetic process (GO:0042534),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SPN
"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,GNL3
cellular response to prostaglandin stimulus (GO:0071379),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,GNB1
regulation of feeding behavior (GO:0060259),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,INS
regulation of lipid kinase activity (GO:0043550),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,F2
morphogenesis of an epithelial sheet (GO:0002011),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TBX20
intracellular protein transmembrane transport (GO:0065002),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SRP19
positive regulation of superoxide anion generation (GO:0032930),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,F2RL1
interleukin-2-mediated signaling pathway (GO:0038110),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,IL2RB
negative regulation of nuclear division (GO:0051784),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,FBXO43
immune response-regulating cell surface receptor signaling pathway (GO:0002768),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,LILRB2
regulation of hydrogen peroxide-induced cell death (GO:1903205),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PYCR1
negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000059),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TAF1
negative regulation of leukocyte cell-cell adhesion (GO:1903038),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,GPNMB
UV-damage excision repair (GO:0070914),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,INO80
negative regulation of bone mineralization (GO:0030502),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CCL3
positive regulation of leukocyte degranulation (GO:0043302),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,F2RL1
regulation of vascular endothelial growth factor signaling pathway (GO:1900746),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,DCN
mesonephros development (GO:0001823),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,OSR2
T-helper cell differentiation (GO:0042093),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,HMGB1
carnitine shuttle (GO:0006853),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ACACB
Golgi ribbon formation (GO:0090161),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TMED5
intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PDK1
myosin filament assembly (GO:0031034),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,OBSL1
brain morphogenesis (GO:0048854),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,BBS2
regulation of actin filament depolymerization (GO:0030834),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,F2RL1
biotin metabolic process (GO:0006768),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ACACB
regulation of ventricular cardiac muscle cell action potential (GO:0098911),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PKP2
"synaptic transmission, dopaminergic (GO:0001963)",1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CRH
mitochondrion distribution (GO:0048311),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CLUH
negative regulation of peptide secretion (GO:0002792),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,INS
negative regulation of amyloid precursor protein catabolic process (GO:1902992),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PRNP
negative regulation of myotube differentiation (GO:0010832),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,BHLHA15
regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CCNT1
stress granule assembly (GO:0034063),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,DDX3X
T cell proliferation (GO:0042098),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TNFRSF4
positive regulation of actin filament depolymerization (GO:0030836),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,F2RL1
regulation of short-term neuronal synaptic plasticity (GO:0048172),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,SHISA9
transcytosis (GO:0045056),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,USO1
negative regulation of protein localization to cell surface (GO:2000009),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,LEPROT
cellular response to interleukin-2 (GO:0071352),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,IL2RB
cochlea morphogenesis (GO:0090103),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,HOXA1
cytoplasmic mRNA processing body assembly (GO:0033962),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,EDC3
regulation of RNA polymerase II transcriptional preinitiation complex assembly (GO:0045898),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,HMGB1
negative regulation of potassium ion transport (GO:0043267),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CAB39
phosphate ion homeostasis (GO:0055062),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,XPR1
fatty acid transmembrane transport (GO:1902001),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ACACB
metanephric mesenchyme development (GO:0072075),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,BASP1
t-circle formation (GO:0090656),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TERF1
negative regulation of heart contraction (GO:0045822),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,RNLS
negative regulation of cardiac muscle hypertrophy (GO:0010614),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ATP2B4
negative regulation of chemotaxis (GO:0050922),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PTPN2
glycerol metabolic process (GO:0006071),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,COQ2
mitotic spindle elongation (GO:0000022),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,AURKB
positive regulation of fatty acid oxidation (GO:0046321),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,IRS1
magnesium ion transport (GO:0015693),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,NIPA2
regulation of serine-type endopeptidase activity (GO:1900003),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,ANXA8
regulation of cardiac muscle cell differentiation (GO:2000725),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,MYOCD
carbohydrate derivative catabolic process (GO:1901136),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,FUCA1
telomere maintenance via telomere trimming (GO:0090737),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TERF1
midbrain dopaminergic neuron differentiation (GO:1904948),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,NR4A2
regulation of mRNA polyadenylation (GO:1900363),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,CCNT1
positive regulation of T-helper cell differentiation (GO:0045624),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,PRKCZ
UDP-N-acetylglucosamine biosynthetic process (GO:0006048),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,RENBP
RNA polymerase II transcriptional preinitiation complex assembly (GO:0051123),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,TAF1
hepatocyte growth factor receptor signaling pathway (GO:0048012),1/11,0.43128166280518815,1,0,0,1.8181818181818181,1.529079804244035,RAC1
protein modification by small protein conjugation (GO:0032446),21/398,0.43163152504553337,1,0,0,1.0552763819095476,0.8866252827045354,BARD1;UBL4A;ZNF451;ANAPC16;USP5;UBA7;SYVN1;FBXL15;KLHL3;BRCA1;AURKB;RNF212;HECTD1;UBB;NEDD4;TPR;ENC1;WAC;ELOB;TOP1;CBLL1
neuron development (GO:0048666),8/144,0.4318797311110838,1,0,0,1.111111111111111,0.9328979218937584,RP1L1;SNAPIN;NEDD4;PLP1;STMN3;RAPGEF2;HMGB1;RAB11A
protein K48-linked ubiquitination (GO:0070936),3/48,0.43306631871249,1,0,0,1.25,1.0460805021359667,SYVN1;KLHL3;RNF187
glycoprotein metabolic process (GO:0009100),3/48,0.43306631871249,1,0,0,1.25,1.0460805021359667,FUT8;MAN1C1;HPSE
regulation of mitotic cell cycle phase transition (GO:1901990),10/184,0.43966967872953955,1,0,0,1.0869565217391304,0.8931864827923585,ANAPC16;UBB;HAUS8;NEK6;CDC16;HAUS4;HAUS3;HAUS6;INO80;PSMA7
cytoskeleton organization (GO:0007010),7/126,0.44310356096080944,1,0,0,1.111111111111111,0.904390849263151,SUN2;ARHGAP10;CCL3;PRPF40A;OBSL1;PLD2;MARK1
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),4/68,0.44400267624141365,1,0,0,1.176470588235294,0.9552055164674429,DDX3X;DNAJB6;SFN;GAS6
regulation of endopeptidase activity (GO:0052548),4/68,0.44400267624141365,1,0,0,1.176470588235294,0.9552055164674429,SERPINB1;SERPINE2;FURIN;SERPINI1
termination of RNA polymerase II transcription (GO:0006369),4/68,0.44400267624141365,1,0,0,1.176470588235294,0.9552055164674429,CPSF4;EIF4A3;CPSF2;SNRPG
organic hydroxy compound biosynthetic process (GO:1901617),3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,CYP39A1;ABCB11;LBR
regulation of reactive oxygen species metabolic process (GO:2000377),3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,BRCA1;RAC1;F2
protein autoubiquitination (GO:0051865),3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,UBE3D;BRCA1;RNF187
positive regulation of response to DNA damage stimulus (GO:2001022),3/49,0.44640402063272916,1,0,0,1.2244897959183672,0.987588809585937,BABAM1;BRCA1;EGFR
beta-catenin-TCF complex assembly (GO:1904837),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,KMT2D;KAT5
positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,CCNT1;EGFR
multivesicular body assembly (GO:0036258),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,VPS25;RAB11A
regulation of ARF protein signal transduction (GO:0032012),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,ADAP2;ASAP2
protein localization to lysosome (GO:0061462),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,SCARB2;NEDD4
positive regulation of phospholipase C activity (GO:0010863),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,LPAR1;EGFR
aminoglycan metabolic process (GO:0006022),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,HSPG2;DCN
CENP-A containing nucleosome assembly (GO:0034080),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,HJURP;CENPM
CENP-A containing chromatin organization (GO:0061641),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,HJURP;CENPM
bile acid metabolic process (GO:0008206),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,CYP39A1;ABCB11
regulation of sodium ion transmembrane transport (GO:1902305),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,FXYD6-FXYD2;ATP2B4
chondroitin sulfate metabolic process (GO:0030204),2/30,0.44657352514826887,1,0,0,1.3333333333333333,1.0748682963163632,NDNF;DCN
viral life cycle (GO:0019058),6/107,0.44689369780524896,1,0,0,1.1214953271028036,0.903291056261686,UBB;ITGB3;TPR;UBAP1;FURIN;GAS6
positive regulation of epithelial cell proliferation (GO:0050679),6/107,0.44689369780524896,1,0,0,1.1214953271028036,0.903291056261686,OSR2;EGFL7;ITGB3;MST1L;TGFBR1;EGFR
T cell activation (GO:0042110),5/88,0.4509193850280069,1,0,0,1.1363636363636362,0.9050757984351353,IFNA7;F2RL1;TNFRSF4;PTPN2;INS
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),5/88,0.4509193850280069,1,0,0,1.1363636363636362,0.9050757984351353,RNF144B;USP5;WAC;NOP53;TAF1
divalent metal ion transport (GO:0070838),5/88,0.4509193850280069,1,0,0,1.1363636363636362,0.9050757984351353,RYR1;PANX1;CACNA1B;CCL3;NIPA2
"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",5/88,0.4509193850280069,1,0,0,1.1363636363636362,0.9050757984351353,UBB;FZD4;RAC1;ROR2;PSMA7
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),4/69,0.45518892642326336,1,0,0,1.1594202898550725,0.9125133023815558,CCDC88A;TGFB3;F2RL1;RAC1
monocarboxylic acid metabolic process (GO:0032787),6/108,0.45579415117862115,1,0,0,1.111111111111111,0.8730155491595808,SCARB2;LDHB;GRHPR;GPAM;ACACB;STRA6
negative regulation of viral genome replication (GO:0045071),3/50,0.4596144044474325,1,0,0,1.2,0.9328408706750739,SRPK2;PARP10;FAM111A
neurogenesis (GO:0022008),3/50,0.4596144044474325,1,0,0,1.2,0.9328408706750739,SALL1;WDR62;FAT4
positive regulation of protein depolymerization (GO:1901881),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,F2RL1
cardiac right ventricle morphogenesis (GO:0003215),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,TBX20
regulation of vasculogenesis (GO:2001212),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,RAPGEF2
regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter (GO:1901836),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,NOP53
negative regulation of chondrocyte differentiation (GO:0032331),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,TGFBR1
positive regulation of interleukin-1 production (GO:0032732),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,HMGB1
regulation of oligodendrocyte differentiation (GO:0048713),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,HES1
negative regulation of protein oligomerization (GO:0032460),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,INS
regulation of DNA-dependent DNA replication (GO:0090329),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,WRNIP1
ribose phosphate metabolic process (GO:0019693),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PGM2
protein localization to kinetochore (GO:0034501),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,AURKB
skeletal myofibril assembly (GO:0014866),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,ACTA1
pentose-phosphate shunt (GO:0006098),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PGM2
mitochondrial outer membrane permeabilization (GO:0097345),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,BNIP3
modification-dependent macromolecule catabolic process (GO:0043632),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,UBL4A
sulfation (GO:0051923),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CHST5
amino sugar biosynthetic process (GO:0046349),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,RENBP
cell differentiation in hindbrain (GO:0021533),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,GRID2
epithelial structure maintenance (GO:0010669),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PBLD
oligodendrocyte development (GO:0014003),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PLP1
histone arginine methylation (GO:0034969),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,COPRS
mitochondrion transport along microtubule (GO:0047497),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,UBB
pre-mRNA cleavage required for polyadenylation (GO:0098789),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CPSF4
cell wall macromolecule catabolic process (GO:0016998),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,SPACA3
positive regulation of potassium ion transmembrane transporter activity (GO:1901018),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,GALR2
DNA ligation involved in DNA repair (GO:0051103),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,HMGB1
polyamine metabolic process (GO:0006595),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,OAZ1
positive regulation of cardiocyte differentiation (GO:1905209),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,MYOCD
phasic smooth muscle contraction (GO:0014821),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,EDN3
eye photoreceptor cell development (GO:0042462),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,MYO7A
response to prostaglandin E (GO:0034695),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,GNB1
histone H3 deacetylation (GO:0070932),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,ELK4
regulation of protein localization to cell periphery (GO:1904375),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,INS
positive regulation of pseudopodium assembly (GO:0031274),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,F2RL1
vasoconstriction (GO:0042310),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,EDN3
regulation of pseudopodium assembly (GO:0031272),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,F2RL1
negative regulation of histone modification (GO:0031057),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,BRCA1
cardiac muscle fiber development (GO:0048739),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,MYH6
negative regulation of interleukin-1 secretion (GO:0050711),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,GAS6
"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,KDM1A
PERK-mediated unfolded protein response (GO:0036499),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,IGFBP1
cellular response to fatty acid (GO:0071398),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PDK4
regulation of antigen receptor-mediated signaling pathway (GO:0050854),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,CD300A
positive regulation of stem cell differentiation (GO:2000738),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,SP7
negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,APLN
dermatan sulfate biosynthetic process (GO:0030208),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,DCN
negative regulation of interleukin-12 production (GO:0032695),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,IRAK3
negative regulation of androgen receptor signaling pathway (GO:0060766),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,HEYL
positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,ITGB3
positive regulation of neuron migration (GO:2001224),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,RAPGEF2
positive regulation of T cell cytokine production (GO:0002726),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,PRKCZ
regulation of catabolic process (GO:0009894),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,FURIN
eye photoreceptor cell differentiation (GO:0001754),1/12,0.4597331726975369,1,0,0,1.6666666666666665,1.2951816952528152,MYO7A
regulation of establishment of planar polarity (GO:0090175),5/89,0.460744839318766,1,0,0,1.1235955056179774,0.8706863855115896,UBB;FZD4;RAC1;ROR2;PSMA7
negative regulation of nucleic acid-templated transcription (GO:1903507),23/444,0.4611294522837551,1,0,0,1.036036036036036,0.8019711153376022,SMAD2;KDM4A;KDM1A;ZC3H4;ZBTB38;ZNF12;AHR;BRCA1;COMMD7;FERD3L;DMBX1;HEYL;SALL1;KAT5;BASP1;TBX20;ZNF658;EPC1;HES1;GAS6;ZBED6;TNFRSF4;SOX7
negative regulation of canonical Wnt signaling pathway (GO:0090090),8/148,0.46236222561490486,1,0,0,1.0810810810810811,0.8339531426705211,IGFBP1;DKK4;CYLD;UBB;TMEM88;FRZB;MLLT3;PSMA7
regulated exocytosis (GO:0045055),8/148,0.46236222561490486,1,0,0,1.0810810810810811,0.8339531426705211,ISLR;TMED10;TGFB3;PROS1;ITGB3;PSAP;PECAM1;GAS6
cellular protein metabolic process (GO:0044267),25/484,0.46277612297750825,1,0,0,1.0330578512396693,0.7959833445482524,ERO1B;UBA7;PROS1;FURIN;INS;RPS15;UBB;RPL15;IGFBP1;UBL4A;NAPSA;PABPC4;F2;HSPG2;GNMT;BACE1;MRPL52;IMMP1L;SPCS3;SPCS2;MRPL51;NUCB1;FAM20C;RPL29;GAS6
negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,IRAK3;GAS6
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,DRD1;F2
regulation of glucose import (GO:0046324),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,IRS1;INS
organelle transport along microtubule (GO:0072384),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,UBB;RAB6A
positive regulation of protein dephosphorylation (GO:0035307),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,CD300A;LILRB2
renal water homeostasis (GO:0003091),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,PRKAR1B;RAB11A
skeletal system morphogenesis (GO:0048705),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,OSR2;TGFBR1
multivesicular body organization (GO:0036257),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,VPS25;RAB11A
positive regulation of interleukin-1 beta production (GO:0032731),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,PANX1;CCL3
response to cadmium ion (GO:0046686),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,MAPK1;EGFR
termination of RNA polymerase I transcription (GO:0006363),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,POLR2F;GTF2H1
positive regulation of bone mineralization (GO:0030501),2/31,0.46353362563600886,1,0,0,1.2903225806451613,0.9920985153401862,OSR2;TGFB3
regulation of ERK1 and ERK2 cascade (GO:0070372),13/247,0.46522197430146467,1,0,0,1.0526315789473684,0.8055164454816833,HMGB1;MERTK;PRKCZ;EGFR;GPNMB;THPO;CCL3;RAPGEF2;F2RL1;CCL1;ROR2;GAS6;PTPN2
regulation of Notch signaling pathway (GO:0008593),4/70,0.4662992293725246,1,0,0,1.1428571428571428,0.8719174032140833,EGFL7;UBB;LLGL1;EGFR
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),4/70,0.4662992293725246,1,0,0,1.1428571428571428,0.8719174032140833,RNF144B;USP5;NOP53;TAF1
positive regulation of phosphorylation (GO:0042327),11/208,0.4683681021557312,1,0,0,1.0576923076923077,0.8022604077649453,PRKAA1;GPNMB;THPO;ITGB3;RAC1;ROR2;F2;GAS6;MERTK;EGFR;INS
negative regulation of transcription from RNA polymerase II promoter (GO:0000122),29/565,0.46943857182924126,1,0,0,1.0265486725663715,0.776294405777963,ZNF451;FOXC2;KDM1A;HMGB1;LRP8;AURKB;ELK4;YY1;SALL1;KAT5;UBB;SOX15;TPR;TBX20;NRIP1;EPC1;HES1;E2F7;E2F8;TCFL5;SMAD2;TGIF1;OSR2;KLF8;NR4A2;NEDD4;BRMS1L;NOP53;TAF1
sensory perception of chemical stimulus (GO:0007606),17/327,0.4698451688662753,1,0,0,1.039755351681957,0.7853813535426518,OR8H2;OR2T27;OR1D2;OR5H1;OR4K17;OR2T12;OR10AD1;OR2L13;OR4C45;OR4A47;OR51B5;OR10A2;OR2B6;OR2A5;OR4C15;OR4C3;OR4A16
protein tetramerization (GO:0051262),5/90,0.4705185605943169,1,0,0,1.111111111111111,0.8376887467502594,RYR1;MCOLN1;ACACB;THG1L;GNMT
regulation of programmed cell death (GO:0043067),14/268,0.472217021741417,1,0,0,1.044776119402985,0.7839128732393905,DFFA;RBM25;DUSP1;TGFB3;BNIP3;BMP8A;DDX42;BRCA1;TP53AIP1;UBB;GAS1;MAP3K8;TNFRSF4;NOP53
regulation of cellular amine metabolic process (GO:0033238),3/51,0.47268752481329424,1,0,0,1.176470588235294,0.881553803378603,OAZ1;PSMA7;INS
regulation of telomere maintenance via telomerase (GO:0032210),3/51,0.47268752481329424,1,0,0,1.176470588235294,0.881553803378603,MAPK1;TERF1;AURKB
telomere maintenance (GO:0000723),3/51,0.47268752481329424,1,0,0,1.176470588235294,0.881553803378603,ERCC4;RPA3;TERF1
regulation of cellular amino acid metabolic process (GO:0006521),3/51,0.47268752481329424,1,0,0,1.176470588235294,0.881553803378603,OAZ1;PSMA7;INS
DNA repair (GO:0006281),15/288,0.4732239343434198,1,0,0,1.0416666666666667,0.7793610087447198,BARD1;GTF2H1;WRNIP1;INO80;BRCA1;FANCB;HMGB1;FANCF;BABAM1;RAD51B;KAT5;UBB;ERCC4;RPA3;NOP53
cilium assembly (GO:0060271),15/288,0.4732239343434198,1,0,0,1.0416666666666667,0.7793610087447198,BBS2;RFX2;HAUS4;HAUS3;HAUS6;SPATA6;RAB11A;RP1L1;TTC8;FAM161A;HAUS8;RFX4;MKS1;TNPO1;CCDC40
cellular response to insulin stimulus (GO:0032869),6/110,0.4734883847029237,1,0,0,1.0909090909090908,0.8155940698683591,FOXC2;IRS1;PDK4;MYO5A;PTPN2;INS
protein glycosylation (GO:0006486),7/130,0.47572414988888423,1,0,0,1.0769230769230769,0.8000645797585316,PARP10;ALG8;KCNE1;FUT8;MAN1C1;ALG12;ALG11
regulation of cation channel activity (GO:2001257),4/71,0.47732691074516864,1,0,0,1.1267605633802817,0.8332999159019496,KCNE1;KCNIP2;CRH;SHISA9
negative regulation of cell differentiation (GO:0045596),8/150,0.4774859646340916,1,0,0,1.0666666666666667,0.7885018804584587,MYOCD;ITGB3;PKP2;HES1;TGFBR1;EGFR;MIXL1;PBLD
cellular response to interleukin-1 (GO:0071347),8/150,0.4774859646340916,1,0,0,1.0666666666666667,0.7885018804584587,RPS6KA4;UBB;IRAK2;CCL3;MAP3K8;IRAK3;CCL1;PSMA7
cellular response to DNA damage stimulus (GO:0006974),17/329,0.48005718141826625,1,0,0,1.033434650455927,0.758386074270581,BARD1;UBA7;ZBTB38;GTF2H1;BRCA1;FMN2;RAD51B;YY1;KIN;ERCC4;WAC;MACROD1;SFN;DTL;NOP53;ZNF385A;TAF1
protein deacetylation (GO:0006476),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,MORF4L1;BRMS1L
7-methylguanosine mRNA capping (GO:0006370),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,POLR2F;GTF2H1
positive regulation of calcium ion transport into cytosol (GO:0010524),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,DRD1;F2
response to zinc ion (GO:0010043),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,SLC30A4;ZNF658
regulation of glutamate receptor signaling pathway (GO:1900449),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,CRH;SHISA9
cellular response to glucagon stimulus (GO:0071377),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,PRKAR1B;GNB1
positive regulation of dendrite development (GO:1900006),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,LRP8;OBSL1
central nervous system neuron differentiation (GO:0021953),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,NR4A2;GRID2
sister chromatid segregation (GO:0000819),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,KIFC1;INO80
chromatin remodeling at centromere (GO:0031055),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,HJURP;CENPM
microtubule bundle formation (GO:0001578),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,RP1L1;CCDC40
7-methylguanosine RNA capping (GO:0009452),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,POLR2F;GTF2H1
mitochondrial transmembrane transport (GO:1990542),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,UCP2;ACACB
endodermal cell differentiation (GO:0035987),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,LAMA3;MIXL1
substrate adhesion-dependent cell spreading (GO:0034446),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,ITGB3;RAC1
positive regulation of telomere maintenance via telomerase (GO:0032212),2/32,0.4801831856912929,1,0,0,1.25,0.9169845137852034,MAPK1;AURKB
phospholipase C-activating G-protein coupled receptor signaling pathway (GO:0007200),5/91,0.48023571472567267,1,0,0,1.0989010989010988,0.8060200255732013,GALR2;LPAR1;F2RL1;FPR3;DRD1
protein-DNA complex assembly (GO:0065004),5/91,0.48023571472567267,1,0,0,1.0989010989010988,0.8060200255732013,RAD51B;UBB;RPA3;DMC1;GTF2H1
chemokine-mediated signaling pathway (GO:0070098),3/52,0.4856142127878605,1,0,0,1.1538461538461537,0.8334701205650645,THPO;CCL3;CCL1
regulation of calcium ion transport (GO:0051924),3/52,0.4856142127878605,1,0,0,1.1538461538461537,0.8334701205650645,CCL3;LILRB2;CAMK2G
B cell differentiation (GO:0030183),3/52,0.4856142127878605,1,0,0,1.1538461538461537,0.8334701205650645,TPD52;IFNA7;PTPN2
positive regulation of cell-substrate adhesion (GO:0010811),3/52,0.4856142127878605,1,0,0,1.1538461538461537,0.8334701205650645,NDNF;RAC1;RSU1
triglyceride metabolic process (GO:0006641),3/52,0.4856142127878605,1,0,0,1.1538461538461537,0.8334701205650645,GPAM;MOGAT2;FABP9
DNA-templated transcriptional preinitiation complex assembly (GO:0070897),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TAF1
dermatan sulfate metabolic process (GO:0030205),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,DCN
positive regulation of histone H3-K4 methylation (GO:0051571),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,BRCA1
negative regulation of macrophage derived foam cell differentiation (GO:0010745),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,ITGB3
negative regulation of hemostasis (GO:1900047),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,SERPINE2
positive regulation of sodium ion transport (GO:0010765),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PKP2
positive regulation of cardiac muscle cell proliferation (GO:0060045),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TBX20
regulation of superoxide anion generation (GO:0032928),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,F2RL1
glycerolipid catabolic process (GO:0046503),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,GDE1
regulation of NMDA receptor activity (GO:2000310),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CRH
regulation of cell aging (GO:0090342),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,NEK6
DNA replication-independent nucleosome organization (GO:0034724),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CABIN1
positive regulation of cellular carbohydrate metabolic process (GO:0010676),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,IRS1
renal absorption (GO:0070293),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,KLHL3
viral translation (GO:0019081),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,DENR
synaptic vesicle cycle (GO:0099504),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PLD2
maintenance of gastrointestinal epithelium (GO:0030277),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PBLD
striated muscle myosin thick filament assembly (GO:0071688),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,OBSL1
negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,VPS25
mRNA cleavage involved in mRNA processing (GO:0098787),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CPSF4
atrial septum development (GO:0003283),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TBX20
regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,EGFR
positive regulation of protein complex disassembly (GO:0043243),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,BNIP3
regulation of macrophage differentiation (GO:0045649),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PTPN2
pathway-restricted SMAD protein phosphorylation (GO:0060389),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TGFBR1
glutamine family amino acid biosynthetic process (GO:0009084),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PYCR1
cardiocyte differentiation (GO:0035051),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,MYOCD
cellular response to interleukin-15 (GO:0071350),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,IL2RB
phospholipase C-activating dopamine receptor signaling pathway (GO:0060158),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,DRD1
tetrahydrofolate metabolic process (GO:0046653),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TYMS
negative regulation of viral release from host cell (GO:1902187),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,MID2
leukocyte differentiation (GO:0002521),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,GAS6
regulation of execution phase of apoptosis (GO:1900117),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,DFFA
neuron fate commitment (GO:0048663),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TGFBR1
ER-associated misfolded protein catabolic process (GO:0071712),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,SDF2L1
positive regulation of muscle contraction (GO:0045933),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,MYOCD
regulation of necrotic cell death (GO:0010939),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,UBB
cranial nerve development (GO:0021545),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,SALL1
positive regulation of lamellipodium assembly (GO:0010592),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,RAC1
secretion (GO:0046903),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TPD52
regulation of fibrinolysis (GO:0051917),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,F2
diacylglycerol metabolic process (GO:0046339),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,DGKA
chondroitin sulfate catabolic process (GO:0030207),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,DCN
positive regulation of interleukin-17 production (GO:0032740),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,SLAMF6
regulation of fatty acid oxidation (GO:0046320),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PDK4
interleukin-15-mediated signaling pathway (GO:0035723),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,IL2RB
glomerular visceral epithelial cell differentiation (GO:0072112),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,BASP1
negative regulation of cartilage development (GO:0061037),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,TGFBR1
negative regulation of chemokine production (GO:0032682),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,F2RL1
response to fatty acid (GO:0070542),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,PDK4
ribonucleoprotein complex disassembly (GO:0032988),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,DENR
detection of calcium ion (GO:0005513),1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,KCNIP2
"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",1/13,0.48676267554205266,1,0,0,1.5384615384615385,1.107659375220991,CPSF4
regulation of neuron death (GO:1901214),4/72,0.48826565745953704,1,0,0,1.111111111111111,0.7965507124555724,PRNP;GRID2;UBB;GPNMB
negative regulation of cysteine-type endopeptidase activity (GO:2000117),4/72,0.48826565745953704,1,0,0,1.111111111111111,0.7965507124555724,DDX3X;DNAJB6;SFN;GAS6
Rho protein signal transduction (GO:0007266),4/72,0.48826565745953704,1,0,0,1.111111111111111,0.7965507124555724,COL1A2;RHOG;ARHGEF3;RAC1
negative regulation of cell cycle (GO:0045786),4/72,0.48826565745953704,1,0,0,1.111111111111111,0.7965507124555724,MYOCD;DUSP1;RPS6KA2;GAS1
cellular response to hypoxia (GO:0071456),7/132,0.49185149962456454,1,0,0,1.0606060606060606,0.7525831919041477,UBB;BNIP3;ELOB;NDNF;FMN2;NOP53;PSMA7
positive regulation of protein kinase activity (GO:0045860),9/172,0.49303432520422835,1,0,0,1.0465116279069768,0.7400684116072249,PRNP;DDX3X;CAB39;ITGB3;NAB2;RAPGEF2;MAP3K8;GAS6;LRP8
glycogen metabolic process (GO:0005977),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,UBB;PGM2
activation of MAPKK activity (GO:0000186),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,RAPGEF1;TGFBR1
positive regulation of cytokine-mediated signaling pathway (GO:0001961),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,ZBP1;GAS6
stem cell differentiation (GO:0048863),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,SETD6;SP7
response to exogenous dsRNA (GO:0043330),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,IFNA7;IRAK3
intra-Golgi vesicle-mediated transport (GO:0006891),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,GOLGA3;RAB6A
platelet aggregation (GO:0070527),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,ITGB3;GAS6
transcription initiation from RNA polymerase I promoter (GO:0006361),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,POLR2F;GTF2H1
regulation of DNA recombination (GO:0000018),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,KDM1A;FIGNL1
positive regulation of biomineral tissue development (GO:0070169),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,OSR2;TGFB3
transcription from RNA polymerase I promoter (GO:0006360),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,POLR2F;GTF2H1
regulation of phosphatidylinositol 3-kinase activity (GO:0043551),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,IRS1;AMBRA1
regulation of intracellular protein transport (GO:0033157),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,TPR;OAZ1
regulation of neurotransmitter receptor activity (GO:0099601),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,CRH;SHISA9
regulation of interleukin-12 production (GO:0032655),2/33,0.496510840077104,1,0,0,1.2121212121212122,0.8486666215153239,IRAK3;HMGB1
neutrophil chemotaxis (GO:0030593),3/53,0.498386049960954,1,0,0,1.1320754716981132,0.788355058353472,EDN3;CCL3;CCL1
regulation of calcium ion-dependent exocytosis (GO:0017158),3/53,0.498386049960954,1,0,0,1.1320754716981132,0.788355058353472,SYT12;SYTL1;SYTL5
positive regulation of cytokine secretion (GO:0050715),4/73,0.49910951364629225,1,0,0,1.095890410958904,0.7615668395449564,F2RL1;HMGB1;PRKCZ;INS
positive regulation of proteasomal protein catabolic process (GO:1901800),4/73,0.49910951364629225,1,0,0,1.095890410958904,0.7615668395449564,RNF144B;USP5;NOP53;TAF1
cellular transition metal ion homeostasis (GO:0046916),5/93,0.4994819883860412,1,0,0,1.075268817204301,0.7464341299256831,PRNP;ALAS2;UBB;NUBP1;ATOX1
cotranslational protein targeting to membrane (GO:0006613),5/93,0.4994819883860412,1,0,0,1.075268817204301,0.7464341299256831,RPS15;SRP19;RPL15;SEC62;RPL29
positive regulation of kinase activity (GO:0033674),6/113,0.4997075653239782,1,0,0,1.0619469026548671,0.7367067833785346,RAPGEF2;ROR2;F2;GAS6;MERTK;EGFR
regulation of canonical Wnt signaling pathway (GO:0060828),11/213,0.5001763192159705,1,0,0,1.0328638497652582,0.7155625020839014,DKK4;IGFBP1;CYLD;DDX3X;UBB;TMEM88;FRZB;BAMBI;MLLT3;SOX7;PSMA7
activation of protein kinase activity (GO:0032147),12/233,0.5002234181309964,1,0,0,1.0300429184549356,0.7135111870553266,CCDC88A;PRKAA1;PRKAR1B;UBB;IRAK2;ITGB3;RAPGEF1;MAPK1;MAP3K8;GAS6;TGFBR1;INS
DNA metabolic process (GO:0006259),16/314,0.5055774318850208,1,0,0,1.019108280254777,0.6950869538334569,BARD1;GTF2H1;BRCA1;HMGB1;TERF1;TYMS;RAD51B;FAM111A;KIN;KAT5;UBB;ERCC4;RPA3;DMC1;TOP1;NOP53
negative regulation of Wnt signaling pathway (GO:0030178),9/174,0.5070452262105105,1,0,0,1.0344827586206895,0.7025742163430991,IGFBP1;DKK4;CYLD;UBB;TMEM88;FRZB;NLK;MLLT3;PSMA7
axon development (GO:0061564),5/94,0.509002443009079,1,0,0,1.0638297872340425,0.7184068753385349,LINGO2;LRFN2;LRFN5;PLP1;LLGL1
cellular response to nutrient levels (GO:0031669),3/54,0.5109953414593842,1,0,0,1.111111111111111,0.7459942281531415,PRKAA1;UCN3;PDK4
intracellular transport of virus (GO:0075733),3/54,0.5109953414593842,1,0,0,1.111111111111111,0.7459942281531415,UBB;TPR;UBAP1
cytoplasmic translation (GO:0002181),3/54,0.5109953414593842,1,0,0,1.111111111111111,0.7459942281531415,EIF4H;RPL15;RPL29
membrane fusion (GO:0061025),3/54,0.5109953414593842,1,0,0,1.111111111111111,0.7459942281531415,DNM3;USO1;OTOF
transport of virus (GO:0046794),3/54,0.5109953414593842,1,0,0,1.111111111111111,0.7459942281531415,UBB;TPR;UBAP1
negative regulation of hydrogen peroxide-induced cell death (GO:1903206),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PYCR1
mitotic cell cycle arrest (GO:0071850),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,DUSP1
positive regulation of cell adhesion mediated by integrin (GO:0033630),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,FOXC2
regulation of Golgi organization (GO:1903358),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,MAPK1
acetyl-CoA metabolic process (GO:0006084),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,ACACB
negative regulation of receptor-mediated endocytosis (GO:0048261),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,RAC1
myeloid dendritic cell activation (GO:0001773),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,HMGB1
regulation of lipase activity (GO:0060191),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,FURIN
gliogenesis (GO:0042063),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PLP1
regulation of nucleocytoplasmic transport (GO:0046822),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,NEDD4
regulation of phosphate metabolic process (GO:0019220),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,BARD1
regulation of platelet aggregation (GO:0090330),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SERPINE2
positive regulation of response to cytokine stimulus (GO:0060760),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,GAS6
neurotransmitter biosynthetic process (GO:0042136),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SLC6A3
detection of chemical stimulus involved in sensory perception of smell (GO:0050911),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,OR7C1
negative regulation of hemopoiesis (GO:1903707),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,MIXL1
glucuronate metabolic process (GO:0019585),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,UGT2A3
cell communication by electrical coupling involved in cardiac conduction (GO:0086064),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PKP2
copper ion transport (GO:0006825),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,ATOX1
neuromuscular process controlling balance (GO:0050885),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,MYO7A
amyloid-beta metabolic process (GO:0050435),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,BACE1
regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle (GO:0031657),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,EGFR
regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,KCNE1
neutrophil activation (GO:0042119),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,F2RL1
"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,ZNF385A
Golgi to vacuole transport (GO:0006896),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CCDC91
metallo-sulfur cluster assembly (GO:0031163),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,NUBP1
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,SYVN1
glycoside metabolic process (GO:0016137),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,FUCA1
regulation of histone modification (GO:0031056),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,MYOCD
"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CPSF4
positive regulation of heart rate (GO:0010460),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,EDN3
regulation of response to interferon-gamma (GO:0060330),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,PTPN2
positive regulation of smooth muscle contraction (GO:0045987),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,MYOCD
negative regulation of cation transmembrane transport (GO:1904063),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,CAB39
positive regulation of interleukin-8 secretion (GO:2000484),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,F2RL1
response to ATP (GO:0033198),1/14,0.5124411756667415,1,0,0,1.4285714285714284,0.9550990767772207,TAF1
epithelial tube morphogenesis (GO:0060562),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,TBX20;HES1
regulation of double-strand break repair (GO:2000779),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,KDM1A;FIGNL1
embryonic limb morphogenesis (GO:0030326),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,OSR2;SALL1
apoptotic mitochondrial changes (GO:0008637),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,BNIP3;SFN
positive regulation of leukocyte migration (GO:0002687),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,EDN3;F2RL1
ncRNA metabolic process (GO:0034660),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,TDRD12;FKBP6
response to peptide (GO:1901652),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,PRNP;IRS1
positive regulation of telomere maintenance via telomere lengthening (GO:1904358),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,MAPK1;AURKB
positive regulation of DNA binding (GO:0043388),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,HES1;HMGB1
negative regulation of endothelial cell migration (GO:0010596),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,HMGB1;DCN
endoplasmic reticulum organization (GO:0007029),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,VMP1;GET4
regulation of interleukin-1 beta secretion (GO:0050706),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,PANX1;CCL3
response to glucagon (GO:0033762),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,PRKAR1B;GNB1
regulation of interferon-beta production (GO:0032648),2/34,0.5125071338352726,1,0,0,1.176470588235294,0.7864007628092599,YY1;DDX3X
peptidyl-lysine modification (GO:0018205),6/115,0.5169320021309768,1,0,0,1.0434782608695652,0.6885328038765365,RNF212;ZNF451;TPR;TOP1;EEF1AKMT2;AURKB
negative regulation of cell growth (GO:0030308),6/115,0.5169320021309768,1,0,0,1.0434782608695652,0.6885328038765365,TCHP;DNAJB2;DDX3X;FRZB;NDUFS3;PTPRJ
positive regulation of programmed cell death (GO:0043068),13/257,0.5233303035504685,1,0,0,1.0116731517509727,0.6551013201044819,BARD1;DDX3X;TNFRSF12A;TGFB3;BNIP3;RRP1B;HMGB1;OBSCN;UBB;FRZB;RPS6KA2;ARHGEF3;RAC1
positive regulation of cysteine-type endopeptidase activity (GO:2001056),3/55,0.5234350892650081,1,0,0,1.0909090909090908,0.706191545588209,DDX3X;HMGB1;SOX7
positive regulation of DNA biosynthetic process (GO:2000573),3/55,0.5234350892650081,1,0,0,1.0909090909090908,0.706191545588209,PARM1;MAPK1;AURKB
Notch signaling pathway (GO:0007219),3/55,0.5234350892650081,1,0,0,1.0909090909090908,0.706191545588209,HEYL;UBB;HES1
positive regulation of protein metabolic process (GO:0051247),5/96,0.5278178232072942,1,0,0,1.0416666666666667,0.6656292568931363,BARD1;NEDD4;DTL;OAZ1;INS
epithelial cell differentiation (GO:0030855),5/96,0.5278178232072942,1,0,0,1.0416666666666667,0.6656292568931363,TST;BASP1;DEUP1;E2F7;E2F8
positive regulation of MAP kinase activity (GO:0043406),9/177,0.5278368946610092,1,0,0,1.0169491525423728,0.6497979199584173,PRKAA1;UBB;EDN3;IRAK2;RAPGEF1;MAPK1;TGFBR1;EGFR;INS
MAPK cascade (GO:0000165),14/278,0.5280373457046903,1,0,0,1.0071942446043165,0.6431824274720813,KSR1;IRS1;PSMA7;EGFR;INS;KITLG;UBB;TPR;IL2RB;CCL3;RAPGEF2;MAPK1;MAP3K8;CAMK2G
regulation of cyclin-dependent protein kinase activity (GO:1904029),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,CCNT1;GTF2H1
positive regulation of peptide secretion (GO:0002793),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,TGFB3;INS
negative regulation of protein kinase B signaling (GO:0051898),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,PTPRJ;NOP53
regulation of endothelial cell apoptotic process (GO:2000351),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,NDNF;GAS6
erythrocyte differentiation (GO:0030218),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,ALAS2;PTPN2
negative regulation of epithelial cell migration (GO:0010633),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,DCN;PBLD
tRNA transport (GO:0051031),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,TPR;TOMM20L
regulation of mitochondrial membrane potential (GO:0051881),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,UBB;PYCR1
regulation of ion transmembrane transport (GO:0034765),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,KCNE1;NEDD4
membrane protein proteolysis (GO:0033619),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,BACE1;NAPSA
negative regulation of tumor necrosis factor production (GO:0032720),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,IRAK3;GAS6
flagellated sperm motility (GO:0030317),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,ATP2B4;CCDC40
sulfur compound catabolic process (GO:0044273),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,HPSE;DCN
protein kinase B signaling (GO:0043491),2/35,0.5281643594916885,1,0,0,1.1428571428571428,0.7295402934851642,CCL3;GAS6
positive regulation of apoptotic signaling pathway (GO:2001235),4/76,0.531017425175643,1,0,0,1.0526315789473684,0.666274150005563,CYLD;TNFRSF12A;BNIP3;TGFBR1
positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437),4/76,0.531017425175643,1,0,0,1.0526315789473684,0.666274150005563,ANAPC16;UBB;CDC16;PSMA7
response to interleukin-1 (GO:0070555),4/76,0.531017425175643,1,0,0,1.0526315789473684,0.666274150005563,IRAK2;CCL3;IRAK3;CCL1
positive regulation of transferase activity (GO:0051347),7/137,0.5314567341654012,1,0,0,1.021897810218978,0.645975826925556,PARM1;ARRDC3;MAPK1;ROR2;MERTK;EGFR;AURKB
ribosome assembly (GO:0042255),3/56,0.5356989644779965,1,0,0,1.0714285714285714,0.6687674026318335,RPS15;DDX3X;NOP53
granulocyte chemotaxis (GO:0071621),3/56,0.5356989644779965,1,0,0,1.0714285714285714,0.6687674026318335,EDN3;CCL3;CCL1
organonitrogen compound catabolic process (GO:1901565),3/56,0.5356989644779965,1,0,0,1.0714285714285714,0.6687674026318335,BACE1;NAPSA;TST
positive regulation of protein transport (GO:0051222),3/56,0.5356989644779965,1,0,0,1.0714285714285714,0.6687674026318335,TGFB3;TPR;OAZ1
cellular iron ion homeostasis (GO:0006879),3/56,0.5356989644779965,1,0,0,1.0714285714285714,0.6687674026318335,ALAS2;UBB;NUBP1
ATP metabolic process (GO:0046034),3/56,0.5356989644779965,1,0,0,1.0714285714285714,0.6687674026318335,NMNAT1;FIGNL1;MYH6
myotube differentiation (GO:0014902),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ADAM12
atrioventricular valve morphogenesis (GO:0003181),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,HEYL
myeloid cell development (GO:0061515),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ZNF385A
regulation of mast cell degranulation (GO:0043304),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CD300A
catecholamine metabolic process (GO:0006584),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,DRD1
retinoic acid metabolic process (GO:0042573),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,STRA6
nuclear pore organization (GO:0006999),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,TPR
selective autophagy (GO:0061912),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,AMBRA1
maintenance of protein location in nucleus (GO:0051457),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SUN2
digestive tract morphogenesis (GO:0048546),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,STRA6
embryonic axis specification (GO:0000578),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SMAD2
positive regulation of mesonephros development (GO:0061213),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,BASP1
L-alpha-amino acid transmembrane transport (GO:1902475),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SLC1A1
G-protein coupled glutamate receptor signaling pathway (GO:0007216),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,GRM7
regulation of mitotic metaphase/anaphase transition (GO:0030071),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,NEK6
positive regulation of protein import (GO:1904591),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,TPR
"protein localization to chromosome, centromeric region (GO:0071459)",1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,AURKB
positive regulation of potassium ion transmembrane transport (GO:1901381),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,KCNE1
positive regulation of cytokine production involved in immune response (GO:0002720),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,F2RL1
regulation of interleukin-4 production (GO:0032673),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PRKCZ
anterograde synaptic vesicle transport (GO:0048490),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SNAPIN
cardiac muscle cell differentiation (GO:0055007),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,MYOCD
negative regulation of coagulation (GO:0050819),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SERPINE2
glycerophospholipid catabolic process (GO:0046475),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,GDE1
regulation of centriole replication (GO:0046599),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,BRCA1
dermatan sulfate proteoglycan biosynthetic process (GO:0050651),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,DCN
nitric oxide mediated signal transduction (GO:0007263),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,NDNF
positive regulation of phosphoprotein phosphatase activity (GO:0032516),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,CD300A
cellular response to virus (GO:0098586),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,RRP1B
positive regulation of acute inflammatory response (GO:0002675),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,OSM
mesenchymal cell development (GO:0014031),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,HEYL
regulation of delayed rectifier potassium channel activity (GO:1902259),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,KCNE1
vasculature development (GO:0001944),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,STRA6
regulation of mitochondrial translation (GO:0070129),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,TSFM
positive regulation of membrane protein ectodomain proteolysis (GO:0051044),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,FURIN
regulation of macrophage chemotaxis (GO:0010758),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,MST1L
negative regulation of signal transduction by p53 class mediator (GO:1901797),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,KDM1A
negative regulation of viral entry into host cell (GO:0046597),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,MID2
amide transport (GO:0042886),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,TAP1
cofactor transport (GO:0051181),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SLC48A1
body fluid secretion (GO:0007589),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,APLN
positive regulation of interleukin-4 production (GO:0032753),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PRKCZ
filopodium assembly (GO:0046847),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,DNM3
microtubule depolymerization (GO:0007019),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,STMN3
negative regulation of RNA metabolic process (GO:0051253),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PTBP3
positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,RAPGEF3
protein O-linked fucosylation (GO:0036066),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,ADAMTS5
JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,MAPK1
negative regulation of mRNA processing (GO:0050686),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,BARD1
regulation of RNA export from nucleus (GO:0046831),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,TPR
regulation of lymphocyte proliferation (GO:0050670),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,AHR
synaptic vesicle transport along microtubule (GO:0099517),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SNAPIN
cytoplasmic sequestering of protein (GO:0051220),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,GET4
sulfate transport (GO:0008272),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,SLC26A11
negative regulation of anoikis (GO:2000811),1/15,0.5368361352216328,1,0,0,1.3333333333333333,0.8294165061381815,PDK4
mitochondrial respiratory chain complex assembly (GO:0033108),5/97,0.5371052771771576,1,0,0,1.0309278350515463,0.6407846977351693,IMMP1L;NDUFB11;LYRM7;NDUFS3;NDUFV3
histone exchange (GO:0043486),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,HJURP;CENPM
muscle cell differentiation (GO:0042692),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,MYOCD;KDM1A
organic hydroxy compound transport (GO:0015850),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,ABCB11;STRA6
regulation of smoothened signaling pathway (GO:0008589),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,GAS1;KCTD6
lymphocyte proliferation (GO:0046651),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,IFNA7;TNFRSF4
natural killer cell activation (GO:0030101),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,IFNA7;SLAMF7
calcium ion transmembrane import into cytosol (GO:0097553),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,RYR1;ATP2B4
heart looping (GO:0001947),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,TBX20;CCDC40
regulation of blood circulation (GO:1903522),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,KCNIP2;MYH6
vesicle-mediated transport in synapse (GO:0099003),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,SNAPIN;TMEM230
centromere complex assembly (GO:0034508),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,HJURP;CENPM
cardiac muscle contraction (GO:0060048),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,TNNI1;MYH6
regulation of ubiquitin protein ligase activity (GO:1904666),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,ANAPC16;CDC16
negative regulation of blood coagulation (GO:0030195),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,SERPINE2;F2
inner mitochondrial membrane organization (GO:0007007),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,APOO;IMMT
glutamate receptor signaling pathway (GO:0007215),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,GRID2;GRM7
cardiac muscle tissue development (GO:0048738),2/36,0.5434764066615513,1,0,0,1.111111111111111,0.6775210926327332,MYOCD;TBX20
positive regulation of cellular biosynthetic process (GO:0031328),8/159,0.5439866166258719,1,0,0,1.0062893081761006,0.6126597577051573,KITLG;DDX3X;IRS1;TGFB3;EIF4A3;EGFR;PTPN2;INS
regulation of protein phosphorylation (GO:0001932),13/261,0.546078898833694,1,0,0,0.9961685823754788,0.6026738340336778,PRNP;TGFB3;ITGB3;BMP8A;F2;EGFR;MOB1B;CCDC88A;GPNMB;THPO;RAC1;GAS6;NOP53
phosphatidylinositol biosynthetic process (GO:0006661),5/98,0.5463079186398003,1,0,0,1.0204081632653061,0.616910723108701,MTMR14;INPP5J;PLEKHA3;PIGW;PLEKHA8
positive regulation of cell growth (GO:0030307),5/98,0.5463079186398003,1,0,0,1.0204081632653061,0.616910723108701,DDX3X;INO80;TGFBR1;EGFR;INS
regulation of glycolytic process (GO:0006110),3/57,0.5477812798713707,1,0,0,1.0526315789473684,0.6335570484502631,PRKAA1;TPR;INS
IRE1-mediated unfolded protein response (GO:0036498),3/57,0.5477812798713707,1,0,0,1.0526315789473684,0.6335570484502631,SYVN1;SRPRB;SEC62
regulation of Rho protein signal transduction (GO:0035023),3/57,0.5477812798713707,1,0,0,1.0526315789473684,0.6335570484502631,LPAR1;F2RL1;RAC1
chloride transmembrane transport (GO:1902476),3/57,0.5477812798713707,1,0,0,1.0526315789473684,0.6335570484502631,CLCN7;SLC1A1;SLC26A11
I-kappaB kinase/NF-kappaB signaling (GO:0007249),3/57,0.5477812798713707,1,0,0,1.0526315789473684,0.6335570484502631,UBB;IRAK2;CARD11
sensory perception of smell (GO:0007608),12/241,0.5478946475793864,1,0,0,0.9958506224066389,0.5991756940670975,OR8H2;OR2T27;OR1D2;OR5H1;OR2L13;OR51B5;OR10A2;OR2T12;OR2B6;OR2A5;OR7C1;OR10AD1
negative regulation of cell proliferation (GO:0008285),18/363,0.5490379252117642,1,0,0,0.9917355371900827,0.5946324885888693,MYOCD;CD300A;TGFB3;OSM;PTPRJ;PBLD;PARP10;DNAJB2;AZGP1;GPNMB;FRZB;RPS6KA2;RAPGEF2;HES1;ROR2;SOX7;E2F7;PTPN2
RNA export from nucleus (GO:0006405),6/119,0.5506572107989453,1,0,0,1.0084033613445378,0.6016565903086142,NPAP1;CPSF4;RBMX2;EIF4A3;TPR;CPSF2
brain development (GO:0007420),6/119,0.5506572107989453,1,0,0,1.0084033613445378,0.6016565903086142,BBS2;DMBX1;RAPGEF2;HSPG2;VCY;AFF2
negative regulation of apoptotic process (GO:0043066),24/485,0.5511223976764702,1,0,0,0.9896907216494845,0.5896561060495205,BARD1;DFFA;PRKAA1;DDX3X;TGFB3;BNIP3;NDNF;FMN2;MERTK;EGFR;INS;NR4A2;RNF144B;ARHGAP10;NUAK2;DNAJB6;UBB;FIGNL1;CLEC5A;IL2RB;PDK4;SFN;ROR2;GAS6
transcription initiation from RNA polymerase II promoter (GO:0006367),8/160,0.5511758519618988,1,0,0,1,0.5957013701808717,NR4A2;MED30;POLR2F;GTF2H1;GTF2E1;NR2C1;NR2C2AP;TAF1
sensory perception of mechanical stimulus (GO:0050954),4/78,0.5517212852986342,1,0,0,1.0256410256410255,0.6099613109295229,KCNE1;GRM7;HOXA1;MYO7A
negative regulation of cell communication (GO:0010648),4/78,0.5517212852986342,1,0,0,1.0256410256410255,0.6099613109295229,OSM;ROR2;MERTK;EGFR
visual perception (GO:0007601),4/78,0.5517212852986342,1,0,0,1.0256410256410255,0.6099613109295229,BBS2;RGS16;CRYBA4;MYO7A
negative regulation of inflammatory response (GO:0050728),4/78,0.5517212852986342,1,0,0,1.0256410256410255,0.6099613109295229,NLRP9;F2;PTPN2;INS
regulation of cell growth (GO:0001558),10/201,0.5523179780186385,1,0,0,0.9950248756218906,0.5906779616132228,TCHP;DNAJB2;DDX3X;FRZB;NDUFS3;PTPRJ;INO80;EGFR;TGFBR1;INS
regulation of small GTPase mediated signal transduction (GO:0051056),7/140,0.554630993923663,1,0,0,1,0.5894522621768664,ARHGAP10;OBSCN;ARHGAP19;RHOG;ARHGEF3;SRGAP3;RAC1
inorganic cation transmembrane transport (GO:0098662),7/140,0.554630993923663,1,0,0,1,0.5894522621768664,SLC30A4;UCP2;ATP2B4;TRPM7;GAS6;MCOLN1;SCN3A
negative regulation of intracellular signal transduction (GO:1902532),8/161,0.558318098786369,1,0,0,0.9937888198757763,0.5792063697084223,PRKAA1;DDX3X;DUSP1;TSPAN6;NDUFS3;ATP2B4;PTPRJ;NOP53
spliceosomal snRNP assembly (GO:0000387),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,SNRPG;SMN1
regulation of sodium ion transmembrane transporter activity (GO:2000649),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,FXYD6-FXYD2;NEDD4
phospholipid biosynthetic process (GO:0008654),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,GPAM;HDHD5
protein K63-linked ubiquitination (GO:0070534),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,HECTD1;NEDD4
regulation of peptidyl-threonine phosphorylation (GO:0010799),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,CAB39;MAPK1
negative regulation of G0 to G1 transition (GO:0070317),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,EPC1;BRCA1
response to steroid hormone (GO:0048545),2/37,0.5584386214472209,1,0,0,1.0810810810810811,0.62984925993825025,PAQR6;TGFB3
negative regulation of growth (GO:0045926),6/120,0.558921512029944,1,0,0,1,0.5817462235027698,TCHP;DNAJB2;DDX3X;FRZB;NDUFS3;PTPRJ
peptidyl-threonine dephosphorylation (GO:0035970),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,DUSP1
negative regulation of NF-kappaB import into nucleus (GO:0042347),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,CYLD
lipopolysaccharide-mediated signaling pathway (GO:0031663),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,CCL3
regulation of systemic arterial blood pressure by hormone (GO:0001990),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,EDN3
C21-steroid hormone biosynthetic process (GO:0006700),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,STARD3NL
dendritic cell chemotaxis (GO:0002407),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,HMGB1
fibrinolysis (GO:0042730),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,F2
positive regulation of cardiac muscle tissue growth (GO:0055023),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,TBX20
regulation of toll-like receptor 4 signaling pathway (GO:0034143),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,F2RL1
glucose 6-phosphate metabolic process (GO:0051156),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,PGM2
leukocyte tethering or rolling (GO:0050901),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SPN
negative regulation of response to wounding (GO:1903035),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,KLK8
regulation of RIG-I signaling pathway (GO:0039535),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,NOP53
regulation of reactive oxygen species biosynthetic process (GO:1903426),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,INS
protein deacylation (GO:0035601),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,LYPLA2
negative regulation of striated muscle cell differentiation (GO:0051154),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,BHLHA15
negative regulation of steroid biosynthetic process (GO:0010894),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,ERLIN2
regulation of histone H3-K4 methylation (GO:0051569),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,BRCA1
leukocyte adhesion to vascular endothelial cell (GO:0061756),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SPN
positive regulation of lymphocyte differentiation (GO:0045621),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,GAS6
guanosine-containing compound metabolic process (GO:1901068),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,GNAI3
extracellular matrix assembly (GO:0085029),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,GAS6
negative regulation of transcription regulatory region DNA binding (GO:2000678),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,TAF1
positive regulation of immune system process (GO:0002684),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,LILRB2
cellular response to pH (GO:0071467),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,MCOLN1
hexose transport (GO:0008645),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SLC2A13
neuron apoptotic process (GO:0051402),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,BNIP3
positive regulation of cilium assembly (GO:0045724),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,CCDC88A
rRNA transcription (GO:0009303),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,GTF3C2
regulation of osteoblast proliferation (GO:0033688),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,HPSE
bone morphogenesis (GO:0060349),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,OSR2
genitalia development (GO:0048806),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,STRA6
positive regulation of nitric-oxide synthase activity (GO:0051000),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,INS
positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,FOXC2
G-protein coupled acetylcholine receptor signaling pathway (GO:0007213),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,GNB1
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,DDX3X
regulation of necroptotic process (GO:0060544),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,UBB
activation of protein kinase A activity (GO:0034199),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,PRKAR1B
regulation of membrane repolarization (GO:0060306),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,KCNE1
positive regulation of leukocyte activation (GO:0002696),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SPACA3
endoplasmic reticulum to cytosol transport (GO:1903513),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SYVN1
ruffle organization (GO:0031529),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,RAC1
myoblast differentiation (GO:0045445),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,SOX15
positive regulation of positive chemotaxis (GO:0050927),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,F2RL1
inner dynein arm assembly (GO:0036159),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,CCDC40
mesenchyme development (GO:0060485),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,TGFBR1
regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,DDIAS
"positive regulation of DNA-templated transcription, initiation (GO:2000144)",1/16,0.560011650943978,1,0,0,1.25,0.7247471127653313,TAF1
negative regulation of mitotic cell cycle phase transition (GO:1901991),4/79,0.561890006637219,1,0,0,1.0126582278481011,0.5837459908567373,UBB;GPNMB;PSMA7;E2F7
cation transport (GO:0006812),4/79,0.561890006637219,1,0,0,1.0126582278481011,0.5837459908567373,PANX1;SLC1A1;MCOLN1;ATOX1
steroid biosynthetic process (GO:0006694),4/79,0.561890006637219,1,0,0,1.0126582278481011,0.5837459908567373,CYP39A1;STARD3NL;ABCB11;LBR
response to calcium ion (GO:0051592),4/79,0.561890006637219,1,0,0,1.0126582278481011,0.5837459908567373,RYR1;KCNIP2;NEDD4;MCOLN1
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),5/100,0.5644459548061124,1,0,0,1,0.5719106399118082,CPSF4;RBMX2;EIF4A3;TPR;CPSF2
cell junction assembly (GO:0034329),3/59,0.5713815260202666,1,0,0,1.0169491525423728,0.5691845296161483,VMP1;FBLIM1;CDH19
regulation of extrinsic apoptotic signaling pathway (GO:2001236),3/59,0.5713815260202666,1,0,0,1.0169491525423728,0.5691845296161483,CYLD;TNFRSF12A;TGFBR1
cell morphogenesis (GO:0000902),3/59,0.5713815260202666,1,0,0,1.0169491525423728,0.5691845296161483,RHOG;RAC1;CDH19
RNA transport (GO:0050658),4/80,0.5719316453053178,1,0,0,1,0.5587357959576575,NPAP1;TST;EIF4A3;TPR
regulation of protein serine/threonine kinase activity (GO:0071900),4/80,0.5719316453053178,1,0,0,1,0.5587357959576575,DDX3X;CCNT1;CAB39;GTF2H1
neuron projection morphogenesis (GO:0048812),8/163,0.5724547815603112,1,0,0,0.9815950920245399,0.5475548769053109,LINGO2;LRFN2;LRFN5;UBB;RHOG;RAC1;KLK8;LLGL1
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),8/163,0.5724547815603112,1,0,0,0.9815950920245399,0.5475548769053109,UBB;SLC20A1;TSPAN6;NEK6;LPAR1;F2RL1;LURAP1;MID2
membrane depolarization during action potential (GO:0086010),2/38,0.5730476768580657,1,0,0,1.0526315789473684,0.5860909053082317,CACNA1B;SCN3A
homotypic cell-cell adhesion (GO:0034109),2/38,0.5730476768580657,1,0,0,1.0526315789473684,0.5860909053082317,ITGB3;GAS6
regulation of cellular pH (GO:0030641),2/38,0.5730476768580657,1,0,0,1.0526315789473684,0.5860909053082317,SLC4A9;SLC26A11
metal ion transport (GO:0030001),5/101,0.5733754172932677,1,0,0,0.9900990099009901,0.5507075230503586,KCNH3;KCNF1;KCNIP2;SCN3A;ATOX1
sulfur compound biosynthetic process (GO:0044272),6/122,0.5752322098774906,1,0,0,0.9836065573770492,0.5439162063367176,EXT1;GSTZ1;EXT2;GSTO2;CHST5;DCN
glycerophospholipid biosynthetic process (GO:0046474),8/164,0.5794459572335974,1,0,0,0.975609756097561,0.5323735396380541,GPAM;DGKA;MTMR14;INPP5J;PLEKHA3;HDHD5;PLD2;PLEKHA8
positive regulation of protein targeting to mitochondrion (GO:1903955),4/81,0.5818428728182232,1,0,0,0.9876543209876543,0.5348689833845679,LEPROT;ITGAX;TDRD12;HES1
epidermis development (GO:0008544),4/81,0.5818428728182232,1,0,0,0.9876543209876543,0.5348689833845679,LAMA3;KRT5;POU2F3;RPTN
sensory perception of light stimulus (GO:0050953),4/81,0.5818428728182232,1,0,0,0.9876543209876543,0.5348689833845679,BBS2;RGS16;CRYBA4;MYO7A
sensory perception of sound (GO:0007605),4/81,0.5818428728182232,1,0,0,0.9876543209876543,0.5348689833845679,KCNE1;GRM7;HOXA1;MYO7A
regulation of protein sumoylation (GO:0033233),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,GNL3
cardiac myofibril assembly (GO:0055003),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,OBSL1
regulation of multicellular organism growth (GO:0040014),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,BBS2
regulation of tissue remodeling (GO:0034103),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,GPNMB
positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,TAF1
cellular glucuronidation (GO:0052695),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,UGT2A3
positive regulation of G-protein coupled receptor protein signaling pathway (GO:0045745),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,F2
regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,IGFBP1
positive regulation of epidermal cell differentiation (GO:0045606),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SFN
cellular response to gamma radiation (GO:0071480),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,KDM1A
ureteric bud development (GO:0001657),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SALL1
preassembly of GPI anchor in ER membrane (GO:0016254),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,PIGW
negative regulation of B cell activation (GO:0050869),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CD300A
"mRNA cis splicing, via spliceosome (GO:0045292)",1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,DDX23
positive regulation of striated muscle cell differentiation (GO:0051155),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,MYOCD
regulation of myelination (GO:0031641),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,KLK8
positive regulation of stem cell proliferation (GO:2000648),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,THPO
spindle assembly checkpoint (GO:0071173),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,TPR
negative regulation of cellular carbohydrate metabolic process (GO:0010677),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,INS
peptidyl-lysine trimethylation (GO:0018023),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,EEF2KMT
rRNA catabolic process (GO:0016075),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,TRIR
regulation of protein localization to membrane (GO:1905475),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,INS
response to purine-containing compound (GO:0014074),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,RYR1
phospholipid catabolic process (GO:0009395),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,GDE1
positive regulation of signal transduction by p53 class mediator (GO:1901798),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,UBB
positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SLAMF6
positive regulation of macrophage activation (GO:0043032),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SPACA3
long-term memory (GO:0007616),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,PRNP
virion assembly (GO:0019068),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,UBB
heterocycle biosynthetic process (GO:0018130),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,PYCR1
defense response to fungus (GO:0050832),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,RNASE7
regulation of T cell migration (GO:2000404),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SPN
regulation of lamellipodium organization (GO:1902743),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,RAC1
regulation of establishment or maintenance of cell polarity (GO:0032878),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,LLGL1
regulation of B cell receptor signaling pathway (GO:0050855),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,CD300A
purine-containing compound metabolic process (GO:0072521),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,MACROD1
mesonephric tubule development (GO:0072164),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SALL1
regulation of early endosome to late endosome transport (GO:2000641),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,MAPK1
nucleobase-containing compound biosynthetic process (GO:0034654),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,TYMS
positive regulation of cation transmembrane transport (GO:1904064),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,KCNE1
platelet-derived growth factor receptor signaling pathway (GO:0048008),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,PTPRJ
positive regulation of transcription of Notch receptor target (GO:0007221),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,HEYL
mitotic spindle assembly checkpoint (GO:0007094),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,TPR
mitotic spindle checkpoint (GO:0071174),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,TPR
positive regulation of natural killer cell mediated immunity (GO:0002717),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,SLAMF6
mitotic G2 DNA damage checkpoint (GO:0007095),1/17,0.5820286217003197,1,0,0,1.176470588235294,0.6367478285654856,NOP53
cell chemotaxis (GO:0060326),3/60,0.5828910435264506,1,0,0,1,0.5397549994176116,RHOG;LPAR1;FPR3
positive regulation of protein binding (GO:0032092),3/60,0.5828910435264506,1,0,0,1,0.5397549994176116,BAMBI;RAPGEF2;TAF1
muscle organ development (GO:0007517),3/60,0.5828910435264506,1,0,0,1,0.5397549994176116,SGCE;COPRS;MYH6
cellular protein complex assembly (GO:0043623),7/144,0.5847203579347515,1,0,0,0.9722222222222222,0.521715412033393,SMAD2;SRP19;IMMP1L;TOMM20L;EIF4H;TBCC;CCDC40
regulation of mitotic cell cycle (GO:0007346),8/165,0.5863836234120163,1,0,0,0.9696969696969696,0.5176058726133539,CYLD;NEK6;CDC16;GAS1;MAP3K8;FBXO43;OBSL1;TTC28
skeletal muscle tissue development (GO:0007519),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,RYR1;ACTA1
ERBB2 signaling pathway (GO:0038128),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,UBB;EGFR
purine ribonucleoside monophosphate metabolic process (GO:0009167),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,FIGNL1;MYH6
positive regulation of reactive oxygen species metabolic process (GO:2000379),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,F2RL1;F2
regulation of plasma membrane bounded cell projection assembly (GO:0120032),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,CYLD;RAC1
Golgi to plasma membrane transport (GO:0006893),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,BBS2;LLGL1
acyl-CoA metabolic process (GO:0006637),2/39,0.5873014514915549,1,0,0,1.0256410256410255,0.5458636358886607,DBI;ACACB
positive regulation of ubiquitin protein ligase activity (GO:1904668),4/82,0.591620653904691,1,0,0,0.975609756097561,0.5120874505494942,ANAPC16;UBB;CDC16;PSMA7
positive regulation of protein secretion (GO:0050714),4/82,0.591620653904691,1,0,0,0.975609756097561,0.5120874505494942,TGFB3;F2RL1;TNFRSF4;INS
actin cytoskeleton reorganization (GO:0031532),3/61,0.5942021207725078,1,0,0,0.9836065573770492,0.5120023739386589,RHOG;S1PR1;RAC1
potassium ion transport (GO:0006813),3/61,0.5942021207725078,1,0,0,0.9836065573770492,0.5120023739386589,KCNH3;KCNF1;KCNIP2
regulation of tyrosine phosphorylation of STAT protein (GO:0042509),3/61,0.5942021207725078,1,0,0,0.9836065573770492,0.5120023739386589,OSM;HES1;PTPN2
positive regulation of T cell proliferation (GO:0042102),3/61,0.5942021207725078,1,0,0,0.9836065573770492,0.5120023739386589,TMIGD2;HMGB1;LILRB2
regulation of tumor necrosis factor production (GO:0032680),3/61,0.5942021207725078,1,0,0,0.9836065573770492,0.5120023739386589,CCL3;IRAK3;GAS6
RNA 3'-end processing (GO:0031123),3/61,0.5942021207725078,1,0,0,0.9836065573770492,0.5120023739386589,CPSF4;EIF4A3;CPSF2
"G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",6/125,0.5991206229248341,1,0,0,0.96,0.4918006342162246,GALR2;NPBWR1;GNAI3;DRD1;HTR4;CCR3
mRNA transport (GO:0051028),5/104,0.599573857726415,1,0,0,0.9615384615384616,0.49186164733317733,CPSF4;RBMX2;EIF4A3;TPR;CPSF2
regulation of protein dephosphorylation (GO:0035304),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,PPP1R14A;LILRB2
sensory organ development (GO:0007423),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,SMCHD1;STRA6
positive regulation of mitotic nuclear division (GO:0045840),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,EDN3;INS
negative regulation of cytokine secretion (GO:0050710),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,F2RL1;GAS6
response to peptide hormone (GO:0043434),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,IRS1;INS
regulation of ATPase activity (GO:0043462),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,DNAJB2;MYH6
determination of heart left/right asymmetry (GO:0061371),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,TBX20;CCDC40
JAK-STAT cascade (GO:0007259),2/40,0.60119891797304,1,0,0,1,0.5088294208836465,MAPK1;HES1
negative regulation of signaling (GO:0023057),4/83,0.6012622374752512,1,0,0,0.963855421686747,0.4903364861494962,OSM;ROR2;MERTK;EGFR
positive regulation of protein ubiquitination (GO:0031398),4/83,0.6012622374752512,1,0,0,0.963855421686747,0.4903364861494962,KDM1A;UBB;ARRDC3;BRCA1
negative regulation of endopeptidase activity (GO:0010951),4/83,0.6012622374752512,1,0,0,0.963855421686747,0.4903364861494962,SERPINB1;SERPINE2;ANXA8;SERPINI1
glucan catabolic process (GO:0009251),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,PGM2
"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,DRD1
membrane protein ectodomain proteolysis (GO:0006509),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,BACE1
iron-sulfur cluster assembly (GO:0016226),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,NUBP1
actin filament polymerization (GO:0030041),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,RAC1
anion transmembrane transport (GO:0098656),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,SLC35A3
regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,SMAD2
negative regulation of osteoclast differentiation (GO:0045671),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,CCL3
regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,IFNA7
release of cytochrome c from mitochondria (GO:0001836),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,SFN
calcium-mediated signaling using intracellular calcium source (GO:0035584),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,PRNP
positive regulation of lipid catabolic process (GO:0050996),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,IRS1
positive regulation of cyclic nucleotide biosynthetic process (GO:0030804),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,GPHB5
regulation of mitochondrial membrane permeability (GO:0046902),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,BNIP3
regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,SCARB2
negative regulation of RNA splicing (GO:0033119),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,PTBP3
regulation of dephosphorylation (GO:0035303),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,PPP1R14A
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,INS
"retrograde protein transport, ER to cytosol (GO:0030970)",1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,SYVN1
regulation of cardiac muscle cell membrane repolarization (GO:0099623),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,KCNE1
tRNA metabolic process (GO:0006399),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,THG1L
glycogen catabolic process (GO:0005980),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,PGM2
acute-phase response (GO:0006953),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,INS
regulation of cAMP-mediated signaling (GO:0043949),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,RAPGEF2
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,INS
positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,IFNA7
negative regulation of protein transport (GO:0051224),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,INS
DNA methylation (GO:0006306),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,ZFP57
regulation of peptidase activity (GO:0052547),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,FURIN
establishment of epithelial cell polarity (GO:0090162),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,CYTH3
glyceraldehyde-3-phosphate metabolic process (GO:0019682),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,PGM2
response to organophosphorus (GO:0046683),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,TYMS
DNA ligation (GO:0006266),1/18,0.6029449082085762,1,0,0,1.111111111111111,0.5621438325188578,HMGB1
positive regulation of type I interferon production (GO:0032481),3/62,0.6053118695713461,1,0,0,0.9677419354838709,0.48581754858797044,ZBP1;DDX3X;POLR2F
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),3/62,0.6053118695713461,1,0,0,0.9677419354838709,0.48581754858797044,UBB;AURKB;PSMA7
negative regulation of peptidase activity (GO:0010466),3/62,0.6053118695713461,1,0,0,0.9677419354838709,0.48581754858797044,SERPINB1;SERPINE2;SERPINI1
establishment of protein localization to organelle (GO:0072594),3/62,0.6053118695713461,1,0,0,0.9677419354838709,0.48581754858797044,NPAP1;IPO11;RAB11A
regulation of T cell proliferation (GO:0042129),3/62,0.6053118695713461,1,0,0,0.9677419354838709,0.48581754858797044,SPN;GPNMB;LILRB2
G2/M transition of mitotic cell cycle (GO:0000086),6/126,0.6069214709956913,1,0,0,0.9523809523809523,0.47557701773519845,UBB;HAUS8;HAUS4;HAUS3;HAUS6;FBXL15
mRNA export from nucleus (GO:0006406),5/105,0.6081022529852088,1,0,0,0.9523809523809523,0.47372593514716843,CPSF4;RBMX2;EIF4A3;TPR;CPSF2
protein modification process (GO:0036211),4/84,0.61076514771337,1,0,0,0.9523809523809523,0.4695645403132304,UBL4A;ERO1B;UBA7;GNMT
regulation of cell cycle G2/M phase transition (GO:1902749),4/84,0.61076514771337,1,0,0,0.9523809523809523,0.4695645403132304,HAUS8;HAUS4;HAUS3;HAUS6
cell cycle G2/M phase transition (GO:0044839),6/127,0.6146383855730021,1,0,0,0.9448818897637795,0.45989402366767695,UBB;HAUS8;HAUS4;HAUS3;HAUS6;FBXL15
bicarbonate transport (GO:0015701),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,SLC4A9;SLC26A11
DNA duplex unwinding (GO:0032508),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,UBB;GTF2H1
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,PCDHB11;CDH19
negative regulation of cell projection organization (GO:0031345),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,PRNP;LPAR1
negative regulation of STAT cascade (GO:1904893),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,LEPROT;DCN
monocyte chemotaxis (GO:0002548),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,CCL3;CCL1
regulation of cellular metabolic process (GO:0031323),2/41,0.6147400385913487,1,0,0,0.975609756097561,0.47468858733322344,PDK4;ACACB
vesicle coating (GO:0006901),3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,TRAPPC6A;TMED10;USO1
COPII vesicle coating (GO:0048208),3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,TRAPPC6A;TMED10;USO1
iron ion homeostasis (GO:0055072),3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,ALAS2;UBB;NUBP1
"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,TRAPPC6A;TMED10;USO1
regulation of proteolysis (GO:0030162),3/63,0.6162178817161523,1,0,0,0.9523809523809523,0.4610996894309503,SERPINE2;F2;INS
RNA splicing (GO:0008380),5/106,0.6165249871762161,1,0,0,0.9433962264150944,0.4562796476411569,SRPK2;EIF4A3;DDX23;SNRPG;WDR62
regulation of cell migration (GO:0030334),15/316,0.6194229331200537,1,0,0,0.949367088607595,0.45471549436208863,SUN2;SERPINE2;PTPRJ;EGFR;TGFBR1;INS;GPNMB;CCL3;F2RL1;AMOTL2;RAC1;ROR2;SRGAP3;DRD1;CBLL1
RNA metabolic process (GO:0016070),9/191,0.620086711238695,1,0,0,0.9424083769633508,0.45037315025853986,DDX3X;DHX57;PABPC4;EIF4A3;DDX23;SNRPG;DDX42;DDX54;POLR2F
mitochondrial ATP synthesis coupled electron transport (GO:0042775),4/85,0.6201271748700885,1,0,0,0.9411764705882353,0.4497230129121684,NDUFB11;NDUFS3;NDUFV3;SDHA
positive regulation of mitochondrion organization (GO:0010822),6/128,0.6222697663749293,1,0,0,0.9375,0.4447327240020074,LEPROT;BNIP3;TDRD12;ITGAX;HES1;DCN
regulation of mitotic spindle assembly (GO:1901673),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TPR
protein import into mitochondrial matrix (GO:0030150),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TOMM20L
regulation of protein kinase A signaling (GO:0010738),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,SPHKAP
negative regulation of lymphocyte activation (GO:0051250),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,GPNMB
protein ADP-ribosylation (GO:0006471),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,PARP10
histone methylation (GO:0016571),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,SETD6
cellular polysaccharide catabolic process (GO:0044247),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,PGM2
NADP metabolic process (GO:0006739),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,PGM2
acetylcholine receptor signaling pathway (GO:0095500),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,GNB1
positive regulation of STAT cascade (GO:1904894),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,HES1
protein exit from endoplasmic reticulum (GO:0032527),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,SYVN1
negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TAF1
sulfur compound transport (GO:0072348),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,SLC26A11
regulation of myotube differentiation (GO:0010830),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,BHLHA15
muscle tissue morphogenesis (GO:0060415),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TBX20
cyclic nucleotide biosynthetic process (GO:0009190),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,GUCY1B2
excitatory postsynaptic potential (GO:0060079),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,GRID2
cellular response to zinc ion (GO:0071294),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,ZNF658
positive regulation of oxidoreductase activity (GO:0051353),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,POR
ribosomal small subunit assembly (GO:0000028),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,RPS15
intracellular estrogen receptor signaling pathway (GO:0030520),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,DDX54
gamma-aminobutyric acid signaling pathway (GO:0007214),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,HTR4
striated muscle cell differentiation (GO:0051146),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,MYOCD
cellular response to interleukin-7 (GO:0098761),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,IRS1
histone deubiquitination (GO:0016578),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,USP21
positive regulation of excitatory postsynaptic potential (GO:2000463),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,PRKCZ
regulation of neuron migration (GO:2001222),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,RAPGEF2
positive regulation of immunoglobulin production (GO:0002639),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TNFRSF4
nucleotide-sugar biosynthetic process (GO:0009226),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,RENBP
regulation of platelet activation (GO:0010543),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,F2
calcium ion transport into cytosol (GO:0060402),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,ATP2B4
interleukin-7-mediated signaling pathway (GO:0038111),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,IRS1
negative regulation of calcium ion transport (GO:0051926),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,LILRB2
telomere capping (GO:0016233),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,TERF1
hexose transmembrane transport (GO:0035428),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,SLC2A13
positive regulation of epithelial cell differentiation (GO:0030858),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,SFN
regulation of cAMP biosynthetic process (GO:0030817),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,GPHB5
mitochondrial membrane organization (GO:0007006),1/19,0.6228154838888618,1,0,0,1.0526315789473684,0.4984262922061619,BNIP3
cellular response to starvation (GO:0009267),5/107,0.6248402405451496,1,0,0,0.9345794392523363,0.43949465144730016,PRKAA1;NUAK2;PDK4;MAPK1;BHLHA15
negative regulation of response to external stimulus (GO:0032102),5/107,0.6248402405451496,1,0,0,0.9345794392523363,0.43949465144730016,GRID2;NLRP9;DRD1;KLK8;PTPN2
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),3/64,0.6269182035693374,1,0,0,0.9375,0.4377555034562452,SMAGP;PECAM1;CDH19
positive regulation of JAK-STAT cascade (GO:0046427),3/64,0.6269182035693374,1,0,0,0.9375,0.4377555034562452,OSM;HES1;F2
NADH dehydrogenase complex assembly (GO:0010257),3/64,0.6269182035693374,1,0,0,0.9375,0.4377555034562452,NDUFB11;NDUFS3;NDUFV3
mitochondrial respiratory chain complex I biogenesis (GO:0097031),3/64,0.6269182035693374,1,0,0,0.9375,0.4377555034562452,NDUFB11;NDUFS3;NDUFV3
mitochondrial respiratory chain complex I assembly (GO:0032981),3/64,0.6269182035693374,1,0,0,0.9375,0.4377555034562452,NDUFB11;NDUFS3;NDUFV3
cellular response to calcium ion (GO:0071277),2/42,0.6279256694973029,1,0,0,0.9523809523809523,0.4431747430401906,RYR1;MCOLN1
calcium ion transmembrane transport (GO:0070588),4/86,0.6293463661035574,1,0,0,0.9302325581395349,0.4307660579611482,ATP2B4;TRPM7;GAS6;MCOLN1
RNA processing (GO:0006396),9/193,0.6324859877108375,1,0,0,0.9326424870466321,0.4272409235217067,SRPK2;KIN;DHX57;PABPC4;EIF4A3;DDX23;SNRPG;DDX54;WDR62
regulation of protein activation cascade (GO:2000257),5/108,0.6330463554564062,1,0,0,0.9259259259259258,0.4233441001393671,C8G;C7;PROS1;SUSD4;F2
nucleotide-excision repair (GO:0006289),5/108,0.6330463554564062,1,0,0,0.9259259259259258,0.4233441001393671,UBB;ERCC4;RPA3;POLR2F;GTF2H1
protein ubiquitination (GO:0016567),24/506,0.63535797093826,1,0,0,0.9486166007905137,0.4302609060868843,BARD1;UBL4A;ANAPC16;USP5;UBA7;UBE3D;SYVN1;FBXL15;KLHL3;BRCA1;PSMA7;FBXL12;RNF144B;HECTD1;UBB;RUSC1;NEDD4;ENC1;WAC;ELOB;DTL;CBLL1;RNF187;TAF1
positive regulation of protein modification by small protein conjugation or removal (GO:1903322),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,UBB;BRCA1;GNL3
negative regulation of cell adhesion (GO:0007162),3/65,0.6374113112791769,1,0,0,0.9230769230769231,0.41569858263660475,SPN;FZD4;CBLL1
regulation of cell cycle (GO:0051726),10/215,0.6379250607189172,1,0,0,0.9302325581395349,0.4181715927669713,SRPK2;CYLD;RPS6KA2;FIGNL1;NEK6;MAP3K8;PRR11;DTL;NOP53;TTC28
mitochondrial translational elongation (GO:0070125),4/87,0.6384210161989183,1,0,0,0.9195402298850575,0.41265040301361416,MRPL52;TSFM;MRPL51;MRPL57
positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060),4/87,0.6384210161989183,1,0,0,0.9195402298850575,0.41265040301361416,ANAPC16;UBB;CDC16;PSMA7
positive regulation of cellular component biogenesis (GO:0044089),4/87,0.6384210161989183,1,0,0,0.9195402298850575,0.41265040301361416,GRID2;TPR;TERF1;MPP7
mitotic metaphase plate congression (GO:0007080),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,KIFC1;RAB11A
male gonad development (GO:0008584),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,KITLG;SOX15
membrane depolarization (GO:0051899),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,CACNA1B;SCN3A
development of primary male sexual characteristics (GO:0046546),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,KITLG;SOX15
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,ZNF346;ZNF385A
response to unfolded protein (GO:0006986),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,DNAJB2;DNAJB5
positive regulation of protein localization to plasma membrane (GO:1903078),2/43,0.6407574714002146,1,0,0,0.9302325581395349,0.41405046828616976,RHOG;EGFR
regulation of complement activation (GO:0030449),5/109,0.6411418318346604,1,0,0,0.9174311926605505,0.4078023669950098,C8G;C7;PROS1;SUSD4;F2
Wnt signaling pathway (GO:0016055),5/109,0.6411418318346604,1,0,0,0.9174311926605505,0.4078023669950098,NR4A2;DDX3X;UBB;FZD4;FRZB
regulation of Wnt signaling pathway (GO:0030111),5/109,0.6411418318346604,1,0,0,0.9174311926605505,0.4078023669950098,DKK4;SALL1;FRZB;NLK;SOX7
regulation of vacuole organization (GO:0044088),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,SCARB2
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,SYVN1
proteoglycan metabolic process (GO:0006029),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,HPSE
regulation of epidermal cell differentiation (GO:0045604),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,SFN
natural killer cell activation involved in immune response (GO:0002323),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,IFNA7
ureteric bud morphogenesis (GO:0060675),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,SALL1
positive regulation of dendritic spine development (GO:0060999),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,LRP8
regulation of regulatory T cell differentiation (GO:0045589),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,LILRB2
regulation of lipoprotein lipase activity (GO:0051004),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,FURIN
response to progesterone (GO:0032570),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,TGFB3
negative regulation of cyclase activity (GO:0031280),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,GNAI3
phosphatidylethanolamine metabolic process (GO:0046337),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,NAPEPLD
neuromuscular junction development (GO:0007528),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,NEDD4
"regulation of DNA-templated transcription, elongation (GO:0032784)",1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,TSFM
regulation of calcium ion transmembrane transport (GO:1903169),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,PRNP
dopamine metabolic process (GO:0042417),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,DRD1
adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,RAPGEF2
autophagy of nucleus (GO:0044804),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,ATG12
regulation of anoikis (GO:2000209),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,PDK4
regulation of cell development (GO:0060284),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,INS
positive regulation of gene silencing by miRNA (GO:2000637),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,EGFR
striated muscle cell development (GO:0055002),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,MYH6
regulation of response to cytokine stimulus (GO:0060759),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,IRAK2
branching involved in ureteric bud morphogenesis (GO:0001658),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,SALL1
negative regulation of telomere maintenance via telomerase (GO:0032211),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,TERF1
growth hormone receptor signaling pathway (GO:0060396),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,MAPK1
organelle disassembly (GO:1903008),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,DENR
regulation of toll-like receptor signaling pathway (GO:0034121),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,IRAK3
steroid hormone mediated signaling pathway (GO:0043401),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,MED30
positive regulation of T cell migration (GO:2000406),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,SPN
adrenergic receptor signaling pathway (GO:0071875),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,RAPGEF2
telomere maintenance via telomerase (GO:0007004),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,TERF1
vesicle cytoskeletal trafficking (GO:0099518),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,MYO5A
regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,APLN
negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,TCHP
negative regulation of adenylate cyclase activity (GO:0007194),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,GNAI3
chondroitin sulfate biosynthetic process (GO:0030206),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,DCN
immune response-activating cell surface receptor signaling pathway (GO:0002429),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,FPR3
dopaminergic neuron differentiation (GO:0071542),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,NR4A2
regulation of transport (GO:0051049),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,RAB11A
positive regulation of cAMP biosynthetic process (GO:0030819),1/20,0.6416925793416899,1,0,0,1,0.4436459383541027,GPHB5
proteasomal protein catabolic process (GO:0010498),11/237,0.643147577200679,1,0,0,0.9282700421940928,0.40972082219583955,UCHL1;KAT5;ANAPC16;UBB;UBXN11;NEDD4;CDC16;ENC1;SYVN1;PSMA7;RNF187
regulation of stem cell differentiation (GO:2000736),4/88,0.6473496582204271,1,0,0,0.9090909090909091,0.39533518222257213,UBB;HES1;SP7;PSMA7
regulation of protein targeting to mitochondrion (GO:1903214),4/88,0.6473496582204271,1,0,0,0.9090909090909091,0.39533518222257213,LEPROT;ITGAX;TDRD12;HES1
positive regulation of protein complex assembly (GO:0031334),4/88,0.6473496582204271,1,0,0,0.9090909090909091,0.39533518222257213,ERCC4;RPA3;GTF2H1;MPP7
purine ribonucleotide metabolic process (GO:0009150),3/66,0.6476960862533626,1,0,0,0.9090909090909091,0.3948488139467768,FIGNL1;GNAI3;MYH6
viral gene expression (GO:0019080),5/110,0.6491253231277532,1,0,0,0.9090909090909091,0.3928449809345964,RPS15;TPR;FURIN;RPL15;RPL29
positive regulation of establishment of protein localization to mitochondrion (GO:1903749),5/110,0.6491253231277532,1,0,0,0.9090909090909091,0.3928449809345964,LEPROT;TDRD12;ITGAX;SFN;HES1
cellular response to peptide hormone stimulus (GO:0071375),5/110,0.6491253231277532,1,0,0,0.9090909090909091,0.3928449809345964,NR4A2;PRKAR1B;IRS1;GNB1;MYO5A
sprouting angiogenesis (GO:0002040),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,E2F7;E2F8
heart contraction (GO:0060047),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,TNNI1;MYH6
regulation of intracellular pH (GO:0051453),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,SLC4A9;SLC26A11
mitotic nuclear envelope disassembly (GO:0007077),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,NEK6;TPR
metaphase plate congression (GO:0051310),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,KIFC1;RAB11A
positive regulation of viral process (GO:0048524),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,CCNT1;POLR2F
myeloid cell differentiation (GO:0030099),2/44,0.6532378269725155,1,0,0,0.9090909090909091,0.38710364483347576,ALAS2;PTPN2
"regulation of transcription, DNA-templated (GO:0006355)",77/1598,0.6532561089683414,1,0,0,0.9637046307884856,0.41033196206176187,KDM1A;ZC3H4;NAB2;ZNF43;BRCA1;HMGB1;AHR;CHD1;FERD3L;YY1;DMBX1;ELK4;RPS6KA4;SALL1;KAT5;ZNF83;BASP1;SOX15;ZNF528;EPC1;PITX2;TNFRSF4;SOX7;OSR2;TSFM;FOXD2;MYOCD;ZBTB38;RFX2;RHOG;ZNF12;ETV2;COMMD7;TGFBR1;RFX4;WAC;GAS6;HOXB7;ZNF432;KMT2D;FOXC2;MLLT3;NLK;TYMS;GTF2E1;EGFR;INS;MED30;TBX20;NRIP1;SAFB2;ZNF789;ZNF623;HES1;ZNF468;SRY;ZBED6;ZNF541;TCFL5;SMAD2;KDM4A;FZD4;ANKRD30A;TGFB3;USP21;NFYC;PRRX2;ATP2B4;CDC5L;HNRNPAB;POU2F3;HEYL;BAMBI;ZNF658;SP7;TAF1;RNF187
SRP-dependent cotranslational protein targeting to membrane (GO:0006614),4/89,0.6561310542796738,1,0,0,0.898876404494382,0.3787817816859613,RPS15;SRP19;RPL15;RPL29
positive regulation of synaptic transmission (GO:0050806),3/67,0.657771791741192,1,0,0,0.8955223880597014,0.3751318467538853,DRD1;PRKCZ;INS
negative regulation of protein binding (GO:0032091),3/67,0.657771791741192,1,0,0,0.8955223880597014,0.3751318467538853,DNAJB2;KDM1A;AURKB
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),3/67,0.657771791741192,1,0,0,0.8955223880597014,0.3751318467538853,MYOCD;CCNT1;GTF2H1
regulation of cardiac conduction (GO:1903779),3/67,0.657771791741192,1,0,0,0.8955223880597014,0.3751318467538853,RYR1;ATP2B4;TNNI3K
regulation of protein localization to plasma membrane (GO:1903076),3/67,0.657771791741192,1,0,0,0.8955223880597014,0.3751318467538853,RHOG;EGFR;INS
"mRNA splicing, via spliceosome (GO:0000398)",12/261,0.6585582788214799,1,0,0,0.9195402298850575,0.38409403156639316,SRPK2;CPSF4;RBMX2;EIF4A3;CPSF2;DDX23;SNRPG;DDX42;POLR2F;CDC5L;PRPF40A;SMN1
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,CHD6
positive regulation of cellular component movement (GO:0051272),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,TGFBR1
GTP metabolic process (GO:0046039),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,GNAI3
RNA-dependent DNA biosynthetic process (GO:0006278),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,TERF1
cortical actin cytoskeleton organization (GO:0030866),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,LLGL1
cellular response to hexose stimulus (GO:0071331),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,GAS6
mesoderm development (GO:0007498),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,FOXC2
establishment of spindle orientation (GO:0051294),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,LLGL1
histone ubiquitination (GO:0016574),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,WAC
zinc II ion transport (GO:0006829),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,SLC30A4
positive regulation of translational initiation (GO:0045948),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,DDX3X
positive regulation of lamellipodium organization (GO:1902745),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,RAC1
regulation of macrophage activation (GO:0043030),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,SPACA3
vesicle docking (GO:0048278),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,USO1
negative regulation of protein tyrosine kinase activity (GO:0061099),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,VPS25
response to nicotine (GO:0035094),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,MAPK1
negative regulation of viral process (GO:0048525),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,MID2
cellular response to misfolded protein (GO:0071218),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,SDF2L1
cellular response to alkaloid (GO:0071312),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,RYR1
negative regulation of cAMP biosynthetic process (GO:0030818),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,GNAI3
negative regulation of cyclin-dependent protein kinase activity (GO:1904030),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,MYOCD
long-term synaptic potentiation (GO:0060291),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,PRKCZ
cellular response to copper ion (GO:0071280),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,PRNP
positive regulation of receptor internalization (GO:0002092),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,APLN
phosphatidylserine acyl-chain remodeling (GO:0036150),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,PLA1A
ERK1 and ERK2 cascade (GO:0070371),1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,MAPK1
"synaptic transmission, glutamatergic (GO:0035249)",1/21,0.6596258189717179,1,0,0,0.9523809523809523,0.3962690911289506,GRID2
phosphatidylinositol metabolic process (GO:0046488),5/112,0.6647517057733329,1,0,0,0.8928571428571428,0.3645907882365566,MTMR14;INPP5J;PLEKHA3;PIGW;PLEKHA8
cell-matrix adhesion (GO:0007160),4/90,0.6647641861492688,1,0,0,0.8888888888888888,0.362953696452133,SGCE;ITGB3;RAC1;HPSE
plasma membrane bounded cell projection assembly (GO:0120031),11/241,0.6647649835515149,1,0,0,0.912863070539419,0.3727418090300206,BBS2;DNM3;CCDC88A;TTC8;FAM161A;RFX4;RFX2;MKS1;S1PR1;RAPGEF2;RAC1
regulation of angiogenesis (GO:0045765),8/177,0.6649907113188037,1,0,0,0.903954802259887,0.36879747468066354,TMIGD2;GPNMB;ADAM12;BRCA1;HSPG2;CCR3;DCN;RAPGEF3
positive regulation of blood vessel endothelial cell migration (GO:0043536),2/45,0.665369764985953,1,0,0,0.8888888888888888,0.3621443158089169,FOXC2;HMGB1
nucleus organization (GO:0006997),2/45,0.665369764985953,1,0,0,0.8888888888888888,0.3621443158089169,SUN2;TPR
"regulation of synaptic transmission, glutamatergic (GO:0051966)",2/45,0.665369764985953,1,0,0,0.8888888888888888,0.3621443158089169,GRM7;DRD1
mitochondrial gene expression (GO:0140053),2/45,0.665369764985953,1,0,0,0.8888888888888888,0.3621443158089169,MRPL51;MRPL57
vesicle-mediated transport (GO:0016192),19/410,0.6668787682352812,1,0,0,0.9268292682926829,0.3755021034509481,SNAPIN;TMED10;CCZ1B;USO1;SYTL1;M6PR;RHOG;MYO5A;FMN2;ASAP2;SYTL5;LRP8;RAB11A;DNM3;CYTH3;ADAP2;SYT12;RAC1;RAB6A
monocarboxylic acid biosynthetic process (GO:0072330),3/68,0.6676380497864279,1,0,0,0.8823529411764706,0.3564786122927678,CYP39A1;ABCB11;DCN
COPII-coated vesicle budding (GO:0090114),3/68,0.6676380497864279,1,0,0,0.8823529411764706,0.3564786122927678,TRAPPC6A;TMED10;USO1
gene expression (GO:0010467),19/411,0.6709624369068253,1,0,0,0.9245742092457421,0.3689440565694562,GTF3C2;CPSF4;PABPC4;EIF4A3;CPSF2;DDX54;PWP1;MRPL52;RPS15;NR4A2;MRPL51;RBMX2;DHX57;TPR;SNRPG;POLR2F;EPC1;RPL15;RPL29
regulation of humoral immune response (GO:0002920),5/113,0.6723926318192525,1,0,0,0.8849557522123893,0.3512502969378424,C8G;C7;PROS1;SUSD4;F2
phagocytosis (GO:0006909),6/135,0.6731831840991095,1,0,0,0.8888888888888888,0.3517669298080437,SCARB2;ITGB3;PECAM1;HMGB1;GAS6;MERTK
lipid transport (GO:0006869),4/91,0.6732482464251353,1,0,0,0.8791208791208791,0.34781639730574376,ABCA6;PSAP;ABCB11;PLEKHA8
regulation of calcium ion transport into cytosol (GO:0010522),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,PRNP
regulation of interferon-gamma-mediated signaling pathway (GO:0060334),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,PTPN2
protein localization to cilium (GO:0061512),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,BBS2
positive regulation of protein targeting to membrane (GO:0090314),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,PRNP
lipid translocation (GO:0034204),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,RFT1
outflow tract septum morphogenesis (GO:0003148),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,TBX20
negative regulation of response to endoplasmic reticulum stress (GO:1903573),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,SYVN1
peripheral nervous system development (GO:0007422),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,SERPINI1
triglyceride catabolic process (GO:0019433),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,FABP9
regulation of cytokine production involved in inflammatory response (GO:1900015),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,F2
regulation of membrane protein ectodomain proteolysis (GO:0051043),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,FURIN
positive regulation of biosynthetic process (GO:0009891),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,INS
regulation of ERBB signaling pathway (GO:1901184),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,EGFR
C21-steroid hormone metabolic process (GO:0008207),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,STARD3NL
viral genome replication (GO:0019079),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,GAS6
inner ear morphogenesis (GO:0042472),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,HOXA1
negative regulation of GTPase activity (GO:0034260),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,RRP1B
ncRNA catabolic process (GO:0034661),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,TRIR
negative regulation of lyase activity (GO:0051350),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,GNAI3
positive regulation of phosphatase activity (GO:0010922),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,CD300A
NLS-bearing protein import into nucleus (GO:0006607),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,TNPO1
digestive system development (GO:0055123),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,MIXL1
glucose transport (GO:0015758),1/22,0.6766623505215513,1,0,0,0.9090909090909091,0.3550753401584873,SLC2A13
protein complex disassembly (GO:0043241),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,LIX1L;TECPR1
nucleocytoplasmic transport (GO:0006913),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,SNRPG;SMN1
positive regulation of protein localization to cell periphery (GO:1904377),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,RHOG;EGFR
nuclear envelope disassembly (GO:0051081),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,NEK6;TPR
regulation of cellular component movement (GO:0051270),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,EGFR;TGFBR1
regulation of DNA metabolic process (GO:0051052),2/46,0.677156889708468,1,0,0,0.8695652173913043,0.3390019916216445,CCDC88A;ZBTB38
regulation of endothelial cell migration (GO:0010594),3/69,0.6772948191670352,1,0,0,0.8695652173913043,0.338824888725687,FOXC2;ITGB3;DCN
regulation of innate immune response (GO:0045088),3/69,0.6772948191670352,1,0,0,0.8695652173913043,0.338824888725687,IFNA7;IRAK3;USP18
response to organic cyclic compound (GO:0014070),3/69,0.6772948191670352,1,0,0,0.8695652173913043,0.338824888725687,PAQR6;CCL3;MAPK1
regulation of immune effector process (GO:0002697),5/114,0.6799176333026349,1,0,0,0.8771929824561403,0.3384066803900328,C8G;C7;PROS1;SUSD4;F2
ER to Golgi vesicle-mediated transport (GO:0006888),8/180,0.683178744936179,1,0,0,0.8888888888888888,0.33866555380766933,TRAPPC6A;TMED10;PROS1;USO1;F2;GAS6;TMED5;INS
positive regulation of endothelial cell migration (GO:0010595),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,FOXC2;ITGB3;HMGB1
stress-activated protein kinase signaling cascade (GO:0031098),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,UBB;MAPK1;MAP3K8
protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,RNF144B;NEDD4;ENC1
Rab protein signal transduction (GO:0032482),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,RAB30;RAB6A;RAB11A
neuropeptide signaling pathway (GO:0007218),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,GALR2;NPBWR1;RAPGEF2
snRNA transcription (GO:0009301),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,CCNT1;POLR2F;GTF2E1
snRNA transcription from RNA polymerase II promoter (GO:0042795),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,CCNT1;POLR2F;GTF2E1
negative regulation of developmental process (GO:0051093),3/70,0.6867423738774998,1,0,0,0.8571428571428571,0.32211090747805676,BNIP3;GAS6;RAPGEF3
polyol metabolic process (GO:0019751),2/47,0.6886033156551076,1,0,0,0.8510638297872339,0.3175233302317852,INPP5A;INPP5J
positive regulation of tumor necrosis factor production (GO:0032760),2/47,0.6886033156551076,1,0,0,0.8510638297872339,0.3175233302317852,SPN;CCL3
positive regulation of organelle assembly (GO:1902117),2/47,0.6886033156551076,1,0,0,0.8510638297872339,0.3175233302317852,CCDC88A;CNOT6L
histone H4 acetylation (GO:0043967),2/47,0.6886033156551076,1,0,0,0.8510638297872339,0.3175233302317852,MORF4L1;EPC1
inositol phosphate metabolic process (GO:0043647),2/47,0.6886033156551076,1,0,0,0.8510638297872339,0.3175233302317852,INPP5A;INPP5J
regulation of autophagy (GO:0010506),9/203,0.6910425757023396,1,0,0,0.8866995073891626,0.32768321009203705,KDM4A;UCHL1;PRKAA1;NEDD4;BNIP3;PSAP;HMGB1;MID2;DCN
mitotic G2/M transition checkpoint (GO:0044818),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,NOP53
regulation of protein oligomerization (GO:0032459),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,INS
positive regulation of cell cycle G1/S phase transition (GO:1902808),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,DDX3X
ammonium transport (GO:0015696),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,SLC6A3
neuronal action potential (GO:0019228),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,SCN3A
microtubule polymerization or depolymerization (GO:0031109),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,STMN3
positive regulation of ERBB signaling pathway (GO:1901186),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,UBB
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,UBB
cell-cell adhesion mediated by cadherin (GO:0044331),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CDH19
zinc II ion transmembrane transport (GO:0071577),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,SLC30A4
protein K48-linked deubiquitination (GO:0071108),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,USP5
"nucleotide-excision repair, DNA damage recognition (GO:0000715)",1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,UBB
cellular nitrogen compound biosynthetic process (GO:0044271),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,ACER3
regulation of smooth muscle contraction (GO:0006940),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,MYOCD
regulation of interleukin-8 secretion (GO:2000482),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,F2RL1
regulation of dendritic spine morphogenesis (GO:0061001),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,LRP8
histone H3-K4 methylation (GO:0051568),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,KMT2D
negative regulation of transcription factor import into nucleus (GO:0042992),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CYLD
cellular response to amyloid-beta (GO:1904646),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,PRNP
regulation of cell size (GO:0008361),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,RAC1
regulation of microtubule cytoskeleton organization (GO:0070507),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,CYLD
NAD metabolic process (GO:0019674),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,NMNAT1
regulation of chondrocyte differentiation (GO:0032330),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,TGFBR1
regulation of ion homeostasis (GO:2000021),1/23,0.6928469690097347,1,0,0,0.8695652173913043,0.31908358966713624,SLC30A4
chromatin remodeling (GO:0006338),5/116,0.6946174064374339,1,0,0,0.8620689655172414,0.3141328270082842,INO80C;MORF4L1;INO80;HMGB1;TOP1
actomyosin structure organization (GO:0031032),3/71,0.6959812822212856,1,0,0,0.8450704225352113,0.30628099636865247,OBSCN;OBSL1;MYH6
histone acetylation (GO:0016573),3/71,0.6959812822212856,1,0,0,0.8450704225352113,0.30628099636865247,MORF4L1;KAT5;EPC1
organelle membrane fusion (GO:0090174),3/71,0.6959812822212856,1,0,0,0.8450704225352113,0.30628099636865247,SYT12;SYTL1;SYTL5
response to insulin (GO:0032868),3/71,0.6959812822212856,1,0,0,0.8450704225352113,0.30628099636865247,IRS1;MYO5A;INS
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),9/204,0.6965667786457328,1,0,0,0.8823529411764706,0.3190514231520267,NLRP9;UBB;SLC20A1;TSPAN6;NEK6;LPAR1;F2RL1;LURAP1;MID2
regulation of apoptotic process (GO:0042981),38/815,0.6973919264465321,1,0,0,0.9325153374233128,0.3360857279819996,PRKAA1;RBM25;DDX3X;DDX42;BRCA1;HMGB1;FMN2;EGFR;INS;TP53AIP1;NUAK2;UBB;FRZB;FIGNL1;RPS6KA2;CLEC5A;MAP3K8;RAC1;TNFRSF4;BARD1;DFFA;GRID2;TNFRSF12A;DUSP1;TGFB3;BNIP3;BMP8A;RRP1B;MERTK;RNF144B;ARHGAP10;OBSCN;IL2RB;ARHGEF3;GAS1;ROR2;GAS6;NOP53
positive regulation of nucleic acid-templated transcription (GO:1903508),23/502,0.6977360995916339,1,0,0,0.9163346613545816,0.3298019743452637,SMAD2;FOXC2;OSR2;MYOCD;FZD4;TGFB3;USP21;RHOG;AHR;BRCA1;MLLT3;HNRNPAB;EGFR;TGFBR1;SALL1;MED30;KAT5;BAMBI;NRIP1;WAC;EPC1;SRY;RNF187
vesicle fusion (GO:0006906),4/94,0.6978008887433855,1,0,0,0.8510638297872339,0.3062310439097954,SYT12;SYTL1;TAP1;SYTL5
skin development (GO:0043588),4/94,0.6978008887433855,1,0,0,0.8510638297872339,0.3062310439097954,RYR1;COL1A2;SFN;RPTN
respiratory electron transport chain (GO:0022904),4/94,0.6978008887433855,1,0,0,0.8510638297872339,0.3062310439097954,NDUFB11;NDUFS3;NDUFV3;SDHA
negative regulation of mitotic cell cycle (GO:0045930),2/48,0.6997136081858564,1,0,0,0.8333333333333333,0.29757013234898655,DUSP1;GAS1
endosome to lysosome transport (GO:0008333),2/48,0.6997136081858564,1,0,0,0.8333333333333333,0.29757013234898655,SNAPIN;M6PR
regulation of epithelial cell migration (GO:0010632),2/48,0.6997136081858564,1,0,0,0.8333333333333333,0.29757013234898655,RAB11A;PBLD
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),2/48,0.6997136081858564,1,0,0,0.8333333333333333,0.29757013234898655,SFN;BRCA1
positive regulation of chemotaxis (GO:0050921),2/48,0.6997136081858564,1,0,0,0.8333333333333333,0.29757013234898655,EDN3;F2RL1
phosphate-containing compound metabolic process (GO:0006796),8/183,0.7007406269620085,1,0,0,0.8743169398907104,0.31092237355176994,INPP5A;SLC20A1;GDE1;INPP5J;FAM20C;DUSP28;TOP1;HDHD2
activation of MAPK activity (GO:0000187),5/117,0.7017912619296536,1,0,0,0.8547008547008547,0.3026660400439901,PRKAA1;UBB;IRAK2;MAPK1;INS
regulation of transcription from RNA polymerase II promoter (GO:0006357),70/1478,0.7034763978537366,1,0,0,0.9472259810554803,0.33315922437888473,DDX3X;CCNT1;KDM1A;ZC3H4;FHOD1;BRCA1;HMGB1;AHR;CHD1;YY1;ELK4;RPS6KA4;SALL1;KAT5;SOX15;EPC1;HOXA1;PITX2;TGIF1;OSR2;FOXD2;MYOCD;ZBTB38;RFX2;EBF1;ETV2;DCN;RFX4;HOXB2;TDGF1P3;HOXB7;KMT2D;FOXC2;LRP8;GTF2E1;EGFR;AURKB;UBB;GALR2;TBX20;TPR;NRIP1;SAFB2;HES1;ZBED6;E2F7;E2F8;ZNF541;TCFL5;SMAD2;GSX1;TGFB3;NFYC;BMP8A;OSM;ATP2B4;CDC5L;GTF2H1;INO80;RRP1B;POU2F3;KLF8;NR4A2;HEYL;BRMS1L;F2RL1;SP7;NOP53;MIXL1;TAF1
cell-cell junction organization (GO:0045216),3/72,0.7050123870135998,1,0,0,0.8333333333333333,0.2912832550768055,TGFB3;F2RL1;CDH19
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),3/72,0.7050123870135998,1,0,0,0.8333333333333333,0.2912832550768055,UBB;FBXL15;PSMA7
regulation of fat cell differentiation (GO:0045598),3/72,0.7050123870135998,1,0,0,0.8333333333333333,0.2912832550768055,FRZB;ZNF385A;MEDAG
regulation of epithelial cell proliferation (GO:0050678),3/72,0.7050123870135998,1,0,0,0.8333333333333333,0.2912832550768055,OSR2;EGFR;PBLD
positive regulation of protein localization to membrane (GO:1905477),4/95,0.7056844804748206,1,0,0,0.8421052631578947,0.2935469919093557,PRNP;RHOG;SFN;EGFR
regulation of cytoskeleton organization (GO:0051493),4/95,0.7056844804748206,1,0,0,0.8421052631578947,0.2935469919093557,CYLD;CCDC88A;STMN3;MAPK1
regulation of cellular component organization (GO:0051128),6/140,0.7067393435253332,1,0,0,0.8571428571428571,0.29750859485229647,NEDD4;HJURP;RAPGEF1;RAPGEF2;IRAK3;KLK8
Golgi vesicle transport (GO:0048193),12/271,0.707848107350006,1,0,0,0.8856088560885608,0.30600066061651077,CYTH3;GOLGA3;TRAPPC6A;TMED10;PROS1;USO1;MYO5A;F2;GAS6;RAB6A;TMED5;INS
positive regulation of histone methylation (GO:0031062),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,BRCA1
positive regulation of microtubule polymerization (GO:0031116),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,RAC1
positive regulation of neutrophil chemotaxis (GO:0090023),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,RAC1
dendritic spine organization (GO:0097061),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,PRNP
negative regulation of protein localization to membrane (GO:1905476),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,KCNE1
histone monoubiquitination (GO:0010390),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,WAC
Golgi to plasma membrane protein transport (GO:0043001),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,BBS2
positive regulation of purine nucleotide biosynthetic process (GO:1900373),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,GPHB5
negative regulation of developmental growth (GO:0048640),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,BBS2
negative regulation of sequestering of calcium ion (GO:0051283),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,RYR1
negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,MYOCD
macromolecule modification (GO:0043412),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,CHD1
receptor catabolic process (GO:0032801),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,NEDD4
regulation of epidermal growth factor-activated receptor activity (GO:0007176),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,VPS25
positive regulation of microtubule polymerization or depolymerization (GO:0031112),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,RAC1
DNA geometric change (GO:0032392),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,HMGB1
regulation of AMPA receptor activity (GO:2000311),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,SHISA9
cilium-dependent cell motility (GO:0060285),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,CFAP44
positive regulation of dephosphorylation (GO:0035306),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,LILRB2
limb development (GO:0060173),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,SALL1
regulation of neuronal synaptic plasticity (GO:0048168),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,SHISA9
regulation of cardiac muscle cell action potential (GO:0098901),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,PKP2
transition metal ion homeostasis (GO:0055076),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,ATOX1
cGMP biosynthetic process (GO:0006182),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,GUCY1B2
regulation of cellular senescence (GO:2000772),1/24,0.7082222339049663,1,0,0,0.8333333333333333,0.28749778737100123,NEK6
glutathione metabolic process (GO:0006749),2/49,0.7104927276749392,1,0,0,0.8163265306122448,0.2790176057147895,GSTZ1;GSTO2
regulation of megakaryocyte differentiation (GO:0045652),2/49,0.7104927276749392,1,0,0,0.8163265306122448,0.2790176057147895,KMT2D;THPO
cilium movement (GO:0003341),2/49,0.7104927276749392,1,0,0,0.8163265306122448,0.2790176057147895,CFAP53;CCDC40
lipid homeostasis (GO:0055088),2/49,0.7104927276749392,1,0,0,0.8163265306122448,0.2790176057147895,PRKAA1;INS
regulation of release of sequestered calcium ion into cytosol (GO:0051279),2/49,0.7104927276749392,1,0,0,0.8163265306122448,0.2790176057147895,DRD1;F2
cellular metal ion homeostasis (GO:0006875),4/96,0.7134178055156833,1,0,0,0.8333333333333333,0.28140670641508325,CCL3;ATP2B4;CCL1;ATOX1
B cell activation (GO:0042113),3/73,0.7138367865008747,1,0,0,0.821917808219178,0.2770692600889438,TPD52;IFNA7;PTPN2
lymphocyte differentiation (GO:0030098),3/73,0.7138367865008747,1,0,0,0.821917808219178,0.2770692600889438,TPD52;IFNA7;PTPN2
canonical Wnt signaling pathway (GO:0060070),3/73,0.7138367865008747,1,0,0,0.821917808219178,0.2770692600889438,NR4A2;FRZB;FZD4
chloride transport (GO:0006821),3/73,0.7138367865008747,1,0,0,0.821917808219178,0.2770692600889438,CLCN7;SLC1A1;SLC26A11
regulation of immune response (GO:0050776),11/251,0.7154113263811371,1,0,0,0.8764940239043825,0.2935357625912092,NCR2;COL1A2;NLRP9;CD300A;SLAMF7;ICAM4;SLAMF6;LILRB2;KIR3DL2;CD300C;HLA-F
regulation of phosphorylation (GO:0042325),5/119,0.7157855087234404,1,0,0,0.8403361344537815,0.2809871644732814,BARD1;CCDC88A;TPR;NOP53;EGFR
"DNA-templated transcription, initiation (GO:0006352)",8/186,0.7176638068592711,1,0,0,0.8602150537634409,0.28537983239781983,NR4A2;MED30;POLR2F;GTF2H1;GTF2E1;NR2C1;NR2C2AP;TAF1
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),6/142,0.7194862015133059,1,0,0,0.8450704225352113,0.2782123358209349,GRID2;SMAGP;PECAM1;FAT4;PCDHB11;CDH19
inflammatory response (GO:0006954),11/252,0.7201975892740423,1,0,0,0.8730158730158729,0.2865497163341436,NLRP9;PTGER1;GPR68;CRH;CCL3;FPR3;CCL1;RAC1;HMGB1;HSPG2;TNFRSF4
regulation of ion transport (GO:0043269),2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,NEDD4;DRD1
blood circulation (GO:0008015),2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,EDN3;HOXB2
receptor internalization (GO:0031623),2/50,0.7209459791839935,1,0,0,0.7999999999999999,0.2617528554824198,DNM3;NEDD4
cell morphogenesis involved in neuron differentiation (GO:0048667),4/97,0.7210011321847114,1,0,0,0.8247422680412371,0.269785213526288,LINGO2;LRFN2;LRFN5;LLGL1
positive regulation of cell proliferation (GO:0008284),19/424,0.7215154782884873,1,0,0,0.8962264150943395,0.29252959968450437,SRPK2;KMT2D;OSR2;CNOT6L;EDN3;IRS1;RHOG;OSM;EGFR;TGFBR1;INS;BAMBI;SOX15;ACER3;TBX20;HES1;HPSE;GAS6;RNF187
positive regulation of epithelial cell migration (GO:0010634),3/74,0.722455815470999,1,0,0,0.8108108108108109,0.2635937966943547,FOXC2;ITGB3;RAB11A
"regulation of gene expression, epigenetic (GO:0040029)",3/74,0.722455815470999,1,0,0,0.8108108108108109,0.2635937966943547,ZFP57;EPC1;POLR2F
mRNA 3'-end processing (GO:0031124),3/74,0.722455815470999,1,0,0,0.8108108108108109,0.2635937966943547,CPSF4;EIF4A3;CPSF2
mitotic nuclear division (GO:0140014),3/74,0.722455815470999,1,0,0,0.8108108108108109,0.2635937966943547,KIFC1;INO80;RAB11A
macromolecular complex assembly (GO:0065003),5/120,0.7226056756270708,1,0,0,0.8333333333333333,0.2707430048728052,IL2RB;ELOB;HES1;LLGL1;SKAP2
negative regulation of wound healing (GO:0061045),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,SERPINE2
regulation of spindle assembly (GO:0090169),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,TPR
response to copper ion (GO:0046688),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,PRNP
glial cell differentiation (GO:0010001),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,PLP1
"negative regulation of gene expression, epigenetic (GO:0045814)",1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,EPC1
regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000058),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,TAF1
cyclic nucleotide metabolic process (GO:0009187),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,GUCY1B2
inorganic cation import across plasma membrane (GO:0098659),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,ATP2B4
neutral amino acid transport (GO:0015804),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,SLC1A1
positive regulation of interleukin-12 production (GO:0032735),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,HMGB1
misfolded or incompletely synthesized protein catabolic process (GO:0006515),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,SDF2L1
response to amyloid-beta (GO:1904645),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,PRNP
chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,DCN
regulation of interleukin-10 production (GO:0032653),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,HMGB1
"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,KDM1A
positive regulation of filopodium assembly (GO:0051491),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,TGFB3
"RNA splicing, via transesterification reactions (GO:0000375)",1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,DDX23
positive regulation of leukocyte mediated cytotoxicity (GO:0001912),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,SLAMF6
regulation of lamellipodium assembly (GO:0010591),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,RAC1
negative regulation of cellular protein localization (GO:1903828),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,LEPROT
modulation of excitatory postsynaptic potential (GO:0098815),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,PRKCZ
cellular response to epidermal growth factor stimulus (GO:0071364),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,EGFR
cellular response to vascular endothelial growth factor stimulus (GO:0035924),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,GAS1
regulation of viral release from host cell (GO:1902186),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,MID2
long-chain fatty acid transport (GO:0015909),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,ACACB
positive regulation of neutrophil migration (GO:1902624),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,RAC1
negative regulation of epithelial to mesenchymal transition (GO:0010719),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,PBLD
protein depolymerization (GO:0051261),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,STMN3
positive regulation of embryonic development (GO:0040019),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,HES1
regulation of cellular protein localization (GO:1903827),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,KDM1A
L-amino acid transport (GO:0015807),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,SLC1A1
regulation of protein import into nucleus (GO:0042306),1/25,0.7228285803914951,1,0,0,0.7999999999999999,0.2596665438632063,TPR
Golgi organization (GO:0007030),5/121,0.7293078982314523,1,0,0,0.8264462809917356,0.26087543733110413,VMP1;RAB30;TMED10;OBSL1;TMED5
positive regulation of macromolecule metabolic process (GO:0010604),12/276,0.7307640483041671,1,0,0,0.8695652173913043,0.2727518701517271,SRPK2;OSR2;ACTA1;PRKAA1;DDX3X;CCL3;MAPK1;BRCA1;DRD1;GAS6;TGFBR1;INS
C-terminal protein lipidation (GO:0006501),3/75,0.7308710279969972,1,0,0,0.7999999999999999,0.2508146136696121,LY6G6D;ATG12;LYPD8
regulation of defense response (GO:0031347),3/75,0.7308710279969972,1,0,0,0.7999999999999999,0.2508146136696121,NLRP9;SETD6;USP18
"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",3/75,0.7308710279969972,1,0,0,0.7999999999999999,0.2508146136696121,TAP1;HLA-F;PSMA7
response to organonitrogen compound (GO:0010243),2/51,0.7310789651903944,1,0,0,0.7843137254901961,0.24567356984329963,SYVN1;IRAK3
carboxylic acid transport (GO:0046942),2/51,0.7310789651903944,1,0,0,0.7843137254901961,0.24567356984329963,PSAP;SLC17A5
positive regulation of actin filament polymerization (GO:0030838),2/51,0.7310789651903944,1,0,0,0.7843137254901961,0.24567356984329963,RHOG;RAC1
protein complex assembly (GO:0006461),8/189,0.7339397778044255,1,0,0,0.8465608465608465,0.261865227785484,KMT2D;GRHPR;TRAPPC6A;COL16A1;TMED10;KAT5;USO1;CAMK2G
positive regulation of cyclin-dependent protein kinase activity (GO:1904031),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,CCNT1
positive regulation of synapse assembly (GO:0051965),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,GRID2
cytoskeleton-dependent intracellular transport (GO:0030705),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,CCDC88A
monovalent inorganic cation homeostasis (GO:0055067),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,PDK4
positive regulation of interferon-beta production (GO:0032728),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,DDX3X
lipid modification (GO:0030258),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,DGKA
nucleotide biosynthetic process (GO:0009165),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,GUCY1B2
regulation of NF-kappaB import into nucleus (GO:0042345),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,CYLD
positive regulation of granulocyte chemotaxis (GO:0071624),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,RAC1
response to ketone (GO:1901654),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,TGFB3
negative chemotaxis (GO:0050919),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,ITGB3
regulation of cardiac muscle cell contraction (GO:0086004),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,PKP2
regulation of microtubule-based process (GO:0032886),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,CYLD
regulation of viral entry into host cell (GO:0046596),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,MID2
positive regulation of release of cytochrome c from mitochondria (GO:0090200),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,BNIP3
GPI anchor metabolic process (GO:0006505),1/26,0.7367044256304639,1,0,0,0.7692307692307693,0.2350527061077511,PIGW
hemopoiesis (GO:0030097),3/76,0.739084180089673,1,0,0,0.7894736842105262,0.2386922002972212,KITLG;THPO;MIXL1
protein homooligomerization (GO:0051260),8/190,0.7392203551026406,1,0,0,0.8421052631578947,0.25444987146859954,RYR1;PRNP;ILDR1;LY6G6D;MCOLN1;ACACB;THG1L;GNMT
positive regulation of ossification (GO:0045778),2/52,0.740897542993205,1,0,0,0.7692307692307693,0.23068687062400378,OSR2;TGFB3
positive regulation of secretion by cell (GO:1903532),2/52,0.740897542993205,1,0,0,0.7692307692307693,0.23068687062400378,EDN3;TGFB3
tumor necrosis factor-mediated signaling pathway (GO:0033209),5/123,0.7423591890762312,1,0,0,0.8130081300813008,0.24221306555432562,UBB;TNFRSF12A;TNFRSF4;COMMD7;PSMA7
cellular calcium ion homeostasis (GO:0006874),5/123,0.7423591890762312,1,0,0,0.8130081300813008,0.24221306555432562,RYR1;CCL3;ATP2B4;CCL1;F2
regulation of translation (GO:0006417),9/213,0.7434405892392165,1,0,0,0.8450704225352113,0.25053500547769336,TSFM;DDX3X;EIF4A3;ENC1;TPR;EIF4H;POLR2F;TYMS;ZNF385A
positive regulation of cytoskeleton organization (GO:0051495),3/77,0.7470972136000291,1,0,0,0.7792207792207791,0.22718958204818146,RHOG;F2RL1;RAC1
regulation of hematopoietic progenitor cell differentiation (GO:1901532),3/77,0.7470972136000291,1,0,0,0.7792207792207791,0.22718958204818146,UBB;PSMA7;MIXL1
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",10/236,0.747807946498183,1,0,0,0.847457627118644,0.2462788898250859,CPSF4;RBMX2;EIF4A3;CPSF2;DDX23;SNRPG;DDX42;POLR2F;CDC5L;PRPF40A
regulation of protein ubiquitination (GO:0031396),4/101,0.7498448770134236,1,0,0,0.792079207920792,0.22803083128155077,DNAJB2;UBB;BRCA1;TGFBR1
phosphatidylcholine acyl-chain remodeling (GO:0036151),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,DBI
mRNA polyadenylation (GO:0006378),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,CPSF4
telomere maintenance via telomere lengthening (GO:0010833),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,TERF1
leukocyte cell-cell adhesion (GO:0007159),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,PECAM1
transition metal ion transport (GO:0000041),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,ATOX1
transcription from RNA polymerase III promoter (GO:0006383),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,GTF3C2
release of sequestered calcium ion into cytosol (GO:0051209),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,RYR1
phosphatidylserine metabolic process (GO:0006658),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,PLA1A
positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,RAC1
cargo loading into vesicle (GO:0035459),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,TMED10
regulation of protein localization to cell surface (GO:2000008),1/27,0.7498862689651448,1,0,0,0.7407407407407407,0.2132101669113366,LEPROT
positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),2/53,0.7504077852742062,1,0,0,0.7547169811320754,0.21670830680118947,OSM;HES1
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),3/78,0.7549122409335416,1,0,0,0.7692307692307693,0.2162721335871487,TAP1;HLA-F;PSMA7
fibroblast growth factor receptor signaling pathway (GO:0008543),3/78,0.7549122409335416,1,0,0,0.7692307692307693,0.2162721335871487,UBB;POLR2F;MAPK1
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),3/78,0.7549122409335416,1,0,0,0.7692307692307693,0.2162721335871487,UBB;ELOB;PSMA7
nervous system development (GO:0007399),20/455,0.7553726882850037,1,0,0,0.8791208791208791,0.24663210959052412,PCDHGB6;PCDH10;NAB2;STMN3;WDR62;PCDHB11;SDHA;PCDHA10;DMBX1;DNM3;SALL1;DPYSL5;ENC1;PCDHGB1;PCDHA4;HES1;FAT4;SERPINI1;DRD1;CAMK2G
cellular response to cytokine stimulus (GO:0071345),20/456,0.7586925684836013,1,0,0,0.8771929824561403,0.24224441381741096,IFNA7;IL31;OSM;IL36G;IRAK3;BRCA1;LRP8;DCN;COL1A2;UBB;IRAK2;TPR;IL2RB;RAPGEF1;ITGAX;CCL3;S1PR1;CCL1;GAS6;PTPN2
sensory perception (GO:0007600),2/54,0.7596159436572443,1,0,0,0.7407407407407407,0.2036609709042825,TTC8;MYO7A
cell morphogenesis involved in differentiation (GO:0000904),2/54,0.7596159436572443,1,0,0,0.7407407407407407,0.2036609709042825,ITGB3;RAC1
protein targeting to mitochondrion (GO:0006626),2/54,0.7596159436572443,1,0,0,0.7407407407407407,0.2036609709042825,IMMP1L;TOMM20L
glycosphingolipid metabolic process (GO:0006687),2/54,0.7596159436572443,1,0,0,0.7407407407407407,0.2036609709042825,PSAP;ARSG
cellular response to tumor necrosis factor (GO:0071356),8/194,0.7596168702829397,1,0,0,0.8247422680412371,0.22675553885422534,TNFRSF12A;UBB;CCL3;CCL1;BRCA1;COMMD7;TNFRSF4;PSMA7
mRNA processing (GO:0006397),12/283,0.7608347028834079,1,0,0,0.8480565371024735,0.23180705734297768,KIN;CPSF4;RBMX2;EIF4A3;CPSF2;DDX23;SNRPG;DDX42;POLR2F;CDC5L;PRPF40A;GTF2H1
regulation of vasculature development (GO:1901342),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,GPNMB
negative regulation of endocytosis (GO:0045806),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,RAC1
RNA polyadenylation (GO:0043631),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,CPSF4
hydrogen ion transmembrane transport (GO:1902600),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,UCP2
negative regulation of homeostatic process (GO:0032845),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,ERCC4
carboxylic acid catabolic process (GO:0046395),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,RENBP
RNA phosphodiester bond hydrolysis (GO:0090501),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,TRIR
acute inflammatory response (GO:0002526),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,INS
cellular amino acid biosynthetic process (GO:0008652),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,PYCR1
aerobic respiration (GO:0009060),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,MTFR1
positive regulation of phosphate metabolic process (GO:0045937),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,EGFR
positive regulation of sprouting angiogenesis (GO:1903672),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,FOXC2
chondrocyte differentiation (GO:0002062),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,OSR2
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,SMAD2
lytic vacuole organization (GO:0080171),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,MYO7A
protein K11-linked ubiquitination (GO:0070979),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,CDC16
positive regulation of cell communication (GO:0010647),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,EDN3
negative regulation of JNK cascade (GO:0046329),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,F2RL1
positive regulation of calcium-mediated signaling (GO:0050850),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,CCL3
production of miRNAs involved in gene silencing by miRNA (GO:0035196),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,SMAD2
neural crest cell migration (GO:0001755),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,PITX2
cGMP metabolic process (GO:0046068),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,GUCY1B2
regulation of defense response to virus by virus (GO:0050690),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,RAC1
positive regulation of lipid biosynthetic process (GO:0046889),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,INS
calcium ion import (GO:0070509),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,CACNA1B
regulation of adenylate cyclase activity (GO:0045761),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,GNAI3
positive regulation of fibroblast proliferation (GO:0048146),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,GAS6
bicellular tight junction assembly (GO:0070830),1/28,0.7624087879510514,1,0,0,0.7142857142857142,0.19376600001083732,MPP7
regulation of endothelial cell proliferation (GO:0001936),3/79,0.7625315297227274,1,0,0,0.7594936708860759,0.2059074082780564,EGFL7;ITGB3;TGFBR1
cell-cell junction assembly (GO:0007043),3/79,0.7625315297227274,1,0,0,0.7594936708860759,0.2059074082780564,PKP2;MPP7;CDH19
anterograde trans-synaptic signaling (GO:0098916),10/240,0.7659017208348684,1,0,0,0.8333333333333333,0.22225118271256633,GRM7;KCNIP2;NPBWR1;SLC1A1;PLP1;CACNA1B;CRH;GAD2;MAPK1;PCDHB11
regulation of cellular catabolic process (GO:0031329),2/55,0.7685284162153218,1,0,0,0.7272727272727272,0.1914747203489268,PSAP;HMGB1
regulation of gene silencing by RNA (GO:0060966),2/55,0.7685284162153218,1,0,0,0.7272727272727272,0.1914747203489268,TPR;POLR2F
regulation of posttranscriptional gene silencing (GO:0060147),2/55,0.7685284162153218,1,0,0,0.7272727272727272,0.1914747203489268,TPR;POLR2F
negative regulation of cellular response to growth factor stimulus (GO:0090288),2/55,0.7685284162153218,1,0,0,0.7272727272727272,0.1914747203489268,NEDD4;APLN
fat cell differentiation (GO:0045444),2/55,0.7685284162153218,1,0,0,0.7272727272727272,0.1914747203489268,BBS2;NR4A2
monovalent inorganic cation transport (GO:0015672),4/104,0.7699363530876122,1,0,0,0.7692307692307693,0.20111340452197826,KCNH3;KCNF1;KCNIP2;SCN3A
"phagocytosis, engulfment (GO:0006911)",4/104,0.7699363530876122,1,0,0,0.7692307692307693,0.20111340452197826,SCARB2;XKR8;RHOG;RAC1
ERBB signaling pathway (GO:0038127),3/80,0.7699574892635191,1,0,0,0.7499999999999999,0.1960649808053572,UBB;MAPK1;EGFR
regulation of hydrolase activity (GO:0051336),3/80,0.7699574892635191,1,0,0,0.7499999999999999,0.1960649808053572,PRR5-ARHGAP8;STMN3;MYH6
negative regulation of defense response (GO:0031348),3/80,0.7699574892635191,1,0,0,0.7499999999999999,0.1960649808053572,NLRP9;IRAK3;PTPN2
peptide biosynthetic process (GO:0043043),7/174,0.7726216545178958,1,0,0,0.8045977011494252,0.20755869048599532,RPS15;MRPL52;MRPL51;PABPC4;FURIN;RPL15;RPL29
dicarboxylic acid transport (GO:0006835),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,SLC1A1
regulation of macrophage derived foam cell differentiation (GO:0010743),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,ITGB3
synaptic vesicle endocytosis (GO:0048488),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,DNM3
keratan sulfate biosynthetic process (GO:0018146),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,CHST5
TRIF-dependent toll-like receptor signaling pathway (GO:0035666),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,UBB
cortical cytoskeleton organization (GO:0030865),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,LLGL1
positive regulation of myeloid cell differentiation (GO:0045639),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,THPO
regulation of neutrophil chemotaxis (GO:0090022),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,RAC1
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,CHD6
lysosome localization (GO:0032418),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,SNAPIN
regulation of chromosome segregation (GO:0051983),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,AURKB
B cell proliferation (GO:0042100),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,IFNA7
synaptic vesicle recycling (GO:0036465),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,PLD2
positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,UBB
semaphorin-plexin signaling pathway (GO:0071526),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,RAC1
regulation of cellular biosynthetic process (GO:0031326),1/29,0.7743049289744676,1,0,0,0.689655172413793,0.17640656406412805,PDK4
translational elongation (GO:0006414),4/105,0.7763456159434972,1,0,0,0.761904761904762,0.192881886919067,MRPL52;TSFM;MRPL51;MRPL57
regulation of secretion by cell (GO:1903530),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,LLGL1;INS
regulation of BMP signaling pathway (GO:0030510),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,SMAD2;FBXL15
protein import (GO:0017038),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,NPAP1;IPO11
negative regulation of cellular catabolic process (GO:0031330),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,KDM4A;INS
autophagosome organization (GO:1905037),2/56,0.7771517166186133,1,0,0,0.7142857142857142,0.180085491565519,AMBRA1;ATG12
BMP signaling pathway (GO:0030509),3/81,0.7771926567464108,1,0,0,0.7407407407407407,0.18671630360614933,TGFB3;BMP8A;TDGF1P3
protein catabolic process (GO:0030163),3/81,0.7771926567464108,1,0,0,0.7407407407407407,0.18671630360614933,BACE1;NAPSA;PSMA7
regulation of cell proliferation (GO:0042127),33/740,0.7775495248875761,1,0,0,0.8918918918918919,0.2244070810443487,KMT2D;IRS1;PTPRJ;BRCA1;EGFR;INS;DNAJB2;GPNMB;FRZB;RPS6KA2;HES1;TNFRSF4;SOX7;E2F7;TCFL5;SRPK2;OSR2;MYOCD;CNOT6L;EDN3;TGFB3;RHOG;OSM;TGFBR1;GNL3;CCDC88A;AZGP1;BAMBI;ACER3;RAPGEF2;ROR2;PTPN2;RNF187
regulation of gene expression (GO:0010468),47/1037,0.7809176524409923,1,0,0,0.9064609450337511,0.2241547144824849,KMT2D;PRKAA1;DDX3X;NAB2;EIF4A3;ZNF43;BRCA1;HMGB1;AHR;NLK;AFF2;INS;YY1;RPS6KA4;SALL1;NLRP9;ZNF83;SOX15;ZNF528;CCL3;SAFB2;ZNF789;MAPK1;ZNF623;ZNF468;DRD1;PITX2;TCFL5;SRPK2;OSR2;KDM4A;PTCD2;EDN3;ANKRD30A;NFYC;PRRX2;ZNF12;RRP1B;TGFBR1;APLN;CLK1;PARP10;ACTA1;GAS6;HOXB7;ZNF432;TAF1
modulation of chemical synaptic transmission (GO:0050804),3/82,0.7842396846897038,1,0,0,0.7317073170731706,0.17783457445402553,GRID2;GRM7;LRP8
mitotic sister chromatid segregation (GO:0000070),3/82,0.7842396846897038,1,0,0,0.7317073170731706,0.17783457445402553,KIFC1;INO80;RAB11A
C-terminal protein amino acid modification (GO:0018410),3/82,0.7842396846897038,1,0,0,0.7317073170731706,0.17783457445402553,LY6G6D;ATG12;LYPD8
negative regulation of binding (GO:0051100),3/82,0.7842396846897038,1,0,0,0.7317073170731706,0.17783457445402553,DNAJB2;KDM1A;AURKB
generation of neurons (GO:0048699),5/130,0.784373955308741,1,0,0,0.7692307692307693,0.18682260656936742,NR4A2;FZD4;RAPGEF2;NDNF;MARK1
positive regulation of cell death (GO:0010942),2/57,0.7854924470082494,1,0,0,0.7017543859649122,0.16943469252891025,PRNP;BNIP3
regulation of actin cytoskeleton reorganization (GO:2000249),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,RAPGEF3
ribosomal large subunit assembly (GO:0000027),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,NOP53
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,SFN
negative regulation of stress-activated MAPK cascade (GO:0032873),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,F2RL1
regulation of cell migration involved in sprouting angiogenesis (GO:0090049),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,FOXC2
acylglycerol catabolic process (GO:0046464),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,FABP9
bile acid and bile salt transport (GO:0015721),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,ABCB11
cellular response to drug (GO:0035690),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,GAS6
negative regulation of transferase activity (GO:0051348),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,TERF1
cyclic purine nucleotide metabolic process (GO:0052652),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,GUCY1B2
negative regulation of DNA biosynthetic process (GO:2000279),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,TERF1
regulation of cell adhesion mediated by integrin (GO:0033628),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,FOXC2
MyD88-independent toll-like receptor signaling pathway (GO:0002756),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,UBB
positive regulation of cation channel activity (GO:2001259),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,GALR2
phosphatidylinositol 3-kinase signaling (GO:0014065),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,IRS1
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,SFN
positive regulation of B cell proliferation (GO:0030890),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,TNFRSF4
nuclear envelope organization (GO:0006998),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,SUN2
negative regulation of cell morphogenesis involved in differentiation (GO:0010771),1/30,0.785605993701368,1,0,0,0.6666666666666666,0.16086659500936684,RAPGEF2
"transcription, DNA-templated (GO:0006351)",15/356,0.787521389853587,1,0,0,0.8426966292134831,0.20129051707784923,GTF2A1L;GTF3C2;CCNT1;GTF2H1;AHR;MLLT3;PWP1;GTF2E1;NR4A2;EPC1;POLR2F;ELOB;SMN1;TCFL5;TAF1
mitochondrial translation (GO:0032543),4/107,0.7887401751709202,1,0,0,0.747663551401869,0.1774342589951246,MRPL52;TSFM;MRPL51;MRPL57
regulation of protein secretion (GO:0050708),4/107,0.7887401751709202,1,0,0,0.747663551401869,0.1774342589951246,TGFB3;LLGL1;RAPGEF3;INS
post-translational protein modification (GO:0043687),15/357,0.7909482383832589,1,0,0,0.8403361344537815,0.1970779424843191,IGFBP1;ASB14;KLHL3;FBXL15;PSMA7;RAB11A;KCTD6;FBXL12;FAM20C;NUCB1;ELOB;ARSG;GAS6;OBSL1;DTL
establishment of protein localization to membrane (GO:0090150),3/83,0.7911013287526669,1,0,0,0.7228915662650601,0.1693946149369998,BBS2;EGFR;RAB11A
negative regulation of neuron death (GO:1901215),3/83,0.7911013287526669,1,0,0,0.7228915662650601,0.1693946149369998,GPNMB;TGFB3;NDNF
cellular response to lipid (GO:0071396),7/178,0.7921477736375266,1,0,0,0.7865168539325842,0.1832641856039621,KAT5;FZD4;NRIP1;PDK4;AHR;LILRB2;EGFR
receptor metabolic process (GO:0043112),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,DNM3;NEDD4
response to light stimulus (GO:0009416),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,ERCC4;DTL
autophagosome assembly (GO:0000045),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,AMBRA1;ATG12
integrin-mediated signaling pathway (GO:0007229),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,COL16A1;ITGB3
positive regulation of cell morphogenesis involved in differentiation (GO:0010770),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,RAC1;OBSL1
post-Golgi vesicle-mediated transport (GO:0006892),2/58,0.7935572729047958,1,0,0,0.689655172413793,0.15946866485970154,MYO5A;LLGL1
cellular protein modification process (GO:0006464),45/1001,0.7937671286327698,1,0,0,0.899100899100899,0.207660973691688,ERO1B;PRKAA1;CCNT1;UBA7;ASB14;NLK;PRKCZ;PSMA7;AURKB;RPS6KA4;NUAK2;IRAK2;RPS6KA2;MACROD1;TLK1;MAPK1;MAP3K8;ELOB;ARSG;MARK1;IGFBP1;SRPK2;UBL4A;KSR1;DUSP1;NEK6;KLHL3;IRAK3;FBXL15;TNNI3K;KSR2;MERTK;RAB11A;KCTD6;TGFBR1;GNMT;FBXL12;PRKAR1B;NUCB1;FAM20C;GAS6;CHST5;DTL;OBSL1;TAF1
positive regulation of ubiquitin-protein transferase activity (GO:0051443),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,ARRDC3
negative regulation of blood vessel endothelial cell migration (GO:0043537),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,HMGB1
regulation of ubiquitin-protein transferase activity (GO:0051438),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,ARRDC3
alpha-amino acid metabolic process (GO:1901605),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,CKB
anterograde axonal transport (GO:0008089),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,SNAPIN
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,BRCA1
cofactor biosynthetic process (GO:0051188),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,NUBP1
lysosome organization (GO:0007040),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,MYO7A
nucleobase-containing small molecule interconversion (GO:0015949),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,TYMS
regulation of cytokine secretion (GO:0050707),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,INS
protein destabilization (GO:0031648),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,PRNP
proton transport (GO:0015992),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,UCP2
vesicle-mediated transport to the plasma membrane (GO:0098876),1/31,0.7963417210162199,1,0,0,0.6451612903225806,0.1469205725810339,LLGL1
positive regulation of supramolecular fiber organization (GO:1902905),3/84,0.7977804363560652,1,0,0,0.7142857142857142,0.16137275842992269,RHOG;F2RL1;RAC1
regulation of neuron differentiation (GO:0045664),3/84,0.7977804363560652,1,0,0,0.7142857142857142,0.16137275842992269,HEYL;CCDC88A;FRMD7
regulation of cell motility (GO:2000145),4/109,0.8005792983505415,1,0,0,0.7339449541284404,0.1632438094873767,SERPINE2;AMOTL2;RAC1;EGFR
positive regulation of gene expression (GO:0010628),34/771,0.8009120872205036,1,0,0,0.8819714656290532,0.19580127414932463,FOXC2;PRKAA1;DDX3X;EIF4A3;BRCA1;AHR;MLLT3;EGFR;INS;SALL1;MED30;KAT5;NRIP1;CCL3;EPC1;POLR2F;MAPK1;SRY;DRD1;SRPK2;SMAD2;OSR2;MYOCD;FZD4;TGFB3;USP21;RHOG;HNRNPAB;TGFBR1;ACTA1;BAMBI;WAC;GAS6;RNF187
regulation of protein metabolic process (GO:0051246),2/59,0.8013529002820844,1,0,0,0.6779661016949152,0.15013820630777816,FURIN;LILRB2
sterol metabolic process (GO:0016125),2/59,0.8013529002820844,1,0,0,0.6779661016949152,0.15013820630777816,CYP39A1;LBR
dicarboxylic acid metabolic process (GO:0043648),2/59,0.8013529002820844,1,0,0,0.6779661016949152,0.15013820630777816,FH;SDHA
GPI anchor biosynthetic process (GO:0006506),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,PIGW
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,CCL3
positive regulation of TOR signaling (GO:0032008),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,GAS6
activation of adenylate cyclase activity (GO:0007190),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,DRD1
positive regulation of T cell differentiation (GO:0045582),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,LILRB2
regulation of nitric oxide biosynthetic process (GO:0045428),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,ATP2B4
mismatch repair (GO:0006298),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,RPA3
vasculogenesis (GO:0001570),1/32,0.806540365201665,1,0,0,0.625,0.13437583301390715,EGFL7
"regulation of mRNA splicing, via spliceosome (GO:0048024)",2/60,0.8088860547790443,1,0,0,0.6666666666666666,0.14139814589399213,SRPK2;RBM25
response to reactive oxygen species (GO:0000302),2/60,0.8088860547790443,1,0,0,0.6666666666666666,0.14139814589399213,MAPK1;EGFR
negative regulation of programmed cell death (GO:0043069),17/408,0.8130845912216467,1,0,0,0.8333333333333333,0.17243343883655135,BARD1;PRKAA1;DDX3X;BNIP3;FMN2;MERTK;EGFR;INS;RNF144B;ARHGAP10;NUAK2;UBB;FIGNL1;CLEC5A;IL2RB;ROR2;GAS6
protein targeting to membrane (GO:0006612),2/61,0.8161634632362453,1,0,0,0.6557377049180327,0.1332069649091696,SRP19;SEC62
positive regulation of cellular amide metabolic process (GO:0034250),2/61,0.8161634632362453,1,0,0,0.6557377049180327,0.1332069649091696,DDX3X;EIF4A3
axonemal dynein complex assembly (GO:0070286),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,CCDC40
positive regulation of adenylate cyclase activity (GO:0045762),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,DRD1
"chemical synaptic transmission, postsynaptic (GO:0099565)",1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,GRID2
oligosaccharide biosynthetic process (GO:0009312),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,FUT8
negative regulation of mitochondrion organization (GO:0010823),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,BNIP3
positive regulation of calcium ion transport (GO:0051928),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,CCL3
tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,TPR
tRNA export from nucleus (GO:0006409),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,TPR
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,UBB
regulation of postsynaptic membrane potential (GO:0060078),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,GRID2
positive regulation of catalytic activity (GO:0043085),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,DAOA
exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay (GO:0043928),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,EDC3
carboxylic acid metabolic process (GO:0019752),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,GSTO2
positive regulation of locomotion (GO:0040017),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,F2RL1
cellular glucose homeostasis (GO:0001678),1/33,0.8162287694193023,1,0,0,0.6060606060606061,0.12306703553305594,GAS6
cellular response to BMP stimulus (GO:0071773),3/87,0.8167521653641692,1,0,0,0.689655172413793,0.13959970848873965,TGFB3;BMP8A;TDGF1P3
calcium ion homeostasis (GO:0055074),3/87,0.8167521653641692,1,0,0,0.689655172413793,0.13959970848873965,CCL3;ATP2B4;CCL1
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",4/112,0.8173248241169633,1,0,0,0.7142857142857142,0.14408477257015773,RPS15;EIF4A3;RPL15;RPL29
viral transcription (GO:0019083),4/113,0.8226434279131911,1,0,0,0.7079646017699115,0.13821765033879096,RPS15;TPR;RPL15;RPL29
regulation of organelle organization (GO:0033043),4/113,0.8226434279131911,1,0,0,0.7079646017699115,0.13821765033879096,SCARB2;STMN3;MAPK1;TBC1D22B
positive regulation of canonical Wnt signaling pathway (GO:0090263),4/113,0.8226434279131911,1,0,0,0.7079646017699115,0.13821765033879096,DDX3X;UBB;BAMBI;PSMA7
cellular amide metabolic process (GO:0043603),2/62,0.8231918367006723,1,0,0,0.6451612903225806,0.12552645874570276,NAPEPLD;ACACB
tRNA processing (GO:0008033),2/62,0.8231918367006723,1,0,0,0.6451612903225806,0.12552645874570276,CPSF4;THG1L
regulation of cellular macromolecule biosynthetic process (GO:2000112),27/631,0.8250670274143169,1,0,0,0.8557844690966718,0.16455935233340183,KMT2D;NAB2;ZNF43;AHR;HMGB1;NLK;INS;RPS6KA4;SALL1;ZNF83;SOX15;ZNF528;ZNF789;ZNF623;ZNF468;PITX2;TCFL5;ANKRD30A;ZBTB38;NFYC;PRRX2;ZNF12;TGFBR1;CCDC88A;HOXB7;ZNF432;TAF1
translation (GO:0006412),9/232,0.8253743816905332,1,0,0,0.7758620689655172,0.14890205140851023,RPS15;MRPL52;TSFM;MRPL51;PABPC4;EIF4H;RPL15;RPL29;MRPL57
negative regulation of DNA binding (GO:0043392),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,KDM1A
keratan sulfate metabolic process (GO:0042339),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,CHST5
positive regulation of muscle cell differentiation (GO:0051149),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,MYOCD
positive regulation of cytokinesis (GO:0032467),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,AURKB
bone development (GO:0060348),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,OSR2
positive regulation of chemokine production (GO:0032722),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,DDX3X
cellular macromolecular complex assembly (GO:0034622),1/34,0.8254324369271197,1,0,0,0.588235294117647,0.11285168470716885,TMED10
regulation of vesicle-mediated transport (GO:0060627),5/138,0.8256627743834776,1,0,0,0.7246376811594203,0.13881800889973492,GAS1;MAPK1;TBC1D22B;LLGL1;RAB11A
mitochondrial translational termination (GO:0070126),3/89,0.8285426848935676,1,0,0,0.6741573033707865,0.1268001726406977,MRPL52;MRPL51;MRPL57
negative regulation of protein modification process (GO:0031400),2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,PRNP;ATP2B4
negative regulation of neuron apoptotic process (GO:0043524),2/63,0.8299778549215587,1,0,0,0.6349206349206349,0.1183214345173536,TGFB3;NDNF
intracellular protein transport (GO:0006886),14/347,0.8302296356556821,1,0,0,0.8069164265129682,0.15012917912960036,IPO11;TMED10;OR1D2;UNC93B1;USO1;RAB11A;NPAP1;RAB30;TLK1;RAB6A;TNPO1;VPS25;TBC1D22B;TMED5
cellular response to growth factor stimulus (GO:0071363),5/139,0.8303434515247903,1,0,0,0.7194244604316546,0.13375242213240954,RAPGEF1;GAS1;RAPGEF2;TGFBR1;EGFR
regulation of primary metabolic process (GO:0080090),5/139,0.8303434515247903,1,0,0,0.7194244604316546,0.13375242213240954,IRS1;PSAP;OAZ1;PSMA7;INS
positive regulation of RNA metabolic process (GO:0051254),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,EGFR
lipid phosphorylation (GO:0046834),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,DGKA
positive regulation of NIK/NF-kappaB signaling (GO:1901224),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,EGFR
antibacterial humoral response (GO:0019731),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,RNASE7
"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,EDC3
negative regulation of cell-substrate adhesion (GO:0010812),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,FZD4
regulation of microtubule polymerization (GO:0031113),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,RAC1
apical junction assembly (GO:0043297),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,MPP7
regulation of mitotic spindle organization (GO:0060236),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,TPR
cholesterol biosynthetic process (GO:0006695),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,LBR
regulation of synapse assembly (GO:0051963),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,GRID2
positive regulation of ATPase activity (GO:0032781),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,DNAJB2
regulation of phosphoprotein phosphatase activity (GO:0043666),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,CD300A
carboxylic acid transmembrane transport (GO:1905039),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,STRA6
regulation of cardiac muscle contraction (GO:0055117),1/35,0.8341755971925006,1,0,0,0.5714285714285714,0.103606486053202,TNNI3K
positive regulation of response to external stimulus (GO:0032103),3/90,0.8341902087803339,1,0,0,0.6666666666666666,0.120862556363351,CCL3;F2RL1;F2
regulation of Ras protein signal transduction (GO:0046578),3/90,0.8341902087803339,1,0,0,0.6666666666666666,0.120862556363351,ADAP2;ASAP2;RALGPS1
regulation of JNK cascade (GO:0046328),3/90,0.8341902087803339,1,0,0,0.6666666666666666,0.120862556363351,F2RL1;HMGB1;EGFR
positive regulation of Wnt signaling pathway (GO:0030177),5/140,0.8349213737401235,1,0,0,0.7142857142857142,0.12886980125028102,SALL1;DDX3X;UBB;BAMBI;PSMA7
positive regulation of protein polymerization (GO:0032273),2/64,0.8365281531009908,1,0,0,0.625,0.11155943955785279,RHOG;RAC1
negative regulation of neuron differentiation (GO:0045665),2/64,0.8365281531009908,1,0,0,0.625,0.11155943955785279,LPAR1;HES1
cellular response to interferon-gamma (GO:0071346),4/116,0.8378353080759515,1,0,0,0.689655172413793,0.1220232603840384,CCL3;CCL1;HLA-F;CAMK2G
cellular protein localization (GO:0034613),13/327,0.8378673380155135,1,0,0,0.7951070336391437,0.1406508553861054,BBS2;GRID2;TMED10;UNC93B1;USO1;EGFR;RAB11A;RAB30;TLK1;RAB6A;TBC1D22B;TMED5;CNTLN
positive regulation of cellular protein metabolic process (GO:0032270),3/91,0.8396768561291149,1,0,0,0.6593406593406593,0.11521197114942941,DDX3X;EIF4A3;INS
actin polymerization or depolymerization (GO:0008154),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,RAC1
regulation of receptor-mediated endocytosis (GO:0048259),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,RAC1
carbohydrate biosynthetic process (GO:0016051),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,FUT8
regulation of muscle cell differentiation (GO:0051147),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,MYOCD
transferrin transport (GO:0033572),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,MCOLN1
positive regulation of signaling (GO:0023056),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,EDN3
sodium ion transmembrane transport (GO:0035725),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,SCN3A
regulation of filopodium assembly (GO:0051489),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,TGFB3
organophosphate biosynthetic process (GO:0090407),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,GPAM
zymogen activation (GO:0031638),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,FURIN
endosome organization (GO:0007032),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,ANXA8
ferric iron transport (GO:0015682),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,MCOLN1
regulation of cell morphogenesis involved in differentiation (GO:0010769),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,NEDD4
acylglycerol metabolic process (GO:0006639),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,DGKA
axonal transport (GO:0098930),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,SNAPIN
spermatid development (GO:0007286),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,RFX2
secondary alcohol biosynthetic process (GO:1902653),1/36,0.8424812699182175,1,0,0,0.5555555555555555,0.09522436030767889,LBR
cellular response to type I interferon (GO:0071357),2/65,0.8428493095437481,1,0,0,0.6153846153846154,0.10521051812214251,IFNA7;HLA-F
cellular response to reactive oxygen species (GO:0034614),2/65,0.8428493095437481,1,0,0,0.6153846153846154,0.10521051812214251,MAPK1;EGFR
negative regulation of blood vessel morphogenesis (GO:2000181),2/65,0.8428493095437481,1,0,0,0.6153846153846154,0.10521051812214251,HSPG2;DCN
type I interferon signaling pathway (GO:0060337),2/65,0.8428493095437481,1,0,0,0.6153846153846154,0.10521051812214251,IFNA7;HLA-F
defense response to Gram-positive bacterium (GO:0050830),2/65,0.8428493095437481,1,0,0,0.6153846153846154,0.10521051812214251,RNASE7;SPACA3
positive regulation of cellular metabolic process (GO:0031325),3/92,0.845005864491722,1,0,0,0.6521739130434782,0.10983372484053684,F2;ACACB;INS
nuclear export (GO:0051168),3/92,0.845005864491722,1,0,0,0.6521739130434782,0.10983372484053684,NPAP1;EIF4A3;TPR
JNK cascade (GO:0007254),2/66,0.8489478345965421,1,0,0,0.6060606060606061,0.09924699267132996,UBB;IRAK2
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),3/93,0.8501804853980194,1,0,0,0.6451612903225806,0.10471394598415903,UBB;ELOB;PSMA7
base-excision repair (GO:0006284),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,RPA3
myelination (GO:0042552),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,PLP1
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,SFN
positive regulation of receptor activity (GO:2000273),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,TAF1
regulation of osteoclast differentiation (GO:0045670),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,CCL3
regulation of carbohydrate catabolic process (GO:0043470),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,TPR
negative regulation of Ras protein signal transduction (GO:0046580),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,STMN3
regulation of metal ion transport (GO:0010959),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,CAMK2G
organic cyclic compound biosynthetic process (GO:1901362),1/37,0.8503713249208762,1,0,0,0.5405405405405406,0.08761198488762709,PYCR1
endocytosis (GO:0006897),10/263,0.8522359775352177,1,0,0,0.7604562737642585,0.12159073883162574,DNM3;RHOG;M6PR;PECAM1;MAPK1;RAC1;GAS6;MERTK;HSPG2;LRP8
negative regulation of cellular process (GO:0048523),22/534,0.8533275613847973,1,0,0,0.8239700374531834,0.13069136600889572,MYOCD;DDX3X;CAB39;TGFB3;BNIP3;OSM;PTPRJ;KLK8;SPN;DNAJB2;TCHP;AZGP1;GPNMB;FRZB;RPS6KA2;NDUFS3;RAPGEF2;ROR2;SOX7;CBLL1;E2F7;PTPN2
regulation of gene silencing by miRNA (GO:0060964),2/67,0.8548301611907013,1,0,0,0.5970149253731343,0.0936432666623936,TPR;POLR2F
regulation of TOR signaling (GO:0032006),2/67,0.8548301611907013,1,0,0,0.5970149253731343,0.0936432666623936,PRKAA1;GAS6
extrinsic apoptotic signaling pathway (GO:0097191),2/67,0.8548301611907013,1,0,0,0.5970149253731343,0.0936432666623936,DDX3X;DEDD
cellular response to fibroblast growth factor stimulus (GO:0044344),3/94,0.855203978006065,1,0,0,0.6382978723404255,0.09983953259459333,UBB;POLR2F;MAPK1
actin filament organization (GO:0007015),4/120,0.8563810483662649,1,0,0,0.6666666666666666,0.10335990128643677,ACTA1;RHOG;RAC1;OBSL1
T cell differentiation (GO:0030217),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,PTPN2
regulation of cellular amide metabolic process (GO:0034248),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,TMED10
positive regulation of innate immune response (GO:0045089),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,ZBP1
regulation of ossification (GO:0030278),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,S1PR1
retina homeostasis (GO:0001895),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,AZGP1
chemical homeostasis (GO:0048878),1/38,0.8578665401729517,1,0,0,0.5263157894736842,0.08068775746154062,KLHL3
skeletal system development (GO:0001501),5/146,0.8603054421308406,1,0,0,0.684931506849315,0.10306012844001264,KIAA1217;EXT1;COL1A2;FRZB;TGFBR1
response to interferon-gamma (GO:0034341),2/68,0.860502636162266,1,0,0,0.588235294117647,0.08837564694787858,CCL3;CCL1
regulation of actin filament polymerization (GO:0030833),2/68,0.860502636162266,1,0,0,0.588235294117647,0.08837564694787858,RHOG;RAC1
chemical synaptic transmission (GO:0007268),11/289,0.8606759332603792,1,0,0,0.7612456747404844,0.11421519203659355,GRID2;GRM7;KCNIP2;NPBWR1;SLC1A1;PLP1;CACNA1B;CRH;GAD2;MAPK1;PCDHB11
ion transport (GO:0006811),11/289,0.8606759332603792,1,0,0,0.7612456747404844,0.11421519203659355,RYR1;PANX1;CLCN7;SLC15A1;UBB;SLC20A1;SLC1A1;SLC17A5;ATP2B4;SLC26A11;MCOLN1
stimulatory C-type lectin receptor signaling pathway (GO:0002223),4/121,0.8607254206096335,1,0,0,0.6611570247933884,0.09916015401943896,UBB;CLEC4E;CARD11;PSMA7
regulation of cell differentiation (GO:0045595),4/121,0.8607254206096335,1,0,0,0.6611570247933884,0.09916015401943896,EDN3;TGFBR1;INS;TCFL5
translational termination (GO:0006415),3/96,0.8648106182658194,1,0,0,0.625,0.09077795902611915,MRPL52;MRPL51;MRPL57
protein localization to nucleus (GO:0034504),3/96,0.8648106182658194,1,0,0,0.625,0.09077795902611915,NPAP1;IPO11;NOP53
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,BRCA1
"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,RBM25
regulation of proteasomal protein catabolic process (GO:0061136),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,UBB
inositol lipid-mediated signaling (GO:0048017),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,IRS1
mitotic DNA damage checkpoint (GO:0044773),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,NOP53
cellular response to amino acid starvation (GO:0034198),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,MAPK1
regulation of coenzyme metabolic process (GO:0051196),1/39,0.8649866555134298,1,0,0,0.5128205128205128,0.07438010221608295,TPR
positive regulation of neurogenesis (GO:0050769),2/69,0.8659715129706728,1,0,0,0.5797101449275363,0.08342218313842696,HEYL;RAPGEF2
negative regulation of angiogenesis (GO:0016525),2/69,0.8659715129706728,1,0,0,0.5797101449275363,0.08342218313842696,HSPG2;DCN
regulation of nucleic acid-templated transcription (GO:1903506),25/607,0.8673812482942784,1,0,0,0.8237232289950576,0.11719659481521788,KMT2D;NAB2;ZNF43;AHR;HMGB1;NLK;INS;RPS6KA4;SALL1;ZNF83;SOX15;ZNF528;ZNF789;ZNF623;ZNF468;PITX2;TCFL5;ANKRD30A;NFYC;PRRX2;ZNF12;TGFBR1;HOXB7;ZNF432;TAF1
response to tumor necrosis factor (GO:0034612),3/97,0.8694002721574682,1,0,0,0.6185567010309279,0.08656802931150201,CCL3;CCL1;BRCA1
vascular endothelial growth factor receptor signaling pathway (GO:0048010),2/70,0.8712429450339811,1,0,0,0.5714285714285714,0.0787625225498065,ITGB3;RAC1
phospholipid metabolic process (GO:0006644),2/70,0.8712429450339811,1,0,0,0.5714285714285714,0.0787625225498065,GPAM;GDE1
interferon-gamma-mediated signaling pathway (GO:0060333),2/70,0.8712429450339811,1,0,0,0.5714285714285714,0.0787625225498065,HLA-F;CAMK2G
negative regulation of transport (GO:0051051),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,ITGB3
intraciliary transport involved in cilium assembly (GO:0035735),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,TNPO1
negative regulation of TOR signaling (GO:0032007),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,PRKAA1
regulation of cellular localization (GO:0060341),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,KDM1A
ameboidal-type cell migration (GO:0001667),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,AMOTL2
sterol biosynthetic process (GO:0016126),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,LBR
negative regulation of ERK1 and ERK2 cascade (GO:0070373),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,PTPN2
detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,AZGP1
regulation of release of cytochrome c from mitochondria (GO:0090199),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,BNIP3
regulation of intracellular transport (GO:0032386),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,GAS1
positive regulation of cytokine biosynthetic process (GO:0042108),1/40,0.8717504251826977,1,0,0,0.5,0.06862605284591321,SPN
nuclear-transcribed mRNA catabolic process (GO:0000956),6/174,0.8724297738292334,1,0,0,0.689655172413793,0.0941193907536509,RPS15;PAN2;CNOT6L;EIF4A3;RPL15;RPL29
innate immune response activating cell surface receptor signaling pathway (GO:0002220),4/124,0.8730902649815165,1,0,0,0.6451612903225806,0.08755892398339275,UBB;CLEC4E;CARD11;PSMA7
regulation of insulin secretion (GO:0050796),3/98,0.8738518002871013,1,0,0,0.6122448979591836,0.08255784648566498,IRS1;BMP8A;RAPGEF3
regulation of cell communication (GO:0010646),2/71,0.8763229800185758,1,0,0,0.5633802816901409,0.07437777878706983,GRID2;LRP8
positive regulation of lymphocyte proliferation (GO:0050671),2/71,0.8763229800185758,1,0,0,0.5633802816901409,0.07437777878706983,LILRB2;TNFRSF4
protein dephosphorylation (GO:0006470),4/125,0.8769959948339774,1,0,0,0.64,0.08400182624919345,DUSP1;PTPRJ;DUSP28;PTPN2
regulation of calcium-mediated signaling (GO:0050848),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,CCL3
peptide transport (GO:0015833),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,TAP1
positive regulation of cell division (GO:0051781),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,AURKB
regulation of substrate adhesion-dependent cell spreading (GO:1900024),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,RAC1
cellular response to peptide (GO:1901653),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,PRNP
sensory perception of bitter taste (GO:0050913),1/41,0.878175666331951,1,0,0,0.4878048780487805,0.0633700633222169,AZGP1
neutrophil degranulation (GO:0043312),19/479,0.8788994523709087,1,0,0,0.7933194154488518,0.1024054594334483,SERPINB1;DDX3X;CAB39;STK11IP;CD300A;FUCA1;RHOG;PTPRJ;LILRB2;HMGB1;CLEC5A;PSAP;ITGAX;PECAM1;PGM2;MAPK1;HPSE;RAC1;RAB6A
lipid biosynthetic process (GO:0008610),2/72,0.8812175551168138,1,0,0,0.5555555555555555,0.07025041245674381,PRKAA1;GPAM
response to metal ion (GO:0010038),2/72,0.8812175551168138,1,0,0,0.5555555555555555,0.07025041245674381,NEDD4;SLC30A4
protein stabilization (GO:0050821),5/152,0.8823360987788662,1,0,0,0.6578947368421052,0.08235673104394964,TMEM88;SYVN1;NLK;NOP53;TAF1
glycolipid biosynthetic process (GO:0009247),1/42,0.8842793063304941,1,0,0,0.47619047619047616,0.05856300421956226,PIGW
cellular response to retinoic acid (GO:0071300),1/42,0.8842793063304941,1,0,0,0.47619047619047616,0.05856300421956226,FZD4
vesicle organization (GO:0016050),4/127,0.884496020278119,1,0,0,0.6299212598425197,0.07731481246950389,SYT12;SYTL1;ANXA8;SYTL5
negative regulation of response to stimulus (GO:0048585),4/127,0.884496020278119,1,0,0,0.6299212598425197,0.07731481246950389,NLRP9;ROR2;MERTK;EGFR
protein lipidation (GO:0006497),4/127,0.884496020278119,1,0,0,0.6299212598425197,0.07731481246950389,PIGW;LY6G6D;ATG12;LYPD8
negative regulation of protein phosphorylation (GO:0001933),6/178,0.8854491489065579,1,0,0,0.6741573033707865,0.08201814595048382,PRNP;DUSP1;SFN;PRKCZ;DCN;PBLD
positive regulation of inflammatory response (GO:0050729),2/73,0.8859324931436037,1,0,0,0.547945205479452,0.06636412280550928,CCL3;OSM
regulation of peptide hormone secretion (GO:0090276),2/73,0.8859324931436037,1,0,0,0.547945205479452,0.06636412280550928,RAPGEF3;INS
cellular divalent inorganic cation homeostasis (GO:0072503),3/101,0.8864097011888528,1,0,0,0.594059405940594,0.07162931796059352,CCL3;ATP2B4;CCL1
regulation of kinase activity (GO:0043549),3/101,0.8864097011888528,1,0,0,0.594059405940594,0.07162931796059352,ROR2;MERTK;EGFR
neutrophil activation involved in immune response (GO:0002283),19/483,0.8868798711076329,1,0,0,0.7867494824016563,0.09444592274191829,SERPINB1;DDX3X;CAB39;STK11IP;CD300A;FUCA1;RHOG;PTPRJ;LILRB2;HMGB1;CLEC5A;PSAP;ITGAX;PECAM1;PGM2;MAPK1;HPSE;RAC1;RAB6A
positive regulation of interferon-gamma production (GO:0032729),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,SLAMF6
RNA catabolic process (GO:0006401),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,PABPC4
protein transmembrane import into intracellular organelle (GO:0044743),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,TOMM20L
regulation of ATP metabolic process (GO:1903578),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,TPR
nucleobase-containing compound catabolic process (GO:0034655),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,PABPC4
branching morphogenesis of an epithelial tube (GO:0048754),1/43,0.8900774268754144,1,0,0,0.46511627906976744,0.05416131327939396,SALL1
nitrogen compound transport (GO:0071705),2/74,0.8904734986911036,1,0,0,0.5405405405405406,0.06270374958254536,SLC48A1;SLC6A3
neutrophil mediated immunity (GO:0002446),19/487,0.8944380524994598,1,0,0,0.7802874743326489,0.08704858365085753,SERPINB1;DDX3X;CAB39;STK11IP;CD300A;FUCA1;RHOG;PTPRJ;LILRB2;HMGB1;CLEC5A;PSAP;ITGAX;PECAM1;PGM2;MAPK1;HPSE;RAC1;RAB6A
organonitrogen compound biosynthetic process (GO:1901566),6/181,0.8944603755722496,1,0,0,0.6629834254143646,0.0739456407948574,GSTZ1;ALAS2;GSTO2;ACER3;PYCR1;FURIN
regulation of actin cytoskeleton organization (GO:0032956),2/75,0.8948461559431564,1,0,0,0.5333333333333333,0.0592551830845253,CCDC88A;RAPGEF3
positive regulation of signal transduction (GO:0009967),7/206,0.8949466944667533,1,0,0,0.6796116504854368,0.07543085943225253,SALL1;IRS1;ITGB3;GAS6;PRKCZ;TGFBR1;INS
ribosomal small subunit biogenesis (GO:0042274),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,RPS15
adherens junction organization (GO:0034332),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,CDH19
detection of chemical stimulus involved in sensory perception of taste (GO:0050912),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,AZGP1
amide biosynthetic process (GO:0043604),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,FURIN
positive regulation of interleukin-8 production (GO:0032757),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,F2RL1
regulation of T cell activation (GO:0050863),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,GPNMB
positive regulation of transport (GO:0051050),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,CBLL1
carboxylic acid biosynthetic process (GO:0046394),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,PYCR1
inorganic anion transport (GO:0015698),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,SLC26A11
posttranscriptional regulation of gene expression (GO:0010608),1/44,0.8955853061573006,1,0,0,0.45454545454545453,0.05012627322480098,ZNF385A
regulation of hematopoietic stem cell differentiation (GO:1902036),2/76,0.8990559259149057,1,0,0,0.5263157894736842,0.056005282852014004,UBB;PSMA7
positive regulation of JNK cascade (GO:0046330),2/76,0.8990559259149057,1,0,0,0.5263157894736842,0.056005282852014004,F2RL1;HMGB1
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),2/76,0.8990559259149057,1,0,0,0.5263157894736842,0.056005282852014004,BRCA1;TGFBR1
hexose metabolic process (GO:0019318),1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,FUCA1
protein polymerization (GO:0051258),1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,RAC1
nicotinamide nucleotide metabolic process (GO:0046496),1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,NMNAT1
peptidyl-tyrosine autophosphorylation (GO:0038083),1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,EGFR
negative regulation of ossification (GO:0030279),1/45,0.9008174591944802,1,0,0,0.4444444444444444,0.046423395514619575,CCL3
water-soluble vitamin metabolic process (GO:0006767),2/77,0.9031081450221422,1,0,0,0.5194805194805194,0.05294180301649679,GSTO2;ACACB
intraciliary transport (GO:0042073),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,TNPO1
cartilage development (GO:0051216),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,OSR2
pyruvate metabolic process (GO:0006090),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,LDHB
regulation of generation of precursor metabolites and energy (GO:0043467),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,TPR
negative regulation of autophagy (GO:0010507),1/46,0.9057876758651223,1,0,0,0.43478260869565216,0.04302189293649987,KDM4A
positive regulation of translation (GO:0045727),2/78,0.9070080241695482,1,0,0,0.5128205128205128,0.0500533240880421,DDX3X;EIF4A3
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),1/47,0.9105090567783704,1,0,0,0.42553191489361697,0.03989422673431822,CYLD
peptide cross-linking (GO:0018149),1/47,0.9105090567783704,1,0,0,0.42553191489361697,0.03989422673431822,NDNF
regulation of organelle assembly (GO:1902115),1/47,0.9105090567783704,1,0,0,0.42553191489361697,0.03989422673431822,CYLD
"positive regulation of gene expression, epigenetic (GO:0045815)",1/47,0.9105090567783704,1,0,0,0.42553191489361697,0.03989422673431822,POLR2F
cellular response to heat (GO:0034605),1/47,0.9105090567783704,1,0,0,0.42553191489361697,0.03989422673431822,TPR
mitochondrial transport (GO:0006839),4/135,0.9106439683988242,1,0,0,0.5925925925925926,0.055468605725438686,BNIP3;UCP2;TOMM20L;SLC25A44
cytokine-mediated signaling pathway (GO:0019221),25/633,0.9112265037279818,1,0,0,0.7898894154818326,0.07343110636046624,IFNA7;IRS1;LRP8;PSMA7;RPS6KA4;UBB;IRAK2;ITGAX;CCL3;S1PR1;MAP3K8;CCL1;TNFRSF4;CAMK2G;IL31;TNFRSF12A;OSM;IL36G;IRAK3;HLA-F;COMMD7;DCN;COL1A2;IL2RB;RAPGEF1
"retrograde vesicle-mediated transport, Golgi to ER (GO:0006890)",2/80,0.9143709716133156,1,0,0,0.5,0.04475945641757651,TMED10;RAB6A
nucleic acid metabolic process (GO:0090304),2/80,0.9143709716133156,1,0,0,0.5,0.04475945641757651,DDX54;POLR2F
NIK/NF-kappaB signaling (GO:0038061),2/80,0.9143709716133156,1,0,0,0.5,0.04475945641757651,UBB;PSMA7
positive regulation of stress-activated MAPK cascade (GO:0032874),2/80,0.9143709716133156,1,0,0,0.5,0.04475945641757651,F2RL1;HMGB1
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),3/109,0.9146032191683431,1,0,0,0.5504587155963303,0.049136668628761794,DDX3X;HMGB1;SOX7
regulation of cell cycle arrest (GO:0071156),1/48,0.914994048233663,1,0,0,0.41666666666666663,0.03701571599601437,BRCA1
regulation of mitochondrion organization (GO:0010821),1/48,0.914994048233663,1,0,0,0.41666666666666663,0.03701571599601437,MYO19
cellular macromolecule catabolic process (GO:0044265),1/48,0.914994048233663,1,0,0,0.41666666666666663,0.03701571599601437,PABPC4
cellular response to mechanical stimulus (GO:0071260),1/48,0.914994048233663,1,0,0,0.41666666666666663,0.03701571599601437,BNIP3
T cell receptor signaling pathway (GO:0050852),5/163,0.9150605393003802,1,0,0,0.6134969325153374,0.05445708756164863,FYB2;UBB;PTPRJ;CARD11;PSMA7
negative regulation of cell death (GO:0060548),2/81,0.9178438273168302,1,0,0,0.49382716049382713,0.042334827448253703,GPNMB;BNIP3
establishment of protein localization to mitochondrion (GO:0072655),1/49,0.919254474341766,1,0,0,0.4081632653061224,0.034364200583535946,TOMM20L
regulation of anatomical structure morphogenesis (GO:0022603),2/82,0.9211839178855769,1,0,0,0.4878048780487805,0.04004661901274316,GPNMB;MYO19
positive regulation of cell cycle (GO:0045787),2/82,0.9211839178855769,1,0,0,0.4878048780487805,0.04004661901274316,SRPK2;CCNT1
neuron differentiation (GO:0030182),4/139,0.9216307962341534,1,0,0,0.5755395683453237,0.04697011427115409,NR4A2;FZD4;PITX2;TGFBR1
regulation of inflammatory response (GO:0050727),5/166,0.9224682232595534,1,0,0,0.6024096385542168,0.04861587348906672,NLRP9;SETD6;CCL3;USP18;PTPN2
cilium organization (GO:0044782),6/192,0.9224978058129646,1,0,0,0.625,0.050418925995509435,BBS2;TTC8;FAM161A;RFX4;RFX2;MKS1
regulation of cellular protein metabolic process (GO:0032268),1/50,0.9233015685863551,1,0,0,0.39999999999999997,0.03191974852547144,INS
fatty acid oxidation (GO:0019395),1/50,0.9233015685863551,1,0,0,0.39999999999999997,0.03191974852547144,ECI1
myeloid leukocyte differentiation (GO:0002573),1/50,0.9233015685863551,1,0,0,0.39999999999999997,0.03191974852547144,F2RL1
regulation of blood vessel endothelial cell migration (GO:0043535),1/50,0.9233015685863551,1,0,0,0.39999999999999997,0.03191974852547144,HMGB1
negative regulation of protein ubiquitination (GO:0031397),1/50,0.9233015685863551,1,0,0,0.39999999999999997,0.03191974852547144,TAF1
fatty acid beta-oxidation (GO:0006635),1/50,0.9233015685863551,1,0,0,0.39999999999999997,0.03191974852547144,ECI1
mitochondrion organization (GO:0007005),5/167,0.9248072028145058,1,0,0,0.5988023952095808,0.046808378792730115,DNM3;IMMP1L;CLUH;BNIP3;MTFR1
peptidyl-tyrosine modification (GO:0018212),1/51,0.9271460027962314,1,0,0,0.39215686274509803,0.029664402156312095,EGFR
negative regulation of neuron projection development (GO:0010977),1/51,0.9271460027962314,1,0,0,0.39215686274509803,0.029664402156312095,LPAR1
regulation of exocytosis (GO:0017157),1/51,0.9271460027962314,1,0,0,0.39215686274509803,0.029664402156312095,LLGL1
coenzyme metabolic process (GO:0006732),1/51,0.9271460027962314,1,0,0,0.39215686274509803,0.029664402156312095,DBI
activation of GTPase activity (GO:0090630),2/84,0.9274839879498789,1,0,0,0.47619047619047616,0.035847499197840214,RHOG;TBC1D22B
transcription from RNA polymerase II promoter (GO:0006366),18/485,0.9280010817337284,1,0,0,0.7422680412371133,0.0554640350364895,GTF2A1L;CPSF4;CCNT1;EIF4A3;CPSF2;GTF2H1;AHR;MLLT3;GTF2E1;NR2C1;NR4A2;MED30;SNRPG;POLR2F;ELOB;NR2C2AP;TCFL5;TAF1
mitotic cell cycle phase transition (GO:0044772),7/221,0.9295999202145803,1,0,0,0.6334841628959276,0.04624496389007068,UBB;HAUS8;RPA3;HAUS4;HAUS3;HAUS6;FBXL15
positive regulation of proteolysis (GO:0045862),1/52,0.9307979155856723,1,0,0,0.38461538461538464,0.027581956513803345,FURIN
positive regulation of nervous system development (GO:0051962),1/52,0.9307979155856723,1,0,0,0.38461538461538464,0.027581956513803345,GRID2
protein O-linked glycosylation (GO:0006493),3/115,0.9313952225161781,1,0,0,0.5217391304347826,0.037080823202493875,ADAMTS5;KCNE1;C1GALT1
cellular response to oxidative stress (GO:0034599),3/115,0.9313952225161781,1,0,0,0.5217391304347826,0.037080823202493875,PYCR1;MAPK1;EGFR
sphingolipid metabolic process (GO:0006665),3/116,0.9338791037872658,1,0,0,0.5172413793103448,0.035383597412689746,PSAP;ACER3;ARSG
monocarboxylic acid transport (GO:0015718),1/53,0.9342669389173686,1,0,0,0.3773584905660377,0.02565776594269266,ABCB11
RNA modification (GO:0009451),1/54,0.9375622230779963,1,0,0,0.37037037037037035,0.02387857483587084,THG1L
positive regulation of immune response (GO:0050778),1/54,0.9375622230779963,1,0,0,0.37037037037037035,0.02387857483587084,F2RL1
positive regulation of response to stimulus (GO:0048584),1/54,0.9375622230779963,1,0,0,0.37037037037037035,0.02387857483587084,EGFR
protein transport (GO:0015031),11/326,0.9385898400456552,1,0,0,0.6748466257668712,0.042769552325530716,BBS2;RAB30;TMED10;UNC93B1;USO1;TLK1;RAB6A;MCOLN1;TBC1D22B;TMED5;RAB11A
regulation of protein kinase activity (GO:0045859),4/147,0.9400369681726386,1,0,0,0.5442176870748299,0.0336522866112513,RAPGEF2;SFN;GAS6;DCN
positive regulation of cellular process (GO:0048522),19/519,0.9413323926200773,1,0,0,0.7321772639691715,0.044266682050055114,SRPK2;KMT2D;OSR2;KCNE1;CNOT6L;DDX3X;EDN3;IRS1;RHOG;OSM;INO80;ACACB;EGFR;TGFBR1;INS;BAMBI;ACER3;HES1;RNF187
endosomal transport (GO:0016197),7/229,0.9436309498735682,1,0,0,0.611353711790393,0.035470823182272494,SNAPIN;UBB;M6PR;UBAP1;ANXA8;RAB6A;VPS25
chromosome organization (GO:0051276),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,UBB
anion transport (GO:0006820),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,SLC17A5
phosphatidylinositol-mediated signaling (GO:0048015),1/56,0.9436659121708673,1,0,0,0.3571428571428571,0.020708243598219184,IRS1
negative regulation of cell migration (GO:0030336),3/121,0.9450990402667404,1,0,0,0.49586776859504134,0.027999447503273347,PTPRJ;SRGAP3;PBLD
cellular response to acid chemical (GO:0071229),2/91,0.9459848142593618,1,0,0,0.43956043956043955,0.024408247313871943,FZD4;PDK4
cellular response to lipopolysaccharide (GO:0071222),2/91,0.9459848142593618,1,0,0,0.43956043956043955,0.024408247313871943,CCL3;LILRB2
negative regulation of kinase activity (GO:0033673),2/91,0.9459848142593618,1,0,0,0.43956043956043955,0.024408247313871943,SFN;DCN
epidermal growth factor receptor signaling pathway (GO:0007173),1/57,0.9464904210788941,1,0,0,0.3508771929824561,0.01929629078749377,EGFR
response to retinoic acid (GO:0032526),1/57,0.9464904210788941,1,0,0,0.3508771929824561,0.01929629078749377,FZD4
tRNA modification (GO:0006400),1/58,0.9491734416512021,1,0,0,0.3448275862068965,0.017987494665677846,THG1L
cholesterol homeostasis (GO:0042632),1/58,0.9491734416512021,1,0,0,0.3448275862068965,0.017987494665677846,CYP39A1
sterol homeostasis (GO:0055092),1/58,0.9491734416512021,1,0,0,0.3448275862068965,0.017987494665677846,CYP39A1
sodium ion transport (GO:0006814),1/58,0.9491734416512021,1,0,0,0.3448275862068965,0.017987494665677846,SCN3A
proteolysis involved in cellular protein catabolic process (GO:0051603),2/93,0.9503836736321627,1,0,0,0.43010752688172044,0.021887960833825593,UBL4A;PSMA7
dephosphorylation (GO:0016311),3/124,0.9509542388487732,1,0,0,0.48387096774193544,0.024333549956038612,DUSP1;DUSP28;HDHD2
Fc-epsilon receptor signaling pathway (GO:0038095),5/182,0.9530841869588073,1,0,0,0.5494505494505494,0.026402219968743503,UBB;MAPK1;RAC1;CARD11;PSMA7
nucleosome assembly (GO:0006334),1/60,0.95414298697788,1,0,0,0.3333333333333333,0.015647245745596144,CABIN1
membrane lipid biosynthetic process (GO:0046467),1/60,0.95414298697788,1,0,0,0.3333333333333333,0.015647245745596144,ACER3
Fc receptor signaling pathway (GO:0038093),5/183,0.9545717676979407,1,0,0,0.5464480874316939,0.025405710303325155,UBB;MAPK1;RAC1;CARD11;PSMA7
regulation of cell death (GO:0010941),2/96,0.9563462737985303,1,0,0,0.41666666666666663,0.018598008511252703,UBB;BNIP3
regulation of vesicle fusion (GO:0031338),1/61,0.956442628953957,1,0,0,0.32786885245901637,0.014601466257298934,TBC1D22B
proteolysis (GO:0006508),9/291,0.9578154578835197,1,0,0,0.6185567010309279,0.026659887993880003,BACE1;SPCS3;NAPSA;CAPN9;HTRA1;FURIN;LAP3;F2;LRP8
regulation of mRNA stability (GO:0043488),3/128,0.9578577572454201,1,0,0,0.46875,0.02018249573547579,UBB;TNPO1;PSMA7
mRNA metabolic process (GO:0016071),2/97,0.9581767039032599,1,0,0,0.41237113402061853,0.017617759662583495,KIN;SNRPG
negative regulation of cell motility (GO:2000146),2/97,0.9581767039032599,1,0,0,0.41237113402061853,0.017617759662583495,PTPRJ;SRGAP3
regulation of actin filament-based process (GO:0032970),1/62,0.9586270516234485,1,0,0,0.3225806451612903,0.013630055718159003,CCDC88A
cellular protein catabolic process (GO:0044257),1/62,0.9586270516234485,1,0,0,0.3225806451612903,0.013630055718159003,BNIP3
response to molecule of bacterial origin (GO:0002237),2/98,0.9599334606764933,1,0,0,0.4081632653061224,0.01669033008887676,IRAK3;TNFRSF4
defense response to bacterium (GO:0042742),7/241,0.960039090830733,1,0,0,0.5809128630705394,0.023690367646265958,SPN;GNLY;DEFB126;RNASE7;SPACA3;DEFB134;LYPD8
oligosaccharide metabolic process (GO:0009311),1/63,0.9607020222041087,1,0,0,0.31746031746031744,0.012727297981234762,FUT8
negative regulation of dephosphorylation (GO:0035305),1/63,0.9607020222041087,1,0,0,0.31746031746031744,0.012727297981234762,RRP1B
ribosomal large subunit biogenesis (GO:0042273),1/63,0.9607020222041087,1,0,0,0.31746031746031744,0.012727297981234762,NOP53
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),13/396,0.9624198577544166,1,0,0,0.6565656565656566,0.025149406689352286,FOXC2;IRS1;ITGB3;PTPRJ;INS;UBB;RAPGEF1;PDK4;RAPGEF2;POLR2F;MAPK1;RAC1;PTPN2
regulation of lipid metabolic process (GO:0019216),2/100,0.9632369873558141,1,0,0,0.39999999999999997,0.014982321868347009,IRS1;PSAP
central nervous system development (GO:0007417),6/217,0.9632432419576695,1,0,0,0.5529953917050692,0.020709296613592415,DMBX1;NR4A2;SERPINI1;HSPG2;VCY;AFF2
protein oligomerization (GO:0051259),6/217,0.9632432419576695,1,0,0,0.5529953917050692,0.020709296613592415,PANX1;PRNP;GRHPR;ILDR1;LY6G6D;CAMK2G
O-glycan processing (GO:0016266),1/65,0.9645452489317999,1,0,0,0.3076923076923077,0.011107241028940524,C1GALT1
regulation of myeloid cell differentiation (GO:0045637),1/65,0.9645452489317999,1,0,0,0.3076923076923077,0.011107241028940524,KMT2D
fatty acid catabolic process (GO:0009062),1/65,0.9645452489317999,1,0,0,0.3076923076923077,0.011107241028940524,ECI1
protein targeting (GO:0006605),3/133,0.9652081031256262,1,0,0,0.45112781954887216,0.015975135331615462,SPCS3;SPCS2;TMEM50B
cellular response to organic substance (GO:0071310),3/133,0.9652081031256262,1,0,0,0.45112781954887216,0.015975135331615462,CCL3;MAPK1;PTPN2
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),3/133,0.9652081031256262,1,0,0,0.45112781954887216,0.015975135331615462,MAPK1;RAC1;PLD2
ion transmembrane transport (GO:0034220),6/219,0.9654559511064683,1,0,0,0.547945205479452,0.019262904677982636,RYR1;CLCN7;KCNE1;UBB;KCNIP2;ATP2B4
negative regulation of epithelial cell proliferation (GO:0050680),1/66,0.9663236546235302,1,0,0,0.30303030303030304,0.010380743845736572,PBLD
sphingolipid biosynthetic process (GO:0030148),1/66,0.9663236546235302,1,0,0,0.30303030303030304,0.010380743845736572,ACER3
Fc-gamma receptor signaling pathway (GO:0038094),3/134,0.9665252718637258,1,0,0,0.4477611940298507,0.015245298295546113,MAPK1;RAC1;PLD2
plasma membrane invagination (GO:0099024),2/103,0.9677062755799263,1,0,0,0.38834951456310673,0.01274822216284486,SCARB2;AURKB
Fc receptor mediated stimulatory signaling pathway (GO:0002431),3/135,0.9677952919812572,1,0,0,0.4444444444444444,0.014548750798032252,MAPK1;RAC1;PLD2
epidermal cell differentiation (GO:0009913),1/67,0.9680129340715097,1,0,0,0.29850746268656714,0.00970442691065804,PITX2
transmembrane transport (GO:0055085),12/378,0.9681986152959499,1,0,0,0.6349206349206349,0.020519385181881827,RYR1;CLCN7;MFSD14A;SVOPL;AZGP1;UBB;UCP2;ATP2B4;TAP1;ERLIN2;ABCB11;PSMA7
axonogenesis (GO:0007409),6/223,0.969519994924091,1,0,0,0.5381165919282511,0.016656958147475365,LINGO2;LYPLA2;LRFN2;LRFN5;MAPK1;LLGL1
negative regulation of phosphatase activity (GO:0010923),1/68,0.9696175495526317,1,0,0,0.2941176470588235,0.009074577660222398,RRP1B
cholesterol metabolic process (GO:0008203),1/68,0.9696175495526317,1,0,0,0.2941176470588235,0.009074577660222398,LBR
positive regulation of T cell activation (GO:0050870),1/68,0.9696175495526317,1,0,0,0.2941176470588235,0.009074577660222398,LILRB2
G1/S transition of mitotic cell cycle (GO:0000082),2/105,0.9703900668342258,1,0,0,0.380952380952381,0.011450345737401156,RPA3;TYMS
regulation of endocytosis (GO:0030100),1/69,0.9711417402987961,1,0,0,0.2898550724637681,0.00848778197469868,CBLL1
response to cytokine (GO:0034097),3/138,0.9713377151896119,1,0,0,0.43478260869565216,0.012643943360258838,IRAK2;IRAK3;PTPN2
fatty acid metabolic process (GO:0006631),2/106,0.9716500119085215,1,0,0,0.3773584905660377,0.010852682798281577,SCARB2;GPAM
ribosome biogenesis (GO:0042254),6/226,0.9722745936369446,1,0,0,0.5309734513274336,0.014929386199993113,RPS15;ZNF658;RPL15;RRP1B;RPL29;GNL3
cytoskeleton-dependent cytokinesis (GO:0061640),1/70,0.972589533427257,1,0,0,0.2857142857142857,0.007940897858985217,AURKB
ncRNA processing (GO:0034470),6/227,0.973140576025505,1,0,0,0.5286343612334802,0.014392985196507162,RPS15;SMAD2;RPL15;RRP1B;RPL29;THG1L
response to lipid (GO:0033993),3/140,0.9734908104308518,1,0,0,0.42857142857142855,0.011514383115519571,PAQR6;IRAK3;TNFRSF4
phosphatidylcholine metabolic process (GO:0046470),1/71,0.9739647545480367,1,0,0,0.28169014084507044,0.00743103163098366,DBI
rRNA metabolic process (GO:0016072),5/200,0.974082820759166,1,0,0,0.5,0.013129473687164658,TRIR;RPS15;RPL15;RRP1B;RPL29
negative regulation of protein kinase activity (GO:0006469),2/109,0.9751270159817813,1,0,0,0.3669724770642202,0.009243135290725672,SFN;DCN
regulation of phosphatase activity (GO:0010921),1/72,0.9752710378445755,1,0,0,0.27777777777777773,0.006955516411879717,RRP1B
apoptotic process (GO:0006915),6/231,0.9763607350904777,1,0,0,0.5194805194805194,0.012427613106955096,TP53AIP1;TCHP;BNIP3;BRCA1;AHR;ZNF385A
protein autophosphorylation (GO:0046777),4/175,0.9776183591008238,1,0,0,0.45714285714285713,0.010347845016468711,NEK6;EGFR;AURKB;TAF1
positive regulation of defense response (GO:0031349),1/74,0.9776904281936729,1,0,0,0.2702702702702703,0.00609789044447976,CCL3
negative regulation of phosphorylation (GO:0042326),1/75,0.9788099305759348,1,0,0,0.26666666666666666,0.005711413813620137,PRNP
purine ribonucleotide biosynthetic process (GO:0009152),1/75,0.9788099305759348,1,0,0,0.26666666666666666,0.005711413813620137,GUCY1B2
epithelium development (GO:0060429),2/115,0.9808862990126357,1,0,0,0.34782608695652173,0.0067126014891210894,SALL1;TST
peptidyl-tyrosine phosphorylation (GO:0018108),1/79,0.982754056231908,1,0,0,0.2531645569620253,0.004404148673065393,EGFR
cytosolic transport (GO:0016482),2/118,0.9832579796031666,1,0,0,0.3389830508474576,0.005723305818546954,CCDC91;RAB6A
"retrograde transport, endosome to Golgi (GO:0042147)",1/82,0.9852227825319085,1,0,0,0.24390243902439024,0.003631094688901337,RAB6A
ephrin receptor signaling pathway (GO:0048013),1/82,0.9852227825319085,1,0,0,0.24390243902439024,0.003631094688901337,RAC1
response to lipopolysaccharide (GO:0032496),3/155,0.9853816332969996,1,0,0,0.3870967741935484,0.0057004907906696945,IRAK3;LILRB2;TNFRSF4
positive regulation of homeostatic process (GO:0032846),1/83,0.9859645609779344,1,0,0,0.24096385542168675,0.0034059921056594548,GNL3
protein maturation (GO:0051604),1/83,0.9859645609779344,1,0,0,0.24096385542168675,0.0034059921056594548,FURIN
receptor-mediated endocytosis (GO:0006898),4/188,0.9861417530755054,1,0,0,0.42553191489361697,0.0059383697515552085,DNM3;NEDD4;M6PR;HSPG2
cellular response to molecule of bacterial origin (GO:0071219),1/84,0.9866691325855008,1,0,0,0.23809523809523808,0.00319536216504813,LILRB2
organic anion transport (GO:0015711),2/124,0.987173993434516,1,0,0,0.3225806451612903,0.004164183852806964,SLC4A9;SLC26A11
cell cycle G1/S phase transition (GO:0044843),1/92,0.99117152080333,1,0,0,0.21739130434782608,0.00192775676491022,RPA3
rRNA processing (GO:0006364),4/202,0.9918367365809941,1,0,0,0.396039603960396,0.003246243683774304,RPS15;RPL15;RRP1B;RPL29
regulation of B cell activation (GO:0050864),1/95,0.9924358915832194,1,0,0,0.21052631578947367,0.0015984971305800805,AHR
steroid metabolic process (GO:0008202),1/99,0.9938447802854349,1,0,0,0.20202020202020202,0.0012473214492474535,CYP39A1
response to endoplasmic reticulum stress (GO:0034976),1/106,0.9957088736018097,1,0,0,0.18867924528301885,8.113886235340445e-4,SYVN1
negative regulation of hydrolase activity (GO:0051346),1/108,0.9961291716353845,1,0,0,0.18518518518518517,7.182110017849846e-4,RRP1B
antigen receptor-mediated signaling pathway (GO:0050851),5/257,0.9966120679245654,1,0,0,0.38910505836575876,0.0013204996547304835,FYB2;UBB;PTPRJ;PSMA7;CARD11
axon guidance (GO:0007411),2/158,0.9972522129779103,1,0,0,0.2531645569620253,6.965997768865359e-4,LYPLA2;MAPK1
positive regulation of B cell activation (GO:0050871),1/119,0.9978042883455355,1,0,0,0.1680672268907563,3.694329014686676e-4,TNFRSF4
enzyme linked receptor protein signaling pathway (GO:0007167),1/120,0.9979145873773808,1,0,0,0.16666666666666666,3.479316872290341e-4,RAPGEF1
